{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": [],
      "gpuType": "A100",
      "authorship_tag": "ABX9TyPDA/bIiwWPz31d5nE5+j1D",
      "include_colab_link": true
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    },
    "accelerator": "GPU",
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "9ba0daab32a741e58814e7bd28980412": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "VBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "VBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "VBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_7da80a8b3cbb488f8e75d326561e27ee",
              "IPY_MODEL_0df6627b8279438290c3404b435fae4a",
              "IPY_MODEL_5b0884ee37ab4de183b9bf80a59f36d4",
              "IPY_MODEL_4ccffe8cb82244528041da37d4c2a204"
            ],
            "layout": "IPY_MODEL_249f6326856c4afe805da0c90a922dc2"
          }
        },
        "4e64565c8ada4ac2b5e4c1ad9fd828b7": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_89858661a160428c877e38a8be848ea8",
            "placeholder": "​",
            "style": "IPY_MODEL_29107f48c09747eaa1b3050dd7186c69",
            "value": "<center> <img\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.svg\nalt='Hugging Face'> <br> Copy a token from <a\nhref=\"https://huggingface.co/settings/tokens\" target=\"_blank\">your Hugging Face\ntokens page</a> and paste it below. <br> Immediately click login after copying\nyour token or it might be stored in plain text in this notebook file. </center>"
          }
        },
        "bb000665a2a144579b082861a3762f9e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "PasswordModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "PasswordModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "PasswordView",
            "continuous_update": true,
            "description": "Token:",
            "description_tooltip": null,
            "disabled": false,
            "layout": "IPY_MODEL_161a2852375444969f4bfb232790ce94",
            "placeholder": "​",
            "style": "IPY_MODEL_6c755e33d228451eb10ca6a95c504749",
            "value": ""
          }
        },
        "13fc61c082b4445e8b3b50438af0e63f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "CheckboxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "CheckboxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "CheckboxView",
            "description": "Add token as git credential?",
            "description_tooltip": null,
            "disabled": false,
            "indent": true,
            "layout": "IPY_MODEL_762e62799fee479f992db06e5d0540b7",
            "style": "IPY_MODEL_17d3d9165dd748978a909112132aedeb",
            "value": true
          }
        },
        "2ce149f2f3244584ac9eb1d180b443cf": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ButtonView",
            "button_style": "",
            "description": "Login",
            "disabled": false,
            "icon": "",
            "layout": "IPY_MODEL_a147b1a3e00c4d2683b0f73110121ef3",
            "style": "IPY_MODEL_851dcf2869604c37aa494f40da8e56f0",
            "tooltip": ""
          }
        },
        "43698abe228f415da200dbd44988b72b": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_28377122767b44b5b2d0f49c2059152e",
            "placeholder": "​",
            "style": "IPY_MODEL_d5d583143fbd4f6fbf8786bf7854d287",
            "value": "\n<b>Pro Tip:</b> If you don't already have one, you can create a dedicated\n'notebooks' token with 'write' access, that you can then easily reuse for all\nnotebooks. </center>"
          }
        },
        "249f6326856c4afe805da0c90a922dc2": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": "center",
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": "flex",
            "flex": null,
            "flex_flow": "column",
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": "50%"
          }
        },
        "89858661a160428c877e38a8be848ea8": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "29107f48c09747eaa1b3050dd7186c69": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "161a2852375444969f4bfb232790ce94": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6c755e33d228451eb10ca6a95c504749": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "762e62799fee479f992db06e5d0540b7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "17d3d9165dd748978a909112132aedeb": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a147b1a3e00c4d2683b0f73110121ef3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "851dcf2869604c37aa494f40da8e56f0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ButtonStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ButtonStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "button_color": null,
            "font_weight": ""
          }
        },
        "28377122767b44b5b2d0f49c2059152e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d5d583143fbd4f6fbf8786bf7854d287": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "484b9077d78e44e3a472acd5b46f2694": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_7309fb2e70684582a5aa09a0710c0466",
            "placeholder": "​",
            "style": "IPY_MODEL_59e9172f60294da5b6ed8aae9d6cd324",
            "value": "Connecting..."
          }
        },
        "7309fb2e70684582a5aa09a0710c0466": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "59e9172f60294da5b6ed8aae9d6cd324": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "7da80a8b3cbb488f8e75d326561e27ee": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_07348eb0e6074d80bd8c1818d4412931",
            "placeholder": "​",
            "style": "IPY_MODEL_0377e1bd18e94634ae2755947c0f0e25",
            "value": "Token is valid (permission: read)."
          }
        },
        "0df6627b8279438290c3404b435fae4a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c2cb4f2ee8804995bee76ef968c2287d",
            "placeholder": "​",
            "style": "IPY_MODEL_6940a9fda30f49e3bf6bda021137192c",
            "value": "Your token has been saved in your configured git credential helpers (store)."
          }
        },
        "5b0884ee37ab4de183b9bf80a59f36d4": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_0b1be3d9778c432aac56ebb9d6d1cf22",
            "placeholder": "​",
            "style": "IPY_MODEL_c3b1d55116a1443abecd474b32bef501",
            "value": "Your token has been saved to /root/.cache/huggingface/token"
          }
        },
        "4ccffe8cb82244528041da37d4c2a204": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "LabelModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "LabelModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "LabelView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_52fe37e22db5431db382622b59ee1a34",
            "placeholder": "​",
            "style": "IPY_MODEL_3a046c64d3734ac6994c5604e4a2f967",
            "value": "Login successful"
          }
        },
        "07348eb0e6074d80bd8c1818d4412931": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0377e1bd18e94634ae2755947c0f0e25": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "c2cb4f2ee8804995bee76ef968c2287d": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "6940a9fda30f49e3bf6bda021137192c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0b1be3d9778c432aac56ebb9d6d1cf22": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c3b1d55116a1443abecd474b32bef501": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "52fe37e22db5431db382622b59ee1a34": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3a046c64d3734ac6994c5604e4a2f967": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3930b751ddbd4594a9039e966c4ae6b0": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f35698f1ccae416785664023ccd6a035",
              "IPY_MODEL_a946b5dca31c4137882d67267be9f68f",
              "IPY_MODEL_5a6e173dad4c4b92b8c2c1e7151589b5"
            ],
            "layout": "IPY_MODEL_a0ec603503714f15b6153292e98e1ae9"
          }
        },
        "f35698f1ccae416785664023ccd6a035": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_09735bc39b9d4cdb8a2d6c797c3c7a48",
            "placeholder": "​",
            "style": "IPY_MODEL_8bbaf957be454fe69533c55dd4a93241",
            "value": "Fetching 3 files: 100%"
          }
        },
        "a946b5dca31c4137882d67267be9f68f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_5786cb8771794112ad3e8b41231105ca",
            "max": 3,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7a3d36e78efb4102b26b1624f4c0ae86",
            "value": 3
          }
        },
        "5a6e173dad4c4b92b8c2c1e7151589b5": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_eb9b2feeff514e8ead665b75f2c04d74",
            "placeholder": "​",
            "style": "IPY_MODEL_2c9e92ec51694b65876828e758285e67",
            "value": " 3/3 [01:13&lt;00:00, 73.35s/it]"
          }
        },
        "a0ec603503714f15b6153292e98e1ae9": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "09735bc39b9d4cdb8a2d6c797c3c7a48": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "8bbaf957be454fe69533c55dd4a93241": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "5786cb8771794112ad3e8b41231105ca": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7a3d36e78efb4102b26b1624f4c0ae86": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "eb9b2feeff514e8ead665b75f2c04d74": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "2c9e92ec51694b65876828e758285e67": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "0e1df0f2b3b3413398b3d51471e20769": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_f7628235027d453684ff5e5b3ae14b98",
              "IPY_MODEL_b0f54b7d765342d0ac761c00b2cea2c2",
              "IPY_MODEL_f8a1f0631dba4952bd51b2728dbbd83c"
            ],
            "layout": "IPY_MODEL_e5bd8c5c7eba4af0a04757ed3216b49e"
          }
        },
        "f7628235027d453684ff5e5b3ae14b98": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_c16fa26f216c453a88010e687743e17f",
            "placeholder": "​",
            "style": "IPY_MODEL_9143d9d8421b4b3788f806effcb0c53f",
            "value": "params.json: 100%"
          }
        },
        "b0f54b7d765342d0ac761c00b2cea2c2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_edccb3085447456eabd965c827d4461a",
            "max": 202,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_d7d7e291e9f341bab258264ef672fa36",
            "value": 202
          }
        },
        "f8a1f0631dba4952bd51b2728dbbd83c": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_26959868ba444071a3ed69f73d69a46b",
            "placeholder": "​",
            "style": "IPY_MODEL_806c260333bd4c4e9cbc58d6b183394a",
            "value": " 202/202 [00:00&lt;00:00, 7.87kB/s]"
          }
        },
        "e5bd8c5c7eba4af0a04757ed3216b49e": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "c16fa26f216c453a88010e687743e17f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "9143d9d8421b4b3788f806effcb0c53f": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "edccb3085447456eabd965c827d4461a": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "d7d7e291e9f341bab258264ef672fa36": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "26959868ba444071a3ed69f73d69a46b": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "806c260333bd4c4e9cbc58d6b183394a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "a0dc609811f540cca538ebc92c619366": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_201b1bf87814488286be43d8f5db6709",
              "IPY_MODEL_43a12101ee2840029d4a8063d0b365d8",
              "IPY_MODEL_dcedada82a8242f4a225a849a3aab5dd"
            ],
            "layout": "IPY_MODEL_08a33c341e4e41f18fb97b2e75112c30"
          }
        },
        "201b1bf87814488286be43d8f5db6709": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_68dae69e5172451493503e6c28464dd4",
            "placeholder": "​",
            "style": "IPY_MODEL_08cf250020374f97b4d6c17126037cf2",
            "value": "tokenizer.model.v3: 100%"
          }
        },
        "43a12101ee2840029d4a8063d0b365d8": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3de5fe0500464416877643cb30c76974",
            "max": 587404,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_a8146f2d1cf843cdb9b55ee8dbf4fe3e",
            "value": 587404
          }
        },
        "dcedada82a8242f4a225a849a3aab5dd": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_967240a248a04569a7a2f31281db45e7",
            "placeholder": "​",
            "style": "IPY_MODEL_667db14685454e109b706349297e4bd9",
            "value": " 587k/587k [00:00&lt;00:00, 2.67MB/s]"
          }
        },
        "08a33c341e4e41f18fb97b2e75112c30": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "68dae69e5172451493503e6c28464dd4": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "08cf250020374f97b4d6c17126037cf2": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3de5fe0500464416877643cb30c76974": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a8146f2d1cf843cdb9b55ee8dbf4fe3e": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "967240a248a04569a7a2f31281db45e7": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "667db14685454e109b706349297e4bd9": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "4568cd3754a9404aaa375e611ec7596d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_37bc614d471b4da99737be58504fc9e1",
              "IPY_MODEL_31118d1599a9471c9d3b6f31be694b37",
              "IPY_MODEL_5e49cd86f33f44aba05b20b63f440b1a"
            ],
            "layout": "IPY_MODEL_bb153c4fabc547d5ad6337741bdf6b7f"
          }
        },
        "37bc614d471b4da99737be58504fc9e1": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_345f8a0c102d48a3a5dcb7be4531a746",
            "placeholder": "​",
            "style": "IPY_MODEL_a40103c99537449ea3bea49e2768ea2a",
            "value": "consolidated.safetensors: 100%"
          }
        },
        "31118d1599a9471c9d3b6f31be694b37": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_ab5cca6111f94b36bd7f8a80dab2c8bb",
            "max": 14496078512,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_7e1597ea181b4d76bd0941e99229c520",
            "value": 14496078512
          }
        },
        "5e49cd86f33f44aba05b20b63f440b1a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_9522b17635d44738a50a44d6c5f47439",
            "placeholder": "​",
            "style": "IPY_MODEL_0eadd0e672c0481eb0f0de639d0ecf9d",
            "value": " 14.5G/14.5G [01:12&lt;00:00, 297MB/s]"
          }
        },
        "bb153c4fabc547d5ad6337741bdf6b7f": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "345f8a0c102d48a3a5dcb7be4531a746": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "a40103c99537449ea3bea49e2768ea2a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "ab5cca6111f94b36bd7f8a80dab2c8bb": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "7e1597ea181b4d76bd0941e99229c520": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "9522b17635d44738a50a44d6c5f47439": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "0eadd0e672c0481eb0f0de639d0ecf9d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "656cd828459a43a5965aac09083eea0d": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HBoxModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_e179f2528e7f479da26dc60907a00312",
              "IPY_MODEL_3e7dcafb21c2449ba583d86588a5659a",
              "IPY_MODEL_2de6888470c74a079393f581f9fa86e6"
            ],
            "layout": "IPY_MODEL_ad10d665429f4d82939a3b9e9b5ef525"
          }
        },
        "e179f2528e7f479da26dc60907a00312": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_4dcdcd0d283f460eac6fe4471af33da3",
            "placeholder": "​",
            "style": "IPY_MODEL_dab4b6513e2245e0b1b27c7e8072f847",
            "value": "Loading checkpoint shards: 100%"
          }
        },
        "3e7dcafb21c2449ba583d86588a5659a": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "FloatProgressModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_3712f702c37c4a679ba16e62234a8107",
            "max": 3,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_3c5fad19115143318de986107e85be15",
            "value": 3
          }
        },
        "2de6888470c74a079393f581f9fa86e6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "HTMLModel",
          "model_module_version": "1.5.0",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_beda73c8b00f4747af73ca06ceb44b65",
            "placeholder": "​",
            "style": "IPY_MODEL_efbb652bfcfd46aea706008a8c44f6a6",
            "value": " 3/3 [00:06&lt;00:00,  2.12s/it]"
          }
        },
        "ad10d665429f4d82939a3b9e9b5ef525": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "4dcdcd0d283f460eac6fe4471af33da3": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "dab4b6513e2245e0b1b27c7e8072f847": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "3712f702c37c4a679ba16e62234a8107": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "3c5fad19115143318de986107e85be15": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "ProgressStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "beda73c8b00f4747af73ca06ceb44b65": {
          "model_module": "@jupyter-widgets/base",
          "model_name": "LayoutModel",
          "model_module_version": "1.2.0",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "efbb652bfcfd46aea706008a8c44f6a6": {
          "model_module": "@jupyter-widgets/controls",
          "model_name": "DescriptionStyleModel",
          "model_module_version": "1.5.0",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        }
      }
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/SonnyDev/drepa_ai/blob/main/Mistral_Finetuning.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AT6D4rqmPkjR",
        "outputId": "9adce938-0261-4032-f1dd-045b24abdeca"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m9.1/9.1 MB\u001b[0m \u001b[31m77.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m302.6/302.6 kB\u001b[0m \u001b[31m2.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m21.3/21.3 MB\u001b[0m \u001b[31m73.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m119.8/119.8 MB\u001b[0m \u001b[31m12.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h"
          ]
        }
      ],
      "source": [
        "!pip install -q -U transformers\n",
        "!pip install -q -U accelerate\n",
        "!pip install -q -U bitsandbytes"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoTokenizer, AutoModelForCausalLM, BitsAndBytesConfig, pipeline\n",
        "import torch\n",
        "\n",
        "bnb_config = BitsAndBytesConfig(\n",
        "    load_in_4bit=True,\n",
        "    bnb_4bit_quant_type=\"nf4\",\n",
        "    bnb_4bit_use_double_quant=True,\n",
        ")"
      ],
      "metadata": {
        "id": "BzQd1gaBP2ej"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from huggingface_hub import notebook_login\n",
        "\n",
        "notebook_login()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 145,
          "referenced_widgets": [
            "9ba0daab32a741e58814e7bd28980412",
            "4e64565c8ada4ac2b5e4c1ad9fd828b7",
            "bb000665a2a144579b082861a3762f9e",
            "13fc61c082b4445e8b3b50438af0e63f",
            "2ce149f2f3244584ac9eb1d180b443cf",
            "43698abe228f415da200dbd44988b72b",
            "249f6326856c4afe805da0c90a922dc2",
            "89858661a160428c877e38a8be848ea8",
            "29107f48c09747eaa1b3050dd7186c69",
            "161a2852375444969f4bfb232790ce94",
            "6c755e33d228451eb10ca6a95c504749",
            "762e62799fee479f992db06e5d0540b7",
            "17d3d9165dd748978a909112132aedeb",
            "a147b1a3e00c4d2683b0f73110121ef3",
            "851dcf2869604c37aa494f40da8e56f0",
            "28377122767b44b5b2d0f49c2059152e",
            "d5d583143fbd4f6fbf8786bf7854d287",
            "484b9077d78e44e3a472acd5b46f2694",
            "7309fb2e70684582a5aa09a0710c0466",
            "59e9172f60294da5b6ed8aae9d6cd324",
            "7da80a8b3cbb488f8e75d326561e27ee",
            "0df6627b8279438290c3404b435fae4a",
            "5b0884ee37ab4de183b9bf80a59f36d4",
            "4ccffe8cb82244528041da37d4c2a204",
            "07348eb0e6074d80bd8c1818d4412931",
            "0377e1bd18e94634ae2755947c0f0e25",
            "c2cb4f2ee8804995bee76ef968c2287d",
            "6940a9fda30f49e3bf6bda021137192c",
            "0b1be3d9778c432aac56ebb9d6d1cf22",
            "c3b1d55116a1443abecd474b32bef501",
            "52fe37e22db5431db382622b59ee1a34",
            "3a046c64d3734ac6994c5604e4a2f967"
          ]
        },
        "id": "580huQYrUqxu",
        "outputId": "41723040-1e10-4437-acc9-fd79daf5fc96"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "VBox(children=(HTML(value='<center> <img\\nsrc=https://huggingface.co/front/assets/huggingface_logo-noborder.sv…"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "9ba0daab32a741e58814e7bd28980412"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from huggingface_hub import snapshot_download\n",
        "from pathlib import Path\n",
        "\n",
        "mistral_models_path = Path.home().joinpath('mistral_models', '7B-Instruct-v0.3')\n",
        "mistral_models_path.mkdir(parents=True, exist_ok=True)\n",
        "\n",
        "snapshot_download(repo_id=\"mistralai/Mistral-7B-Instruct-v0.3\", allow_patterns=[\"params.json\", \"consolidated.safetensors\", \"tokenizer.model.v3\"], local_dir=mistral_models_path)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 163,
          "referenced_widgets": [
            "3930b751ddbd4594a9039e966c4ae6b0",
            "f35698f1ccae416785664023ccd6a035",
            "a946b5dca31c4137882d67267be9f68f",
            "5a6e173dad4c4b92b8c2c1e7151589b5",
            "a0ec603503714f15b6153292e98e1ae9",
            "09735bc39b9d4cdb8a2d6c797c3c7a48",
            "8bbaf957be454fe69533c55dd4a93241",
            "5786cb8771794112ad3e8b41231105ca",
            "7a3d36e78efb4102b26b1624f4c0ae86",
            "eb9b2feeff514e8ead665b75f2c04d74",
            "2c9e92ec51694b65876828e758285e67",
            "0e1df0f2b3b3413398b3d51471e20769",
            "f7628235027d453684ff5e5b3ae14b98",
            "b0f54b7d765342d0ac761c00b2cea2c2",
            "f8a1f0631dba4952bd51b2728dbbd83c",
            "e5bd8c5c7eba4af0a04757ed3216b49e",
            "c16fa26f216c453a88010e687743e17f",
            "9143d9d8421b4b3788f806effcb0c53f",
            "edccb3085447456eabd965c827d4461a",
            "d7d7e291e9f341bab258264ef672fa36",
            "26959868ba444071a3ed69f73d69a46b",
            "806c260333bd4c4e9cbc58d6b183394a",
            "a0dc609811f540cca538ebc92c619366",
            "201b1bf87814488286be43d8f5db6709",
            "43a12101ee2840029d4a8063d0b365d8",
            "dcedada82a8242f4a225a849a3aab5dd",
            "08a33c341e4e41f18fb97b2e75112c30",
            "68dae69e5172451493503e6c28464dd4",
            "08cf250020374f97b4d6c17126037cf2",
            "3de5fe0500464416877643cb30c76974",
            "a8146f2d1cf843cdb9b55ee8dbf4fe3e",
            "967240a248a04569a7a2f31281db45e7",
            "667db14685454e109b706349297e4bd9",
            "4568cd3754a9404aaa375e611ec7596d",
            "37bc614d471b4da99737be58504fc9e1",
            "31118d1599a9471c9d3b6f31be694b37",
            "5e49cd86f33f44aba05b20b63f440b1a",
            "bb153c4fabc547d5ad6337741bdf6b7f",
            "345f8a0c102d48a3a5dcb7be4531a746",
            "a40103c99537449ea3bea49e2768ea2a",
            "ab5cca6111f94b36bd7f8a80dab2c8bb",
            "7e1597ea181b4d76bd0941e99229c520",
            "9522b17635d44738a50a44d6c5f47439",
            "0eadd0e672c0481eb0f0de639d0ecf9d"
          ]
        },
        "id": "RFSAka-VPsAA",
        "outputId": "0a250477-6bbc-46df-f03d-a6d316790ea1"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Fetching 3 files:   0%|          | 0/3 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3930b751ddbd4594a9039e966c4ae6b0"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "params.json:   0%|          | 0.00/202 [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "0e1df0f2b3b3413398b3d51471e20769"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "tokenizer.model.v3:   0%|          | 0.00/587k [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "a0dc609811f540cca538ebc92c619366"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "consolidated.safetensors:   0%|          | 0.00/14.5G [00:00<?, ?B/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "4568cd3754a9404aaa375e611ec7596d"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'/root/mistral_models/7B-Instruct-v0.3'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install mistral_inference mistral_common"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "collapsed": true,
        "id": "PrZgGSdxVQEJ",
        "outputId": "ff415043-95f7-4c23-c622-d8c578137b90"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting mistral_inference\n",
            "  Downloading mistral_inference-1.1.0-py3-none-any.whl (21 kB)\n",
            "Collecting mistral_common\n",
            "  Downloading mistral_common-1.1.0-py3-none-any.whl (703 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m703.9/703.9 kB\u001b[0m \u001b[31m19.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting fire>=0.6.0 (from mistral_inference)\n",
            "  Downloading fire-0.6.0.tar.gz (88 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m88.4/88.4 kB\u001b[0m \u001b[31m13.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: safetensors>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from mistral_inference) (0.4.3)\n",
            "Collecting simple-parsing>=0.1.5 (from mistral_inference)\n",
            "  Downloading simple_parsing-0.1.5-py3-none-any.whl (113 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m113.6/113.6 kB\u001b[0m \u001b[31m14.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting xformers>=0.0.24 (from mistral_inference)\n",
            "  Downloading xformers-0.0.26.post1-cp310-cp310-manylinux2014_x86_64.whl (222.7 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m222.7/222.7 MB\u001b[0m \u001b[31m7.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting jsonschema==4.21.1 (from mistral_common)\n",
            "  Downloading jsonschema-4.21.1-py3-none-any.whl (85 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m85.5/85.5 kB\u001b[0m \u001b[31m14.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hCollecting pydantic==2.6.1 (from mistral_common)\n",
            "  Downloading pydantic-2.6.1-py3-none-any.whl (394 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m394.8/394.8 kB\u001b[0m \u001b[31m43.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: sentencepiece==0.1.99 in /usr/local/lib/python3.10/dist-packages (from mistral_common) (0.1.99)\n",
            "Requirement already satisfied: typing-extensions<5.0.0,>=4.11.0 in /usr/local/lib/python3.10/dist-packages (from mistral_common) (4.11.0)\n",
            "Requirement already satisfied: attrs>=22.2.0 in /usr/local/lib/python3.10/dist-packages (from jsonschema==4.21.1->mistral_common) (23.2.0)\n",
            "Requirement already satisfied: jsonschema-specifications>=2023.03.6 in /usr/local/lib/python3.10/dist-packages (from jsonschema==4.21.1->mistral_common) (2023.12.1)\n",
            "Requirement already satisfied: referencing>=0.28.4 in /usr/local/lib/python3.10/dist-packages (from jsonschema==4.21.1->mistral_common) (0.35.1)\n",
            "Requirement already satisfied: rpds-py>=0.7.1 in /usr/local/lib/python3.10/dist-packages (from jsonschema==4.21.1->mistral_common) (0.18.1)\n",
            "Requirement already satisfied: annotated-types>=0.4.0 in /usr/local/lib/python3.10/dist-packages (from pydantic==2.6.1->mistral_common) (0.7.0)\n",
            "Collecting pydantic-core==2.16.2 (from pydantic==2.6.1->mistral_common)\n",
            "  Downloading pydantic_core-2.16.2-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.2 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.2/2.2 MB\u001b[0m \u001b[31m82.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: six in /usr/local/lib/python3.10/dist-packages (from fire>=0.6.0->mistral_inference) (1.16.0)\n",
            "Requirement already satisfied: termcolor in /usr/local/lib/python3.10/dist-packages (from fire>=0.6.0->mistral_inference) (2.4.0)\n",
            "Requirement already satisfied: docstring-parser~=0.15 in /usr/local/lib/python3.10/dist-packages (from simple-parsing>=0.1.5->mistral_inference) (0.16)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from xformers>=0.0.24->mistral_inference) (1.25.2)\n",
            "Requirement already satisfied: torch==2.3.0 in /usr/local/lib/python3.10/dist-packages (from xformers>=0.0.24->mistral_inference) (2.3.0+cu121)\n",
            "Requirement already satisfied: filelock in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (3.14.0)\n",
            "Requirement already satisfied: sympy in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (1.12)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (3.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (3.1.4)\n",
            "Requirement already satisfied: fsspec in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (2023.6.0)\n",
            "Requirement already satisfied: nvidia-cuda-nvrtc-cu12==12.1.105 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.105)\n",
            "Requirement already satisfied: nvidia-cuda-runtime-cu12==12.1.105 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.105)\n",
            "Requirement already satisfied: nvidia-cuda-cupti-cu12==12.1.105 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.105)\n",
            "Requirement already satisfied: nvidia-cudnn-cu12==8.9.2.26 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (8.9.2.26)\n",
            "Requirement already satisfied: nvidia-cublas-cu12==12.1.3.1 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.3.1)\n",
            "Requirement already satisfied: nvidia-cufft-cu12==11.0.2.54 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (11.0.2.54)\n",
            "Requirement already satisfied: nvidia-curand-cu12==10.3.2.106 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (10.3.2.106)\n",
            "Requirement already satisfied: nvidia-cusolver-cu12==11.4.5.107 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (11.4.5.107)\n",
            "Requirement already satisfied: nvidia-cusparse-cu12==12.1.0.106 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.0.106)\n",
            "Requirement already satisfied: nvidia-nccl-cu12==2.20.5 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (2.20.5)\n",
            "Requirement already satisfied: nvidia-nvtx-cu12==12.1.105 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.1.105)\n",
            "Requirement already satisfied: triton==2.3.0 in /usr/local/lib/python3.10/dist-packages (from torch==2.3.0->xformers>=0.0.24->mistral_inference) (2.3.0)\n",
            "Requirement already satisfied: nvidia-nvjitlink-cu12 in /usr/local/lib/python3.10/dist-packages (from nvidia-cusolver-cu12==11.4.5.107->torch==2.3.0->xformers>=0.0.24->mistral_inference) (12.5.40)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->torch==2.3.0->xformers>=0.0.24->mistral_inference) (2.1.5)\n",
            "Requirement already satisfied: mpmath>=0.19 in /usr/local/lib/python3.10/dist-packages (from sympy->torch==2.3.0->xformers>=0.0.24->mistral_inference) (1.3.0)\n",
            "Building wheels for collected packages: fire\n",
            "  Building wheel for fire (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for fire: filename=fire-0.6.0-py2.py3-none-any.whl size=117029 sha256=c98bd12dd90c59208afd184c0f68be9d58b62127e9130a899f89ccdde60026ee\n",
            "  Stored in directory: /root/.cache/pip/wheels/d6/6d/5d/5b73fa0f46d01a793713f8859201361e9e581ced8c75e5c6a3\n",
            "Successfully built fire\n",
            "Installing collected packages: simple-parsing, pydantic-core, fire, pydantic, jsonschema, xformers, mistral_common, mistral_inference\n",
            "  Attempting uninstall: pydantic-core\n",
            "    Found existing installation: pydantic_core 2.18.2\n",
            "    Uninstalling pydantic_core-2.18.2:\n",
            "      Successfully uninstalled pydantic_core-2.18.2\n",
            "  Attempting uninstall: pydantic\n",
            "    Found existing installation: pydantic 2.7.1\n",
            "    Uninstalling pydantic-2.7.1:\n",
            "      Successfully uninstalled pydantic-2.7.1\n",
            "  Attempting uninstall: jsonschema\n",
            "    Found existing installation: jsonschema 4.19.2\n",
            "    Uninstalling jsonschema-4.19.2:\n",
            "      Successfully uninstalled jsonschema-4.19.2\n",
            "Successfully installed fire-0.6.0 jsonschema-4.21.1 mistral_common-1.1.0 mistral_inference-1.1.0 pydantic-2.6.1 pydantic-core-2.16.2 simple-parsing-0.1.5 xformers-0.0.26.post1\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from mistral_inference.model import Transformer\n",
        "from mistral_inference.generate import generate\n",
        "\n",
        "from mistral_common.tokens.tokenizers.mistral import MistralTokenizer\n",
        "from mistral_common.protocol.instruct.messages import UserMessage\n",
        "from mistral_common.protocol.instruct.request import ChatCompletionRequest\n",
        "\n",
        "\n",
        "tokenizer = MistralTokenizer.from_file(f\"{mistral_models_path}/tokenizer.model.v3\")\n",
        "model = Transformer.from_folder(mistral_models_path)\n",
        "\n",
        "completion_request = ChatCompletionRequest(messages=[UserMessage(content=\"What is the consequence of replacing an adenine with a thymine in the DNA strand corresponding to the glutamate codon\")])\n",
        "\n",
        "tokens = tokenizer.encode_chat_completion(completion_request).tokens\n",
        "\n",
        "out_tokens, _ = generate([tokens], model, max_tokens=64, temperature=0.0, eos_id=tokenizer.instruct_tokenizer.tokenizer.eos_id)\n",
        "result = tokenizer.instruct_tokenizer.tokenizer.decode(out_tokens[0])\n",
        "\n",
        "print(result)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "iCIA0GQVTq11",
        "outputId": "dfbc314a-bfcf-4f13-d956-17f1c4e8a9ec"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "The DNA codon for the amino acid glutamate is GAA or GAG. Replacing an adenine (A) with a thymine (T) would not occur in DNA, as DNA strands have adenine paired with thymine (A-T), and\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "### Ablation study\n",
        "\n",
        "# Question 1. What are some of the challenges faced by sickle cells (drépanocytes) in the bloodstream\n",
        "# Question 2. What is the consequence of replacing an adenine with a thymine in the DNA strand corresponding to the glutamate codon\n"
      ],
      "metadata": {
        "id": "zsS5EicCVcMT"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "%%capture\n",
        "%pip install -U bitsandbytes\n",
        "%pip install -U transformers\n",
        "%pip install -U peft\n",
        "%pip install -U accelerate\n",
        "%pip install -U trl"
      ],
      "metadata": {
        "id": "ZFSzMYWBbZdb"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import AutoModelForCausalLM, AutoTokenizer, BitsAndBytesConfig,HfArgumentParser,TrainingArguments,pipeline, logging\n",
        "from peft import LoraConfig, PeftModel, prepare_model_for_kbit_training, get_peft_model\n",
        "import os,torch\n",
        "from datasets import load_dataset\n",
        "from trl import SFTTrainer"
      ],
      "metadata": {
        "id": "WkFgdbe5bTCm"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "dataset_name = \"sonny-dev/drepa_instruct_dataset\"\n",
        "base_model = \"mistralai/Mistral-7B-Instruct-v0.3\"\n",
        "new_model = \"mistral_7b_drepa\""
      ],
      "metadata": {
        "id": "6gghbtT6ZUCb"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "#Importing the dataset\n",
        "dataset = load_dataset(dataset_name, split=\"train\")"
      ],
      "metadata": {
        "id": "UgHi6KjGbMII"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "dataset[\"messages\"][0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "af47lYc3b63A",
        "outputId": "1f7795fd-2a6f-407f-b3be-4b8af0244623"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[{'content': \"What is sickle cell disease and how does it affect the delivery of oxygen to the body's tissues?\",\n",
              "  'role': 'user'},\n",
              " {'content': 'Sickle cell disease is an inherited blood disorder marked by flawed hemoglobin. It interferes with the delivery of oxygen to the tissues because red blood cells with sickle cell hemoglobin are stiff, sticky, and form into a sickle or crescent shape when they lose their oxygen. These cells stick together, block small blood vessels, and impede the movement of healthy, normal oxygen-carrying blood, causing pain.',\n",
              "  'role': 'assistant'}]"
            ]
          },
          "metadata": {},
          "execution_count": 22
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "bnb_config = BitsAndBytesConfig(\n",
        "    load_in_4bit= True,\n",
        "    bnb_4bit_quant_type= \"nf4\",\n",
        "    bnb_4bit_compute_dtype= torch.bfloat16,\n",
        "    bnb_4bit_use_double_quant= False,\n",
        ")\n",
        "model = AutoModelForCausalLM.from_pretrained(\n",
        "        base_model,\n",
        "        quantization_config=bnb_config,\n",
        "        torch_dtype=torch.bfloat16,\n",
        "        device_map=\"auto\",\n",
        "        trust_remote_code=True,\n",
        ")\n",
        "model.config.use_cache = False # silence the warnings\n",
        "model.config.pretraining_tp = 1\n",
        "model.gradient_checkpointing_enable()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 49,
          "referenced_widgets": [
            "656cd828459a43a5965aac09083eea0d",
            "e179f2528e7f479da26dc60907a00312",
            "3e7dcafb21c2449ba583d86588a5659a",
            "2de6888470c74a079393f581f9fa86e6",
            "ad10d665429f4d82939a3b9e9b5ef525",
            "4dcdcd0d283f460eac6fe4471af33da3",
            "dab4b6513e2245e0b1b27c7e8072f847",
            "3712f702c37c4a679ba16e62234a8107",
            "3c5fad19115143318de986107e85be15",
            "beda73c8b00f4747af73ca06ceb44b65",
            "efbb652bfcfd46aea706008a8c44f6a6"
          ]
        },
        "id": "edtSo4v8bwKg",
        "outputId": "bb32369e-06dd-496c-d914-b2bcce28c220"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "Loading checkpoint shards:   0%|          | 0/3 [00:00<?, ?it/s]"
            ],
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "656cd828459a43a5965aac09083eea0d"
            }
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "tokenizer = AutoTokenizer.from_pretrained(base_model, trust_remote_code=True)\n",
        "tokenizer.padding_side = 'right'\n",
        "tokenizer.pad_token = tokenizer.eos_token\n",
        "tokenizer.add_eos_token = True\n",
        "tokenizer.add_bos_token, tokenizer.add_eos_token"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "IYSUmN1ncbvk",
        "outputId": "19126ac9-6f4a-4d6e-fef7-0d395e5cfda6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(True, True)"
            ]
          },
          "metadata": {},
          "execution_count": 54
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Prepare the model for k-bit training\n",
        "model = prepare_model_for_kbit_training(model)\n",
        "\n",
        "# Create a PEFT configuration with Lora\n",
        "peft_config = LoraConfig(\n",
        "    lora_alpha=16,\n",
        "    lora_dropout=0.1,\n",
        "    r=64,\n",
        "    bias=\"none\",\n",
        "    task_type=\"CAUSAL_LM\",  # Use the appropriate task type\n",
        "    target_modules=[\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\", \"gate_proj\"]\n",
        ")"
      ],
      "metadata": {
        "id": "CtrcDdcPc-3b"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def print_trainable_parameters(model):\n",
        "    \"\"\"\n",
        "    Prints the number of trainable parameters in the model.\n",
        "    \"\"\"\n",
        "    trainable_params = 0\n",
        "    all_param = 0\n",
        "    for _, param in model.named_parameters():\n",
        "        all_param += param.numel()\n",
        "        if param.requires_grad:\n",
        "            trainable_params += param.numel()\n",
        "    print(\n",
        "        f\"trainable params: {trainable_params} || all params: {all_param} || trainable%: {100 * trainable_params / all_param}\"\n",
        "    )"
      ],
      "metadata": {
        "id": "47LTIMtTlJF9"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "from peft import LoraConfig, get_peft_model\n",
        "\n",
        "config = LoraConfig(\n",
        "    r=32,\n",
        "    lora_alpha=64,\n",
        "    target_modules=[\n",
        "        \"q_proj\",\n",
        "        \"k_proj\",\n",
        "        \"v_proj\",\n",
        "        \"o_proj\",\n",
        "        \"gate_proj\",\n",
        "        \"up_proj\",\n",
        "        \"down_proj\",\n",
        "        \"lm_head\",\n",
        "    ],\n",
        "    bias=\"none\",\n",
        "    lora_dropout=0.05,  # Conventional\n",
        "    task_type=\"CAUSAL_LM\",\n",
        ")\n",
        "\n",
        "model = get_peft_model(model, config)\n",
        "print_trainable_parameters(model)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "1FrAS7AqlFhl",
        "outputId": "ade1d9bd-0f43-4ced-fe4f-0f50b8f13116"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "trainable params: 85065728 || all params: 3843428352 || trainable%: 2.213277319342624\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import transformers\n",
        "from datetime import datetime\n",
        "\n",
        "project = \"chat-doctor-finetune\"\n",
        "base_model_name = \"mistral\"\n",
        "run_name = base_model_name + \"-\" + project\n",
        "output_dir = \"./\" + run_name\n",
        "\n",
        "trainer = transformers.Trainer(\n",
        "    model=model,\n",
        "    train_dataset=train_dataset,\n",
        "    args=transformers.TrainingArguments(\n",
        "        output_dir=output_dir,\n",
        "        warmup_steps=1,\n",
        "        per_device_train_batch_size=4,\n",
        "        gradient_accumulation_steps=1,\n",
        "        gradient_checkpointing=True,\n",
        "        max_steps=500,\n",
        "        learning_rate=2.5e-4, # Want a small lr for finetuning\n",
        "        #bf16=True,\n",
        "        optim=\"paged_adamw_8bit\",\n",
        "        logging_steps=25,              # When to start reporting loss\n",
        "        logging_dir=\"./logs\",        # Directory for storing logs\n",
        "        save_strategy=\"steps\",       # Save the model checkpoint every logging step\n",
        "        save_steps=25,                # Save checkpoints every 50 steps\n",
        "        evaluation_strategy=\"steps\", # Evaluate the model every logging step\n",
        "        eval_steps=25,               # Evaluate and save checkpoints every 50 steps\n",
        "        do_eval=True,                # Perform evaluation at the end of training\n",
        "    ),\n",
        "    data_collator=transformers.DataCollatorForLanguageModeling(tokenizer, mlm=False),\n",
        ")\n"
      ],
      "metadata": {
        "id": "a2fSuT3jk1sz"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "model.config.use_cache = False  # silence the warnings. Please re-enable for inference!\n",
        "trainer.train(resume_from_checkpoint=True)"
      ],
      "metadata": {
        "id": "ikc7nqR6lkxc"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "training_arguments = TrainingArguments(\n",
        "    output_dir=\"./results\",\n",
        "    num_train_epochs=1,\n",
        "    per_device_train_batch_size=4,\n",
        "    gradient_accumulation_steps=1,\n",
        "    optim=\"paged_adamw_32bit\",\n",
        "    save_steps=25,\n",
        "    logging_steps=25,\n",
        "    learning_rate=2e-4,\n",
        "    weight_decay=0.001,\n",
        "    fp16=False,\n",
        "    bf16=False,\n",
        "    max_grad_norm=0.3,\n",
        "    max_steps=-1,\n",
        "    warmup_ratio=0.03,\n",
        "    group_by_length=True,\n",
        "    lr_scheduler_type=\"constant\",\n",
        ")"
      ],
      "metadata": {
        "id": "x4lIjo60dGEd"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "import pandas as pd"
      ],
      "metadata": {
        "id": "s1LqCA_2fu1W"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "# Create a DataFrame\n",
        "df = pd.DataFrame(dataset)"
      ],
      "metadata": {
        "id": "D7YxaSg-fnoJ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def concatenate_messages(messages):\n",
        "    conversation = \"\"\n",
        "    for msg in messages:\n",
        "        conversation += f\"{msg['role']}: {msg['content']} \"\n",
        "    return conversation.strip()\n",
        "\n",
        "# Apply the function to the messages column\n",
        "df['text'] = df['messages'].apply(concatenate_messages)\n",
        "\n",
        "# Check the processed DataFrame\n",
        "print(df['text'].head())"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lcr9HD5lfyS5",
        "outputId": "3bd2c868-640b-4cc3-8c76-3ea4d54dfad8"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "0    user: What is sickle cell disease and how does...\n",
            "1    user: How is sickle cell disease inherited? as...\n",
            "2    user: How is sickle cell disease inherited? as...\n",
            "3    user: What is the chance of parents who are ca...\n",
            "4    user: What are some symptoms and complications...\n",
            "Name: text, dtype: object\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "\n",
        "# Function to extract user inputs and assistant responses\n",
        "def extract_conversations(messages):\n",
        "    user_inputs = []\n",
        "    assistant_responses = []\n",
        "    for conversation in messages:\n",
        "        if isinstance(conversation, list):\n",
        "            print(\"Processing conversation:\", conversation)\n",
        "            for i in range(len(conversation) - 1):\n",
        "                try:\n",
        "                    if conversation[i]['role'] == 'user' and conversation[i + 1]['role'] == 'assistant':\n",
        "                        user_inputs.append(conversation[i]['content'])\n",
        "                        assistant_responses.append(conversation[i + 1]['content'])\n",
        "                except KeyError as e:\n",
        "                    print(f\"KeyError encountered: {e} in message: {conversation[i]}\")\n",
        "        else:\n",
        "            print(f\"Unexpected data format: {conversation}\")\n",
        "    return user_inputs, assistant_responses\n",
        "\n",
        "# Apply the function to the messages column\n",
        "user_inputs, assistant_responses = extract_conversations(df['messages'])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "n1fsPbf1gjxQ",
        "outputId": "aaa98ffb-c18e-4370-c003-35a64233e62b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Processing conversation: [{'content': \"What is sickle cell disease and how does it affect the delivery of oxygen to the body's tissues?\", 'role': 'user'}, {'content': 'Sickle cell disease is an inherited blood disorder marked by flawed hemoglobin. It interferes with the delivery of oxygen to the tissues because red blood cells with sickle cell hemoglobin are stiff, sticky, and form into a sickle or crescent shape when they lose their oxygen. These cells stick together, block small blood vessels, and impede the movement of healthy, normal oxygen-carrying blood, causing pain.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is sickle cell disease inherited?', 'role': 'user'}, {'content': 'Sickle cell disease is inherited when a person receives a defective gene from both their mother and father.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is sickle cell disease inherited?', 'role': 'user'}, {'content': 'Sickle cell disease is inherited when a person inherits two genes—one from the mother and one from the father.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the chance of parents who are carriers of a sickle cell gene having a child with sickle cell disease?', 'role': 'user'}, {'content': 'There is a 1 in 4, or a 25% chance of having a child with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms and complications associated with sickle cell disease?', 'role': 'user'}, {'content': 'Some symptoms and complications associated with sickle cell disease include anemia, pain crisis (or sickle crisis), and tissue death due to interruption in blood flow.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is acute chest syndrome in sickle cell disease and how does it occur?', 'role': 'user'}, {'content': \"Acute chest syndrome occurs when sickling of cells happens in the chest, blocking the flow of oxygen in the lungs' tiny vessels. It can be life-threatening and is often triggered by infection, fever, or dehydration.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is splenic sequestration and how can it affect individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Splenic sequestration is when sickle cells pool in the spleen, causing a sudden drop in hemoglobin and potentially life-threatening complications. It can lead to an enlarged and painful spleen, which can become permanently damaged over time.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is priapism and how is it related to sickle cell disease?', 'role': 'user'}, {'content': 'Priapism is a painful obstruction of the blood vessels in the penis by sickle cells. If not promptly treated, it can result in impotence. It is related to sickle cell disease because the misshapen cells can block blood vessels throughout the body, including in the penis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is hemoglobin electrophoresis and how is it used in diagnosing sickle cell disease?', 'role': 'user'}, {'content': 'Hemoglobin electrophoresis is a blood test that can determine if a person is a carrier of sickle cell, or has any of the diseases associated with the sickle cell gene. It is used in diagnosing sickle cell disease by identifying the presence of abnormal hemoglobin molecules in the blood.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is early diagnosis and treatment important in sickle cell disease?', 'role': 'user'}, {'content': 'Early diagnosis and treatment can reduce the risk of complications and prevent organ damage, strokes, infections, and treat symptoms.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of drinking plenty of water daily in sickle cell disease treatment?', 'role': 'user'}, {'content': 'To prevent and treat pain crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the complications of sickle cell disease?', 'role': 'user'}, {'content': 'Complications of sickle cell disease include severe anemia, pain crises, acute chest syndrome, retinopathy, and the need for blood transfusions. In some cases, bone marrow transplants may be considered as a treatment option.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some complications of sickle cell disease?', 'role': 'user'}, {'content': 'Some complications of sickle cell disease include increased infections, leg ulcers, bone damage, early gallstones, kidney damage, eye damage, and multiple organ failure.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the problems that may be caused by sickle cell disease?', 'role': 'user'}, {'content': 'Some problems that may be caused by sickle cell disease include increased infections, leg ulcers, bone damage, early gallstones, kidney damage, eye damage, and multiple organ failure.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some factors that may trigger a crisis for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some factors that may trigger a crisis for individuals with sickle cell disease include high altitudes, cold weather, swimming in cold water, and heavy physical labor.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some tips to help you get the most from a visit to your health care provider?', 'role': 'user'}, {'content': 'Some tips to help you get the most from a visit to your health care provider include writing down questions you want answered before your visit and bringing someone with you to help you ask questions and remember what your provider tells you.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some tips to help you get the most from a visit to your health care provider?', 'role': 'user'}, {'content': 'Some tips to help you get the most from a visit to your health care provider include writing down questions you want answered, bringing someone with you to help ask questions and remember information, writing down the names of new medicines or treatments, noting any new instructions given by your provider, writing down follow-up appointment details, and knowing how to contact your provider with questions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What should you do at a visit with your healthcare provider according to the text?', 'role': 'user'}, {'content': 'At the visit, write down the names of new medicines, treatments, or tests, and any new instructions your provider gives you.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatment centers mentioned in the text?', 'role': 'user'}, {'content': 'Howard County Medical Center, Sibley Memorial Hospital, Suburban Hospital', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the phone number provided at the beginning of the text?', 'role': 'user'}, {'content': '+1-410-502-7683', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the average life expectancy of publicly insured individuals living with sickle cell disease according to the new study?', 'role': 'user'}, {'content': 'The average life expectancy of publicly insured individuals living with sickle cell disease is roughly 52.6 years.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How did those insured by Medicare for disabilities or end-stage renal disease and those dually insured by Medicare and Medicaid fare in terms of survival outcomes among the populations studied?', 'role': 'user'}, {'content': 'They had worse survival outcomes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How many people in the United States are estimated to be affected by SCD?', 'role': 'user'}, {'content': 'An estimated 100,000 people are affected by SCD in the United States.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What percentage of the study population were dually eligible for both Medicare and Medicaid?', 'role': 'user'}, {'content': '43%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the average life expectancy for publicly insured individuals with SCD according to the study?', 'role': 'user'}, {'content': '52.6 years', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the care transforming medical interventions for Sickle Cell Disease (SCD) mentioned in the text?', 'role': 'user'}, {'content': 'Newborn screening, pneumococcal vaccination, and prophylactic antibiotics', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the medical interventions that have improved the life expectancy of children diagnosed with sickle cell disease?', 'role': 'user'}, {'content': 'Newborn screening, pneumococcal vaccination, and prophylactic antibiotics', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did Dr. Jiao emphasize regarding the high cost of gene therapies for sickle cell disease?', 'role': 'user'}, {'content': 'Dr. Jiao emphasized the importance of understanding the long-term effects and value of gene therapies to justify their high prices.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to Dr. Jiao, why is it important to understand the long-term benefits of gene therapies for diseases like beta thalassemia?', 'role': 'user'}, {'content': 'It is important to understand the long-term benefits of gene therapies for diseases like beta thalassemia because of the high cost associated with these therapies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the press release by the American Society of Hematology regarding sickle cell disease?', 'role': 'user'}, {'content': 'Quantifying the Life Expectancy Gap for People Living with Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the press release from the American Society of Hematology regarding sickle cell disease?', 'role': 'user'}, {'content': 'Quantifying the Life Expectancy Gap for People Living with Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main topic of the text?', 'role': 'user'}, {'content': 'The main topic of the text is Sickle Cell Disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell disease and how does it affect red blood cells?', 'role': 'user'}, {'content': \"Sickle cell disease is a group of inherited red blood cell disorders that affect hemoglobin, the protein that carries oxygen through the body. In sickle cell disease, red blood cells become crescent- or 'sickle'-shaped due to a genetic mutation. These sickled red blood cells do not bend or move easily and can block blood flow to the rest of the body.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell disease and how does it affect red blood cells?', 'role': 'user'}, {'content': \"Sickle cell disease is a group of inherited red blood cell disorders that cause red blood cells to become crescent- or 'sickle'-shaped due to a genetic mutation. These sickled red blood cells do not bend or move easily, leading to blocked blood flow and various health problems.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some serious problems that can result from blocked blood flow in the body?', 'role': 'user'}, {'content': 'Some serious problems that can result from blocked blood flow in the body include stroke, eye problems, infections, and episodes of pain called pain crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the estimated number of people affected by sickle cell disease in the United States and worldwide?', 'role': 'user'}, {'content': 'More than 100,000 people in the United States and 20 million people worldwide are affected by sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some recommendations to reduce the chances of experiencing a painful episode (sickle cell crisis) for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some recommendations include drinking plenty of fluids to avoid dehydration, wearing warm clothing to prevent getting cold, and avoiding sudden temperature changes such as swimming in cold water.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some self-help measures that can be taken to manage a sickle cell crisis at home?', 'role': 'user'}, {'content': 'Some self-help measures that can be taken to manage a sickle cell crisis at home include drinking plenty of fluids, wearing warm clothing, and avoiding sudden temperature changes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a medicine that may be recommended for episodes of pain in sickle cell disease?', 'role': 'user'}, {'content': 'Hydroxycarbamide (hydroxyurea)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some ways to manage a sickle cell crisis at home?', 'role': 'user'}, {'content': 'Some ways to manage a sickle cell crisis at home include taking over-the-counter painkillers, staying hydrated, using a warm towel or heated pad, and finding distractions to take your mind off the pain.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is recommended if the measures for pain relief do not work or if the pain is particularly severe for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Contact your GP or go to your local A&E', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What caution should be taken when considering taking iron supplements to treat anaemia caused by sickle cell disease?', 'role': 'user'}, {'content': 'Do not take iron supplements to treat it without seeking medical advice, as they could be dangerous.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the only cure for sickle cell disease?', 'role': 'user'}, {'content': 'Stem cell or bone marrow transplants', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main risk associated with a stem cell transplant for sickle cell disease?', 'role': 'user'}, {'content': 'The main risk is graft versus host disease, a life-threatening problem where the transplanted cells start to attack the other cells in your body.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main risk associated with a stem cell transplant?', 'role': 'user'}, {'content': 'The main risk associated with a stem cell transplant is graft versus host disease, where the transplanted cells start to attack the other cells in the body.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can gallstones be treated in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Gallstones may be treated with gallbladder removal surgery.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What treatment options are mentioned for leg ulcers in the text?', 'role': 'user'}, {'content': 'Cleaning the ulcer and dressing it with a bandage', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What causes sickle cell disease?', 'role': 'user'}, {'content': 'A genetic mutation causes abnormal hemoglobin to clump together, causing the red blood cells to turn sickle shaped.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common inherited blood disorder that affects red blood cells?', 'role': 'user'}, {'content': 'Sickle cell disease (SCD)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the abnormal form of hemoglobin that causes red blood cells to change shape in sickle cell disease?', 'role': 'user'}, {'content': 'Hemoglobin S', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between Hemoglobin SS (HbSS) and Hemoglobin SC (HbSC) in sickle cell disease?', 'role': 'user'}, {'content': 'HbSS is a severe form where a person inherits one gene encoded with hemoglobin S from each parent, while HbSC is a mild to moderate form where a person inherits a hemoglobin S gene from one parent and hemoglobin C from the other parent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the two subtypes of Hemoglobin (HbS) beta thalassemia and how do they differ in severity?', 'role': 'user'}, {'content': \"The two subtypes are 'Plus' (HbS beta +) and 'Zero' (HbS beta 0). The 'Plus' subtype tends to be more mild, affecting about 8% of people with SCD, while the 'Zero' subtype is more severe, affecting about 2% of people with SCD and is similar to hemoglobin SS disease.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between sickle cell anemia and sickle cell disease?', 'role': 'user'}, {'content': \"Sickle cell disease is an umbrella term for the many different types of sickle cell disorders, while healthcare providers reserve the term 'sickle cell anemia' for the types of SCD that cause the most severe anemia, such as hemoglobin SS and hemoglobin beta zero thalassemia.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between sickle cell anemia and sickle cell disease?', 'role': 'user'}, {'content': 'Sickle cell disease is an umbrella term for the many different types of sickle cell disorders, while sickle cell anemia specifically refers to the types of SCD that cause the most severe anemia, such as hemoglobin SS and hemoglobin beta zero thalassemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What causes sickle cell disease?', 'role': 'user'}, {'content': 'A genetic mutation in the HBB gene causes sickle cell disease. People with SCD receive two mutated HBB genes coded for abnormal hemoglobin — one from each parent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What causes sickle cell disease?', 'role': 'user'}, {'content': 'A genetic mutation in the HBB gene causes sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who is at risk of developing sickle cell disease (SCD)?', 'role': 'user'}, {'content': 'Certain groups of people at risk of developing SCD include those of African descent, Hispanic Americans from South America and Central America, and people of Mediterranean, Middle Eastern, Indian, and Asian descent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the complications of sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Some of the complications of sickle cell disease mentioned in the text are frequent pain episodes, anemia, jaundice, and painful swelling of hands and feet.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common complication of sickle cell disease?', 'role': 'user'}, {'content': 'Pain', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is anemia and how does it affect the body?', 'role': 'user'}, {'content': 'Anemia occurs when you don’t have enough healthy red blood cells to carry oxygen throughout your body. It can cause severe fatigue, along with jaundice, irritability, dizziness, and lightheadedness.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can sickled cells affect blood flow in the body?', 'role': 'user'}, {'content': 'Sickled cells can block blood flow in blood vessels, increasing the chances of developing blood clots in deep veins, causing strokes, vision problems, and other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some potential complications of sickle cell disease related to vision?', 'role': 'user'}, {'content': 'Sickled cells can block blood flow in the blood vessels in the eyes, leading to vision loss and potential permanent blindness.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the risks associated with pregnancy for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some risks associated with pregnancy for individuals with sickle cell disease include high blood pressure, blood clots, miscarriage, low birth weight, and premature birth.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is sickle cell disease diagnosed?', 'role': 'user'}, {'content': 'Sickle cell disease is diagnosed through routine newborn screenings in the United States, which includes a blood test to check for various conditions and a hemoglobin electrophoresis to confirm the diagnosis. Prenatal testing such as chorionic villus sampling and amniocentesis can also be used to diagnose the disease before birth.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can cure sickle cell disease?', 'role': 'user'}, {'content': 'A bone marrow transplant (stem cell transplant) can cure sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one potential treatment for sickle cell disease that can cure the condition?', 'role': 'user'}, {'content': 'A bone marrow transplant (stem cell transplant)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the medications used to treat sickle cell disease?', 'role': 'user'}, {'content': 'Some medications used to treat sickle cell disease include Voxelotor and Crizanlizumab.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How does Voxelotor improve blood flow and lower the risk for anemia?', 'role': 'user'}, {'content': 'Voxelotor can prevent red blood cells from sickling and binding together, reducing the destruction of some red blood cells, which improves blood flow to organs and lowers the risk for anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some options for pain medication mentioned in the text?', 'role': 'user'}, {'content': 'Some options for pain medication mentioned in the text include L-glutamine, nonsteroidal anti-inflammatory drugs (NSAIDs), and opiates.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What treatment option can cure Sickle Cell Disease (SCD)?', 'role': 'user'}, {'content': 'A stem cell transplant (also known as blood or marrow transplant) can cure SCD.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are researchers currently testing to treat Sickle Cell Disease (SCD)?', 'role': 'user'}, {'content': \"Researchers are currently testing gene therapy to treat SCD by correcting an abnormal hemoglobin gene or putting a normal hemoglobin gene into a person's stem cells.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one potential treatment being tested for sickle cell disease?', 'role': 'user'}, {'content': \"Gene therapy, which involves correcting an abnormal hemoglobin gene or putting a normal hemoglobin gene into a person's stem cells.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some ways to help manage sickle cell disease in children?', 'role': 'user'}, {'content': 'Some ways to help manage sickle cell disease in children include taking them to see their healthcare provider regularly, ensuring they receive all recommended vaccines, encouraging regular exercise and a heart-healthy diet, and providing fluids and NSAIDs during a pain crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some things you can do to help manage sickle cell disease in a child?', 'role': 'user'}, {'content': 'Some things you can do to help manage sickle cell disease in a child include taking them to see their healthcare provider regularly, ensuring they get all their recommended vaccines, helping them get regular exercise and eat a heart-healthy diet, providing lots of fluids and a nonsteroidal anti-inflammatory drug during a pain crisis, and taking them to the hospital for stronger pain medication if needed.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of complications related to sickle cell disease that require a visit to the emergency room?', 'role': 'user'}, {'content': 'Some symptoms of complications related to sickle cell disease that require a visit to the emergency room include severe pain, symptoms of severe anemia, fever of 101.3 degrees Fahrenheit, vision problems, difficulty breathing, erection lasting for four or more hours, symptoms of acute chest syndrome, and symptoms of stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of acute chest syndrome and stroke in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Symptoms of acute chest syndrome include chest pain, coughing, and fever. Symptoms of stroke include sudden weakness, numbness on one side of the body, and confusion.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can help reduce symptoms and chances of complications for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Early diagnosis and treatment', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the phone number to call for making an appointment at Cleveland Clinic?', 'role': 'user'}, {'content': '866.320.4573', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the address of Cleveland Clinic's main location?\", 'role': 'user'}, {'content': '9500 Euclid Avenue, Cleveland, Ohio 44195', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell anemia and how does it affect red blood cells?', 'role': 'user'}, {'content': \"Sickle cell anemia is a form of the inherited blood disorder, sickle cell disease. It changes red blood cells' shape, turning round flexible discs into stiff and sticky sickle cells that block blood flow.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell anemia?', 'role': 'user'}, {'content': 'Sickle cell anemia is a form of the inherited blood disorder, sickle cell disease, that affects red blood cells by turning them into stiff and sticky sickled cells, leading to a lack of healthy red blood cells and the development of anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who is affected by sickle cell anemia?', 'role': 'user'}, {'content': 'People who have sickle cell anemia are affected by the condition.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How does sickle cell anemia affect people?', 'role': 'user'}, {'content': 'Sickle cell anemia affects people by causing red blood cells to become rigid and sticky, leading to blockages in blood flow and reduced oxygen delivery to tissues, which can result in pain, organ damage, and other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of sickle cell anemia?', 'role': 'user'}, {'content': 'Some symptoms of sickle cell anemia include extreme tiredness, swollen hands and feet, jaundice, and increased risk for bacterial infections.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How do people inherit sickle cell anemia?', 'role': 'user'}, {'content': 'People with sickle cell anemia inherit the disease from their biological parents. In sickle cell anemia, the gene that helps make normal red blood cells mutates, or changes. People who inherit the mutated hemoglobin protein gene from both biological parents have sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What happens when the hemoglobin gene mutates?', 'role': 'user'}, {'content': \"When the hemoglobin gene mutates, it creates sickled cells that can't navigate the network of blood vessels, leading to blockages in blood flow.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the signs and symptoms of medical conditions linked to sickle cell anemia?', 'role': 'user'}, {'content': 'Signs and symptoms of medical conditions linked to sickle cell anemia include blocked blood vessels, reduced blood flow, and a shortage of red blood cells due to the self-destruction of sickled cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'At what age do symptoms of sickle cell anemia typically start in babies?', 'role': 'user'}, {'content': '5 to 6 months old', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common reason why people with sickle cell anemia go to the emergency room or need to spend time in the hospital?', 'role': 'user'}, {'content': 'Vaso-inclusive crisis (VOC) or acute pain crisis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common reason why people with sickle cell anemia go to the emergency room or need to spend time in the hospital?', 'role': 'user'}, {'content': 'Vaso-inclusive crisis (VOC) or acute pain crises', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Why is sickle cell anemia sometimes referred to as the 'invisible illness'?\", 'role': 'user'}, {'content': \"Sickle cell anemia is sometimes referred to as the 'invisible illness' because people experiencing a pain crisis often do not have symptoms other than sudden excruciating pain that can only be relieved with opioid painkillers.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common complication of sickle cell anemia?', 'role': 'user'}, {'content': 'The most common complication of sickle cell anemia is Acute chest syndrome (ACS).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of anemia in people with sickle cell anemia?', 'role': 'user'}, {'content': 'Some symptoms of anemia in people with sickle cell anemia include pale skin color, fatigue, trouble breathing, fussiness in babies, delayed growth in children, and delayed puberty.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of stroke that are mentioned in the text?', 'role': 'user'}, {'content': 'Some symptoms of stroke mentioned in the text include severe headache, sudden weakness on one side of the body, change in alertness, trouble speaking, trouble seeing, and trouble walking.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of bacterial infections in people with sickle cell anemia?', 'role': 'user'}, {'content': 'Some symptoms of bacterial infections in people with sickle cell anemia include fever, coughing, trouble breathing, pain in bones, and headaches.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of pulmonary hypertension (PH) in people with sickle cell anemia?', 'role': 'user'}, {'content': 'Some symptoms of pulmonary hypertension (PH) in people with sickle cell anemia include racing pulse, fainting or dizziness, feeling short of breath during exercise or activity, and difficulty breathing when at rest.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common symptoms of chronic kidney disease in people with sickle cell anemia?', 'role': 'user'}, {'content': 'Common symptoms of chronic kidney disease in people with sickle cell anemia include a need to pee more often, fatigue, loss of appetite, swollen hands, feet and ankles, shortness of breath, blood in pee (hematuria) or pee that looks foamy, puffy eyes, dry and itchy skin (pruritus), trouble concentrating, trouble sleeping, numbness, nausea or vomiting, muscle cramps, high blood pressure (hypertension), skin color that’s noticeably darker than usual, and detached retina.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common symptoms of a detached retina caused by sickled cells?', 'role': 'user'}, {'content': 'Common symptoms include seeing flashes of light, seeing many floaters, darkening of peripheral vision, and darkening or shadows covering part of the vision.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How do healthcare providers diagnose sickle cell anemia?', 'role': 'user'}, {'content': 'Healthcare providers diagnose sickle cell anemia by taking blood samples and using techniques like hemoglobin electrophoresis or high-performance liquid chromatography to identify and measure different types of hemoglobin in red blood cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the chances of a child being born with sickle cell anemia if both parents have sickle cell trait?', 'role': 'user'}, {'content': 'If both parents have sickle cell trait, the child has a 25% chance of being born with sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the chance of a child being born with sickle cell anemia if both parents have sickle cell trait?', 'role': 'user'}, {'content': '25%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How do healthcare providers treat sickle cell anemia?', 'role': 'user'}, {'content': 'Healthcare providers can cure sickle cell anemia through allogenic stem cell transplantation, and they can also manage the condition by providing treatments for complications such as stroke, acute chest syndrome, and recurring pain crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the only way healthcare providers can cure sickle cell anemia?', 'role': 'user'}, {'content': 'Allogenic stem cell transplantation', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some medications used to treat sickle cell anemia?', 'role': 'user'}, {'content': 'Some medications used to treat sickle cell anemia include hydroxyurea, voxlelotor, L-glutamine therapy, and crizanlizumab.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some benefits of hydroxyurea for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some benefits of hydroxyurea for individuals with sickle cell disease include cutting the number of VOC/acute pain crises by 50%, decreasing instances of acute chest syndrome, reducing the need for blood transfusions, improving anemia symptoms, and easing dactylitis in children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of L-glutamine therapy (Endari®) in the treatment of sickle cell anemia?', 'role': 'user'}, {'content': 'L-glutamine therapy helps reduce some of the complications linked to sickle cell anemia by protecting sickled cells from becoming more misshapen.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can someone prevent sickle cell anemia?', 'role': 'user'}, {'content': 'One way to prevent sickle cell anemia is to have a blood test to find out if you have sickle cell trait that you could pass on to your children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the life expectancy for someone who has sickle cell anemia?', 'role': 'user'}, {'content': 'People who have sickle cell anemia live 20 to 30 years less than people who don’t have the condition.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What suggestions does the U.S. Centers for Disease Control and Prevention (CDC) have for living well with sickle cell anemia?', 'role': 'user'}, {'content': 'The CDC suggests finding good medical care, as managing sickle cell anemia often requires a multidisciplinary team of healthcare providers who specialize in blood disorders.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some suggestions from the U.S. Centers for Disease Control and Prevention for living well with sickle cell anemia?', 'role': 'user'}, {'content': 'The suggestions include finding good medical care and getting regular checkups with a primary provider who understands the situation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to have a relationship with your healthcare provider when managing sickle cell anemia?', 'role': 'user'}, {'content': 'Having a relationship with your healthcare provider who understands your situation may make it easier to get help if you have an acute pain crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some recommendations for managing sickle cell anemia according to the text?', 'role': 'user'}, {'content': 'Some recommendations include paying attention to emotional health, preventing infections through vaccinations, eating a healthy diet, and managing the environment to maintain a balanced body temperature.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What steps can individuals with sickle cell anemia take to prevent infections?', 'role': 'user'}, {'content': 'Individuals with sickle cell anemia can talk to their healthcare provider about vaccinations and take steps to protect themselves from infection.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for individuals with sickle cell anemia to seek support groups?', 'role': 'user'}, {'content': \"It is important for individuals with sickle cell anemia to seek support groups because most people do not understand what it's like to live with the disease, and support groups can provide understanding and emotional support.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some complications that individuals with sickle cell anemia may face as they grow older?', 'role': 'user'}, {'content': 'Some complications that individuals with sickle cell anemia may face as they grow older include chronic lung disease and painful leg ulcers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms that indicate a person with sickle cell anemia should go to the emergency room?', 'role': 'user'}, {'content': 'Extreme fatigue, shortness of breath, dizziness, and irregular heartbeat.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms that may indicate a person with sickle cell anemia should go to the emergency room?', 'role': 'user'}, {'content': 'Some symptoms that may indicate a person with sickle cell anemia should go to the emergency room include extreme fatigue, shortness of breath, dizziness, irregular heartbeat, symptoms of acute chest syndrome, fever of more than 101.3 degrees Fahrenheit, chest pain, cough, symptoms of stroke such as sudden weakness, numbness on one side of the body, confusion, trouble speaking, seeing or walking, and painful erections lasting four hours or more (priapism).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a symptom of priapism?', 'role': 'user'}, {'content': 'Painful erections that last four hours or more', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of medical center is Cleveland Clinic?', 'role': 'user'}, {'content': 'Cleveland Clinic is a non-profit academic medical center.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the address of Cleveland Clinic?', 'role': 'user'}, {'content': '9500 Euclid Avenue, Cleveland, Ohio 44195', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the cause of Sickle Cell Disease?', 'role': 'user'}, {'content': 'Sickle Cell Disease is caused by a genetic mutation in the hemoglobin gene.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main cause of complications in sickle cell disease?', 'role': 'user'}, {'content': 'The complications in sickle cell disease occur because the sickled cells block blood flow to specific organs.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What causes the red blood cells in sickle cell disease to be rigid and shaped like a 'C' or sickle?\", 'role': 'user'}, {'content': \"Abnormal hemoglobin causes the red blood cells in sickle cell disease to be rigid and shaped like a 'C' or sickle.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What must both parents have in order for a child to inherit sickle cell disease?', 'role': 'user'}, {'content': 'Both parents must have either sickle cell disease (two sickle cell genes) or sickle cell trait (one sickle cell gene).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between sickle cell disease and sickle cell trait?', 'role': 'user'}, {'content': 'Sickle cell disease is inherited when both parents have either sickle cell disease or sickle cell trait, while sickle cell trait is inherited when an individual carries only one defective gene.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some risk factors for sickle cell disease?', 'role': 'user'}, {'content': 'Some risk factors for sickle cell disease include being of African descent, Hispanic-Americans from Central and South America, and people of Middle Eastern, Asian, Indian, and Mediterranean descent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some signs and symptoms of sickle cell disease?', 'role': 'user'}, {'content': 'Some signs and symptoms of sickle cell disease include anemia, dark urine, yellow eyes, painful swelling of hands and feet, frequent pain episodes, stunted growth, and stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatments available to help manage and live with sickle cell disease?', 'role': 'user'}, {'content': 'Treatments for sickle cell disease can include medications like pain relievers and hydroxyurea, blood transfusions, and other options as needed.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are researchers exploring in clinical trials for treating sickle cell disease?', 'role': 'user'}, {'content': 'Researchers are looking at new drugs and exploring the use of bone marrow transplants to treat sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to talk with your doctor if you believe you may have sickle cell disease?', 'role': 'user'}, {'content': 'It is important to talk with your doctor if you believe you may have sickle cell disease in order to receive proper diagnosis and treatment.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What resources are available for medical professionals at Mayo Clinic?', 'role': 'user'}, {'content': 'Medical Professional Resources, Refer a Patient, Continuing Medical Education, AskMayoExpert, Mayo Clinic Laboratories, Video Center, Journals & Publications, Mayo Clinic Alumni Association', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the resources available for medical professionals at Mayo Clinic?', 'role': 'user'}, {'content': 'Medical Professional Resources, Refer a Patient, Continuing Medical Education, AskMayoExpert, Mayo Clinic Laboratories, Video Center, Journals & Publications, Mayo Clinic Alumni Association', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What action can you take on the Mayo Clinic website if you want to make a donation?', 'role': 'user'}, {'content': \"You can click on 'Give Now' or 'Make a Donation' to give to Mayo Clinic.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the sections available on the Mayo Clinic website for patients and visitors?', 'role': 'user'}, {'content': 'Some of the sections available on the Mayo Clinic website for patients and visitors include Diseases & conditions, Find a doctor, Care at Mayo Clinic, Patient-Centered Care, Patient & Visitor Guide, Health Library, and Healthy Lifestyle.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the educational resources offered by Mayo Clinic?', 'role': 'user'}, {'content': 'Mayo Clinic offers resources such as Continuing Medical Education, Mayo Clinic College of Medicine and Science, Mayo Clinic Graduate School of Biomedical Sciences, and Mayo Clinic School of Health Sciences.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell anemia and how does it affect red blood cells?', 'role': 'user'}, {'content': 'Sickle cell anemia is one of a group of inherited disorders known as sickle cell disease. It affects the shape of red blood cells, which carry oxygen to all parts of the body. In sickle cell anemia, some red blood cells are shaped like sickles or crescent moons, and they become rigid and sticky, which can slow or block blood flow.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main effect of sickle cell anemia on red blood cells?', 'role': 'user'}, {'content': 'Sickle cell anemia causes some red blood cells to be shaped like sickles or crescent moons, which become rigid and sticky, slowing or blocking blood flow.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the current approach to treatment for sickle cell anemia?', 'role': 'user'}, {'content': 'The current approach to treatment is to relieve pain and help prevent complications of the disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of sickle cell anemia?', 'role': 'user'}, {'content': 'Some symptoms of sickle cell anemia include anemia, fatigue, and a shortage of red blood cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a major symptom of sickle cell anemia?', 'role': 'user'}, {'content': 'Periodic episodes of extreme pain, called pain crises, are a major symptom of sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can happen when sickle-shaped red blood cells block blood circulation in the hands and feet?', 'role': 'user'}, {'content': 'Swelling of hands and feet can occur.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why can a shortage of healthy red blood cells lead to delayed growth in babies and children?', 'role': 'user'}, {'content': 'A shortage of healthy red blood cells can slow growth in babies and children because red blood cells provide the body with the oxygen and nutrients needed for growth.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for children with sickle cell anemia to seek prompt medical attention for a fever greater than 101.5 degrees Fahrenheit?', 'role': 'user'}, {'content': 'Children with sickle cell anemia are prone to infections, and infections can be life-threatening for them.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms that are mentioned in the text?', 'role': 'user'}, {'content': 'Sudden vision changes, unexplained numbness, and severe headache.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the cause of sickle cell anemia?', 'role': 'user'}, {'content': 'Sickle cell anemia is caused by a change in the gene that tells the body to make hemoglobin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What must both parents carry for a baby to have sickle cell anemia?', 'role': 'user'}, {'content': 'Both parents must carry a sickle cell gene for a baby to have sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the risk factors for a baby to have sickle cell anemia?', 'role': 'user'}, {'content': 'For a baby to have sickle cell anemia, both parents must carry a sickle cell gene. In the United States, sickle cell anemia most commonly affects people of African, Mediterranean and Middle Eastern descent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some complications that can arise from sickle cell anemia?', 'role': 'user'}, {'content': 'Some complications that can arise from sickle cell anemia include stroke, acute chest syndrome, and avascular necrosis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the symptoms of acute chest syndrome?', 'role': 'user'}, {'content': 'Symptoms of acute chest syndrome include chest pain, fever, and difficulty breathing.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some potential complications of sickle cell anemia mentioned in the text?', 'role': 'user'}, {'content': 'Some potential complications of sickle cell anemia mentioned in the text include avascular necrosis, pulmonary hypertension, and organ damage.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can sickle cell anemia lead to blindness?', 'role': 'user'}, {'content': 'Sickle cells can block tiny blood vessels that supply blood to the eyes, which can lead to blindness over time.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one potential complication of sickle cell anemia mentioned in the text?', 'role': 'user'}, {'content': 'One potential complication of sickle cell anemia mentioned in the text is blindness.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some potential complications of sickle cell anemia during pregnancy?', 'role': 'user'}, {'content': 'Some potential complications of sickle cell anemia during pregnancy include high blood pressure, blood clots, miscarriage, premature birth, and low birth weight babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it recommended to see a genetic counselor before getting pregnant if you carry the sickle cell trait?', 'role': 'user'}, {'content': 'To understand the risk of having a child with sickle cell anemia, learn about possible treatments, preventive measures, and reproductive options.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can you find information about the management and prognosis of sickle cell disease?', 'role': 'user'}, {'content': 'One source for information about the management and prognosis of sickle cell disease is the website of UpToDate, accessed on Aug. 4, 2023.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the associated procedures mentioned in the text related to sickle cell anemia?', 'role': 'user'}, {'content': 'Blood transfusion and bone marrow transplant', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some associated procedures mentioned in the text?', 'role': 'user'}, {'content': 'Blood transfusion and bone marrow transplant', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the products and services offered by Mayo Clinic Press?', 'role': 'user'}, {'content': 'Some of the products and services offered by Mayo Clinic Press include books like Mayo Clinic on Incontinence, The Essential Diabetes Book, and Mayo Clinic on Hearing and Balance, as well as newsletters like Mayo Clinic Health Letter.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can individuals do to be a part of the cutting-edge research and care at Mayo Clinic?', 'role': 'user'}, {'content': 'Make a tax-deductible gift', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the resources available for students at Mayo Clinic?', 'role': 'user'}, {'content': 'Degree Programs, Admissions Requirements, and Student & Faculty Portal are some of the resources available for students at Mayo Clinic.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the sections available on the Mayo Clinic website?', 'role': 'user'}, {'content': 'Some of the sections available on the Mayo Clinic website include Laboratories, International Patients, Appointments, Financial Services, International Locations & Offices, Charitable Care & Financial Assistance, Community Health Needs Assessment, and more.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What information can be found in the Mayo Clinic Privacy Policy?', 'role': 'user'}, {'content': 'Information about the use of technologies such as cookies, collection of information from browsers, delivery of relevant advertising, personalization of content, site analytics, and data use rights.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What technologies does Mayo Clinic use to collect information and deliver relevant advertising?', 'role': 'user'}, {'content': 'Mayo Clinic and their partners use technologies such as cookies to collect information from your browser.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the technologies mentioned in the text?', 'role': 'user'}, {'content': 'The technologies mentioned in the text are used for remembering preferences, ensuring security, providing certain features, collecting information to understand website usage, and making advertising messages more relevant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some precautions that individuals with sickle cell disease can take to stay as healthy as possible?', 'role': 'user'}, {'content': 'Individuals with sickle cell disease can stay as healthy as possible by drinking plenty of fluids, avoiding extreme temperatures, and being careful at high altitudes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why should people with sickle cell disease avoid extreme temperatures?', 'role': 'user'}, {'content': 'People with sickle cell disease should avoid extreme temperatures because sudden temperature changes, such as swimming in cold water, can trigger a crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some recommendations for managing sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Some recommendations include avoiding alcohol and smoking, learning relaxation techniques, being prepared for treating painful episodes at home, avoiding infections by following good food hygiene measures, and getting vaccinations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some measures that can be taken to reduce the risk of infections for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some measures that can be taken to reduce the risk of infections for individuals with sickle cell disease include taking antibiotics, having vaccinations, following good food hygiene measures, and taking extra precautions when traveling abroad.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What precautions should women with sickle cell disease take if they are planning a pregnancy?', 'role': 'user'}, {'content': 'Women with sickle cell disease should speak to their healthcare team for advice first, find out if their partner is a carrier of sickle cell, discuss the implications with a genetic counsellor, and stop taking certain sickle cell disease medicines before trying to get pregnant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to inform your healthcare team if you have sickle cell disease before undergoing surgery?', 'role': 'user'}, {'content': 'It is important to inform your healthcare team if you have sickle cell disease before undergoing surgery because general anaesthetic can cause problems for people with sickle cell disease, including an increased risk of experiencing a sickle cell crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to inform your healthcare team if you need to have an operation under general anaesthetic?', 'role': 'user'}, {'content': 'It is important to inform your healthcare team if you need to have an operation under general anaesthetic because general anaesthetic can cause problems for people with sickle cell disease, including an increased risk of experiencing a sickle cell crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of sickle cell disease that require immediate medical attention?', 'role': 'user'}, {'content': 'Some symptoms of sickle cell disease that require immediate medical attention include a high temperature, severe pain not responding to treatment, severe vomiting or diarrhea, breathing difficulties, sudden swelling in the tummy, confusion, fits, weakness on one or both sides of the body, and changes in vision.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of sickle cell disease that require immediate medical attention?', 'role': 'user'}, {'content': 'Breathing difficulties, very pale skin or lips, sudden swelling in the tummy, a painful erection lasting more than 2 hours, confusion, drowsiness or slurred speech, fits (seizures), weakness on 1 or both sides of the body, changes in vision or sudden vision loss.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the importance of informing the medical staff about having sickle cell disease?', 'role': 'user'}, {'content': 'The importance of informing the medical staff about having sickle cell disease is to ensure proper care and treatment tailored to the specific needs of individuals with this condition.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the dates for the next media review and page review mentioned in the text?', 'role': 'user'}, {'content': 'Next media review due on 30 November 2025 and next page review due on 30 November 2025', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article discussed in the text?', 'role': 'user'}, {'content': 'Iron Overload in Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the major and unavoidable complication of transfusions in sickle cell disease?', 'role': 'user'}, {'content': 'Iron overload', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the major and unavoidable complication of transfusions in sickle cell disease?', 'role': 'user'}, {'content': 'Iron overload', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the first section of the text?', 'role': 'user'}, {'content': 'Introduction', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why do patients with sickle cell disease (SCD) may be relatively protected from iron mediated cardiac and endocrine gland toxicity compared to thalassemic patients?', 'role': 'user'}, {'content': 'Patients with SCD may be relatively protected from iron mediated cardiac and endocrine gland toxicity compared to thalassemic patients due to the fact that the human body has no effective physiological mechanism for excreting excess iron, leading to different pathways of iron overload in the two conditions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one factor that contributes to iron overload in thalassemia?', 'role': 'user'}, {'content': 'Ineffective erythropoiesis contributes to iron overload in thalassemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is iron homeostasis maintained in humans?', 'role': 'user'}, {'content': 'Iron homeostasis in humans is maintained by the strict regulation of absorption based on body needs.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is ferric iron reduced to ferrous iron in the duodenal enterocyte?', 'role': 'user'}, {'content': 'Ferric iron is reduced to ferrous iron in the duodenal enterocyte by a ferric reductase (DcytB).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is iron transported in the body and stored in different organs?', 'role': 'user'}, {'content': 'Iron is bound to transferrin in circulation and transported to the liver and bone marrow. In the liver, iron is stored as ferritin and released when needed. In erythroid precursors, iron is utilized for erythropoiesis. During red cell senescence, iron is released into macrophages in the reticuloendothelial system and stored as ferritin and hemosiderin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who holds the copyright for the image of iron absorption and transport in Figure 1?', 'role': 'user'}, {'content': 'Massachusetts Medical Society', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the principal hormone involved in regulating iron absorption?', 'role': 'user'}, {'content': 'Hepcidin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What effect does anemia, hypoxia, and erythropoiesis have on hepcidin gene expression?', 'role': 'user'}, {'content': 'Anemia, hypoxia, and erythropoiesis decrease hepcidin gene expression.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is believed to positively regulate hepcidin production?', 'role': 'user'}, {'content': 'Hemojuvelin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of Matriptase 2 in iron regulation?', 'role': 'user'}, {'content': 'Matriptase 2 is a sensor of iron deficiency and an inhibitor of hepcidin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of Heme Carrier Protein 1 (HCP-1) in heme iron absorption?', 'role': 'user'}, {'content': 'HCP-1 is believed to facilitate heme iron uptake by transporting heme iron into the duodenal enterocyte brush border.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of the Feline Leukemia Virus subgroup C Receptor (FLVCR) in transporting heme?', 'role': 'user'}, {'content': 'The FLVCR plays a role in transporting heme from erythroid precursors.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of the human heme exporter identified in the text?', 'role': 'user'}, {'content': 'The human heme exporter identified in the text is essential for erythropoiesis, red blood cell differentiation, and iron homeostasis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the best-validated uses of transfusion in sickle cell disease (SCD)?', 'role': 'user'}, {'content': 'The best-validated uses of transfusion in SCD are in preoperative prophylaxis, treatment of acute chest syndrome (ACS) and prophylaxis, and treatment of stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one of the demonstrated benefits of transfusions in patients with sickle cell disease?', 'role': 'user'}, {'content': 'One of the demonstrated benefits of transfusions in patients with sickle cell disease is reducing recurrent strokes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the result of the study mentioned in the text regarding transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography?', 'role': 'user'}, {'content': 'The study showed a 92% reduction in incidence of first stroke in transfused high-risk patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why was the STOP2 study halted prematurely?', 'role': 'user'}, {'content': 'The STOP2 study was halted prematurely when a significant increase in abnormal TCD velocity and stroke risk was seen in the group in which transfusion therapy had been halted.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, what are some of the benefits of transfusion in sickle cell disease (SCD) other than preventing strokes?', 'role': 'user'}, {'content': 'Transfusion is beneficial in other complications of SCD such as Acute Chest Syndrome (ACS) and improves oxygenation in ACS. It also shows a significant reduction in the frequency of ACS and painful crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did Vichinsky et al. show about transfusion in ACS?', 'role': 'user'}, {'content': 'Vichinsky et al. showed that transfusion improves oxygenation in ACS.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the impact of chronic transfusion on the incidence of pain and acute chest syndrome during the Stroke Prevention Trial in sickle-cell anemia?', 'role': 'user'}, {'content': 'Chronic transfusion had a positive impact on reducing the incidence of pain and acute chest syndrome during the Stroke Prevention Trial in sickle-cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was observed in the group of patients who received prophylactic transfusions in the study mentioned?', 'role': 'user'}, {'content': 'A significant reduction in pain crises was observed in the group of patients who received prophylactic transfusions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the recommended hemoglobin level to maintain through preoperative simple transfusion for patients with sickle cell disease?', 'role': 'user'}, {'content': '10\\u2009gm/dL', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The topic of the text is the mechanism of transfusion mediated iron overload.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a dreaded and inevitable consequence of ongoing transfusion therapy?', 'role': 'user'}, {'content': 'Iron overload', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is knowledge of iron toxicity in sickle cell disease (SCD) considered to be of paramount importance?', 'role': 'user'}, {'content': 'Knowledge of iron toxicity in SCD is considered to be of paramount importance because patients with SCD are far less likely to be screened for end organ damage than patients with thalassemia, despite a similar transfusion history.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How much additional elemental iron is provided per mL of packed red blood cells (RBCs) transfused?', 'role': 'user'}, {'content': '1 mg per mL', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the term used to describe the subset of NTBI that may cause end organ damage due to its high redox potential?', 'role': 'user'}, {'content': 'Labile Plasma Iron (LPI)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the subset of NTBI that may cause end organ damage due to its high redox potential?', 'role': 'user'}, {'content': 'Labile Plasma Iron (LPI)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the potential consequence of iron overload in sickle cell disease (SCD)?', 'role': 'user'}, {'content': 'End organ toxicity', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the potential consequence of saturation of transferrin by excess circulating iron?', 'role': 'user'}, {'content': 'Increased levels of NTBI and LPI, which can lead to the formation of reactive oxygen species (ROS)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the result of NTBI and LPI entering tissues more readily?', 'role': 'user'}, {'content': 'Formation of reactive oxygen species (ROS) such as the hydroxyl radical by the Haber Weiss reaction', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the consequences of excess iron in the body?', 'role': 'user'}, {'content': 'Excess iron tends to deposit in the hepatic parenchyma, in endocrine organs, and in cardiac myocytes, causing end organ damage by ROS-mediated lipid peroxidation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. G. Goddard and G. D. Sweeney mentioned in the text?', 'role': 'user'}, {'content': 'Ferric nitrilotriacetate: a potent stimulant of in vivo lipid peroxidation in mice', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the end organ damages that can result from iron overload in patients with thalassemia major?', 'role': 'user'}, {'content': 'Cardiac damage, liver fibrosis, gonadal dysfunction, and growth retardation', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did the available data suggest about iron-induced cardiac and endocrine organ damage in SCD patients compared to TM patients?', 'role': 'user'}, {'content': 'The available data suggest that SCD patients are relatively protected from iron-induced cardiac and endocrine organ damage compared to TM patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What differences were observed between patients with transfusion-dependent thalassemia (TM) and sickle cell disease (SCD) in terms of cardiac disease and gonadal dysfunction?', 'role': 'user'}, {'content': 'Cardiac disease and gonadal dysfunction were not present in SCD patients with similar serum ferritin levels and equivalent liver iron content, while they were prevalent in patients with TM.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one caution that must be taken when comparing the sequelae of iron overload in TM versus SCD?', 'role': 'user'}, {'content': 'One must be cautious in applying conclusions from these studies given the many differences between TM and SCD patients clinically.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the potential factors modifying iron toxicity in SCD?', 'role': 'user'}, {'content': 'Some of the potential factors modifying iron toxicity in SCD include relative distribution of iron loading in RES versus parenchymal cells, levels of NTBI and LPI, coexisting hereditary iron loading defects, and the impact of ineffective erythropoiesis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'In a small study comparing NTBI levels between SCD and TM, what was observed about the NTBI levels in SCD compared to TM?', 'role': 'user'}, {'content': 'NTBI levels in SCD were less than half of those seen in TM.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference in transfusion burden between patients with Thalassemia Major (TM) and patients with HbSS (Sickle Cell Disease)?', 'role': 'user'}, {'content': 'TM patients had a significantly greater transfusion burden than patients with HbSS.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the relationship between hemochromatosis polymorphisms of European origin and iron loading in African Americans with SCD?', 'role': 'user'}, {'content': 'Hemochromatosis polymorphisms of European origin are less frequent in African Americans and do not seem to contribute to exacerbated iron loading in African Americans with SCD.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some causes of primary and dietary iron overload described in populations of African descent?', 'role': 'user'}, {'content': 'Some causes of primary and dietary iron overload described in populations of African descent include dietary iron overload persisting in rural sub-Saharan Africa and primary iron overload in African Americans.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of hepcidin in the pathophysiology of iron overload in sickle cell disease (SCD)?', 'role': 'user'}, {'content': 'The role of hepcidin in the pathophysiology of iron overload in SCD remains controversial.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What may be speculated about hepcidin levels in sickle cell disease based on the analogy with the anemia of chronic inflammation?', 'role': 'user'}, {'content': 'One may speculate that hepcidin levels would be elevated in sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, were hepcidin levels elevated in sickle cell disease (SCD) patients compared to normal controls?', 'role': 'user'}, {'content': 'No, hepcidin levels were not elevated in SCD patients compared to normal controls.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was found in 5 patients with sickle cell disease in the study mentioned?', 'role': 'user'}, {'content': 'In 5 patients with sickle cell disease in the study, hepcidin levels were below the lower limit of normal, attributed to increased erythropoietic activity.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can affect the estimation of hepcidin in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Coexistent iron deficiency can affect the estimation of hepcidin in individuals with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the impact of transfusion on hepcidin mRNA expression in steady-state SCD patients?', 'role': 'user'}, {'content': 'Transfusion acutely upregulates hepcidin mRNA expression in steady-state SCD patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What happens to hepcidin levels in patients with ineffective erythropoiesis such as thalassemia?', 'role': 'user'}, {'content': 'Hepcidin is significantly downregulated in patients with ineffective erythropoiesis such as thalassemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the relationship between urinary hepcidin levels and iron burden in conditions with augmented but ineffective erythropoiesis?', 'role': 'user'}, {'content': 'Depressed urinary hepcidin levels relative to iron burden have been associated with augmented but ineffective erythropoiesis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one factor that may mediate hepcidin suppression in thalassemia?', 'role': 'user'}, {'content': 'Growth differentiation factor 15 (GDF-15)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of GDF-15 in thalassemia and sickle cell disease?', 'role': 'user'}, {'content': 'GDF-15 levels are elevated in thalassemia but not in sickle cell disease. In thalassemia, GDF-15 suppresses expression of the iron regulatory protein hepcidin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is twisted gastrulation (TWSG1) highly expressed in thalassemic mice?', 'role': 'user'}, {'content': 'The spleen, bone marrow, and liver', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the normal range for hepatic iron content (HIC) in the absence of cirrhosis?', 'role': 'user'}, {'content': 'The normal range for hepatic iron content (HIC) in the absence of cirrhosis is between 0.4 and 2.2\\u2009mg/g of liver dry weight.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What level of iron concentration is consistently associated with liver fibrosis?', 'role': 'user'}, {'content': '15\\u2009mg/g', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What methods have been evaluated as predictors of hepatic iron concentration (HIC) in the text?', 'role': 'user'}, {'content': 'Noninvasive methods including blood tests (ferritin and iron saturation) and imaging techniques (MRI-based techniques)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did the study of 27 children with SCD who received chronic transfusion therapy without chelation find regarding transfusion volume and hepatic iron content?', 'role': 'user'}, {'content': 'The study found that transfusion volume correlated with hepatic iron content (HIC) in the children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did the study of 20 patients with SCD undergoing chronic transfusion therapy with iron chelation find regarding HIC?', 'role': 'user'}, {'content': 'The study found a positive correlation between HIC and the duration of transfusion and liver fibrosis, but not with serum markers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, what serum ferritin level was correlated with low transfusion burden and low measured HIC?', 'role': 'user'}, {'content': '1500\\u2009ng/mL', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What imaging techniques have been developed for noninvasive determination of HIC?', 'role': 'user'}, {'content': 'The Superconducting Quantum Interference Device (SQUID) and T2* MRI.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What imaging technique has been validated as a reliable noninvasive means to assess iron stores in the liver and heart?', 'role': 'user'}, {'content': 'T2* MRI', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What does 20 milliseconds in nonfibrotic livers correlate with, according to the text?', 'role': 'user'}, {'content': 'Increased HIC by biopsy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the effects associated with a 20\\u2009ms decline in left ventricular ejection fraction values?', 'role': 'user'}, {'content': 'Some of the effects associated with a 20\\u2009ms decline in left ventricular ejection fraction values include an increase in cardiac arrhythmias and the need for cardiac medications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of Table 1 in the text?', 'role': 'user'}, {'content': 'Tests to estimate iron load.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What nonpharmacological techniques have been evaluated for preventing and treating iron overload in patients with hypersplenism?', 'role': 'user'}, {'content': 'Substituting erythracytapharesis for simple transfusion, transfusing younger red cells, and performing splenectomy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the main finding regarding iron overload in SCD patients treated with erythrocytapharesis compared to those treated with simple transfusion?', 'role': 'user'}, {'content': 'The degree of iron overload, as assessed by serum ferritin, was significantly reduced in SCD patients treated by erythrocytapharesis compared to those treated with simple transfusion.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the practical limitations that hamper the approach of using donor units in patients with sickle cell disease?', 'role': 'user'}, {'content': 'Some of the practical limitations include resource limitations at donor centers and complications of permanent vascular access.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one of the risks associated with increased exposure to donor units in sickle cell patients?', 'role': 'user'}, {'content': 'One of the risks associated with increased exposure to donor units in sickle cell patients is the risk of alloimmunization.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main benefit of transfusion of young erythrocytes called neocytes?', 'role': 'user'}, {'content': 'The main benefit is that it significantly reduces transfusion requirements and prolongs transfusion interval by 15–25%.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What were the findings of the retrospective analysis on pediatric patients with sickle cell disease before and after splenectomy?', 'role': 'user'}, {'content': 'The retrospective analysis showed a significant reduction in transfusion requirements after splenectomy for splenic sequestration or hypersplenism.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of chelation therapy in SCD patients?', 'role': 'user'}, {'content': 'Chelation therapy is employed to prevent and treat iron overload in chronically transfused SCD patients by targeting unbound iron in the blood.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is considered the gold standard for predicting iron overload and determining the need for chelation therapy?', 'role': 'user'}, {'content': 'Determining HIC by liver biopsy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How many pediatric patients with SCD were studied in the research mentioned?', 'role': 'user'}, {'content': '12', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What percentage of the SCD patients described by Vichinsky et al. had an elevated fibrosis score at liver biopsy?', 'role': 'user'}, {'content': '39%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What percentage of SCD patients in the study had an elevated fibrosis score at liver biopsy?', 'role': 'user'}, {'content': '39%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What parameter is mentioned as a better indicator for noninvasive estimation of iron overload in patients with sickjson', 'role': 'user'}, {'content': 'transfusional iron load (TIL)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the indication to start chelation therapy in the pediatric population according to the text?', 'role': 'user'}, {'content': '100\\u2009mg/kg closely correlated with high liver iron stores and liver fibrosis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can one find more information about the recommended dosage of 2500\\u2009ng/mL for chelation therapy in SCD?', 'role': 'user'}, {'content': 'National Cancer Comprehensive Network Clinical Practice Guidelines in Oncology v.2.2010', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is Deferoxamine (DFO) administered due to its poor oral absorption?', 'role': 'user'}, {'content': 'Deferoxamine (DFO) is administered parenterally.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some alternatives to continuous parenteral administration of DFO for treating thalassemia?', 'role': 'user'}, {'content': 'Some alternatives to continuous parenteral administration of DFO for treating thalassemia include subcutaneous DFO injections every twelve hours, Deferasirox (DFS), and Deferiprone (DFP).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the side effects associated with Deferasirox (DFS) therapy?', 'role': 'user'}, {'content': 'Some of the side effects associated with Deferasirox (DFS) therapy include headache, skin rash, gastrointestinal toxicity, hearing and visual side effects.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common side effects associated with the drug Deferiprone?', 'role': 'user'}, {'content': 'Some common side effects associated with the drug Deferiprone include headache, skin rash, gastrointestinal toxicity, hearing and visual side effects.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is being studied in terms of combination therapy for iron overload in patients with SCD?', 'role': 'user'}, {'content': 'The efficacy and safety of combination therapy using different chelators.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What factors should be considered when deciding to start chelation therapy for patients with SCD?', 'role': 'user'}, {'content': 'Chelation therapy should be considered when adult patients with SCD have received 20–30 units of RBC transfusions, pediatric patients with SCD are approaching a TIL of 100 mg/Kg, and/or HIC in any age group exceeds 7–9\\u2009mg/g.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some challenges that remain in the prevention and management of iron overload in SCD?', 'role': 'user'}, {'content': 'Some challenges that remain in the prevention and management of iron overload in SCD include clarification of the indications for transfusion therapy in adults with SCD, improved catheter technology for safe exchange transfusions, and optimal chelation therapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who reviewed the manuscript and provided valuable suggestions for the text?', 'role': 'user'}, {'content': 'Dr. Lawrence Cytryn and Dr. Oswaldo Castro', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. E. Fleming and B. R. Bacon?', 'role': 'user'}, {'content': 'Orchestration of iron homeostasis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of the serine protease TMPRSS6 in sensing iron deficiency?', 'role': 'user'}, {'content': 'The serine protease TMPRSS6 is required to sense iron deficiency.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by X. Du, E. She, T. Gelbart et al. published in 2008?', 'role': 'user'}, {'content': 'The serine protease TMPRSS6 is required to sense iron deficiency', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. G. Quigley, Z. Yang, M. T. Worthington et al.?', 'role': 'user'}, {'content': 'Identification of a human heme exporter that is essential for erythropoiesis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by S. B. Keel, R. T. Doty, Z. Yang et al. published in 2008?', 'role': 'user'}, {'content': \"The title of the article is 'A heme export protein is required for red blood cell differentiation and iron homeostasis.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. J. Adams et al. published in the New England Journal of Medicine in 1998?', 'role': 'user'}, {'content': 'Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. J. Adams and D. Brambilla published in the New England Journal of Medicine in 2005?', 'role': 'user'}, {'content': 'Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the impact of chronic transfusion on the incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia?', 'role': 'user'}, {'content': 'Chronic transfusion had an impact on reducing the incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by M. Koshy et al. published in the New England Journal of Medicine in 1988?', 'role': 'user'}, {'content': 'Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by E. P. Vichinsky et al. published in the New England Journal of Medicine in 1995?', 'role': 'user'}, {'content': 'A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by S. K. Ballas that discusses the impact of iron overload on patients with sickle cell disease?', 'role': 'user'}, {'content': 'Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by S. K. Ballas that discusses the impact of iron overload on adult patients with sickle cell disease?', 'role': 'user'}, {'content': 'Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"In which journal was the article 'Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity' published?\", 'role': 'user'}, {'content': 'British Journal of Haematology', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by C. Hershko, G. Graham, G. W. Bates, and E. A. Rachmilewitz published in the British Journal of Haematology in 1978?', 'role': 'user'}, {'content': 'Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by C. Hershko, G. Link, A. M. Konijn, and Z. I. Cabantchik?', 'role': 'user'}, {'content': \"The title of the article is 'Objectives and mechanism of iron chelation therapy.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. G. Goddard and G. D. Sweeney?', 'role': 'user'}, {'content': 'Ferric nitrilotriacetate: a potent stimulant of in vivo lipid peroxidation in mice', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. C. Wood et al. published in 2004?', 'role': 'user'}, {'content': 'Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study by P. B. Walter et al. published in the British Journal of Haematology in 2006?', 'role': 'user'}, {'content': 'The focus of the study is on oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by V. R. Gordeuk, R. D. Boyd, and G. M. Brittenham published in 1986?', 'role': 'user'}, {'content': \"The title of the article is 'Dietary iron overload persists in rural sub-Saharan Africa.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. P. Hebbel, R. Osarogiagbon, and D. Kaul?', 'role': 'user'}, {'content': 'The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. K. Wurapa, V. R. Gordeuk, G. M. Brittenham, A. Khiyami, G. P. Schechter, and C. Q. Edwards published in the American Journal of Medicine in 1996?', 'role': 'user'}, {'content': 'Primary iron overload in African Americans', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the potential role of activated monocytes in sickle cell disease according to the study by Belcher et al.?', 'role': 'user'}, {'content': 'The potential role of activated monocytes in sickle cell disease is in the activation of vascular endothelium and vaso-occlusion.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the potential role of activated monocytes in sickle cell disease according to the text?', 'role': 'user'}, {'content': 'The potential role of activated monocytes in sickle cell disease is in the activation of vascular endothelium and vaso-occlusion.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. J. C. Kroot, C. M. M. Laarakkers, E. H. J. M. Kemna, B. J. Biemond, and D. W. Swinkels?', 'role': 'user'}, {'content': \"The title of the article is 'Regulation of serum hepcidin levels in sickle cell disease.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the research in the article 'Hepcidin in iron overload disorders' by G. Papanikolaou et al.?\", 'role': 'user'}, {'content': 'The focus of the research is on hepcidin in iron overload disorders.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main focus of the research discussed in the text?', 'role': 'user'}, {'content': 'The main focus of the research is on the regulation of iron absorption and hepcidin expression in individuals with beta-thalassemia and other chronic anemias.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by T. Tanno, N. V. Bhanu, P. A. Oneal et al. published in Nature Medicine in 2007?', 'role': 'user'}, {'content': 'High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by E. Angelucci, G. M. Brittenham, C. E. McLaren et al. published in the New England Journal of Medicine in 2000?', 'role': 'user'}, {'content': \"The title of the article is 'Hepatic iron concentration and total body iron stores in thalassemia major.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by P. T. Telfer et al. published in the British Journal of Haematology in 2000?', 'role': 'user'}, {'content': 'Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by K. Brown, C. Subramony, W. May et al. published in the Journal of Pediatric Hematology/Oncology in 2009?', 'role': 'user'}, {'content': 'Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by T. V. Adamkiewicz, M. R. Abboud, C. Paley et al. published in Blood in 2009?', 'role': 'user'}, {'content': \"The title of the article is 'Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of using magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease?', 'role': 'user'}, {'content': 'The purpose is to assess the level of iron overload in the patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. C. Wood et al. published in 2005?', 'role': 'user'}, {'content': 'MRI R2 and R2∗ mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study by H. C. Kim et al. mentioned in the text?', 'role': 'user'}, {'content': 'The study focuses on erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. N. Haricharan et al. published in the Journal of Pediatric Surgery in 2008?', 'role': 'user'}, {'content': \"The title of the article is 'Splenectomy reduces packed red cell transfusion requirement in children with sickle cell disease.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. N. Haricharan, J. M. Roberts, T. L. Morgan et al. published in 2008?', 'role': 'user'}, {'content': 'Splenectomy reduces packed red cell transfusion requirement in children with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"In which journal was the article 'Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia' published?\", 'role': 'user'}, {'content': 'Journal of Pathology', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by G. M. Brittenham, P. M. Griffith, A. W. Nienhuis et al.?', 'role': 'user'}, {'content': 'Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"In the text, what is the main focus of M. D. Cappellini's article?\", 'role': 'user'}, {'content': \"The main focus of M. D. Cappellini's article is overcoming the challenge of patient compliance with iron chelation therapy.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by E. Vichinsky et al. comparing deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease?', 'role': 'user'}, {'content': \"The title of the article is 'A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by D. J. Roberts et al. regarding iron chelation in people with thalassaemia?', 'role': 'user'}, {'content': 'Oral deferiprone for iron chelation in people with thalassaemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of license allows unrestricted use, distribution, and reproduction of the article?', 'role': 'user'}, {'content': 'Creative Commons Attribution License', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the protein found in red blood cells that allows them to carry oxygen to the body's tissues?\", 'role': 'user'}, {'content': 'Hemoglobin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who does sickle cell disease typically affect?', 'role': 'user'}, {'content': 'Sickle cell disease typically affects those with African heritage and Hispanics with Caribbean ancestry, but other heritages found to carry the trait include Indian, Mediterranean, Latin American, Native American, and Middle Eastern.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common form of sickle cell disease?', 'role': 'user'}, {'content': 'Sickle cell anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the factors that may increase the risk of people with sickle cell trait developing complications similar to those of sickle cell disease?', 'role': 'user'}, {'content': 'Severe dehydration, extreme physical exertion, exposure to very high altitude', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What factors may increase the risk of people with sickle cell trait developing complications similar to those of sickle cell disease?', 'role': 'user'}, {'content': 'Factors that may increase this risk include severe dehydration, extreme physical exertion, exposure to very high altitude, and sickle cell gene variations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common and most severe type of sickle cell disease?', 'role': 'user'}, {'content': 'Sickle cell hemoglobin S disease or homozygous SS disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between sickle cell hemoglobin E disease and Hemoglobin S-beta-thalassemia?', 'role': 'user'}, {'content': 'Sickle cell hemoglobin E disease is common in populations of Southeast Asia and may not exhibit any symptoms or may cause mild to moderate anemia symptoms. Hemoglobin S-beta-thalassemia is a form of the disease where a person inherits the gene for thalassemia along with the gene for sickle cell disease, causing milder symptoms than sickle cell disease but can also lead to severe symptoms and complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is early diagnosis of sickle cell disease crucial?', 'role': 'user'}, {'content': 'Early diagnosis is crucial so doctors can take measures to ease some of the devastating effects of sickle cell anemia, increase life expectancy, and decrease the risk of infection or other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is early diagnosis crucial for adult sickle cell disease?', 'role': 'user'}, {'content': 'Early diagnosis is crucial so doctors can take measures to ease some of the devastating effects of sickle cell anemia, increase life expectancy, and decrease the risk of infection or other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common anemia symptoms associated with adult sickle cell disease?', 'role': 'user'}, {'content': 'Common symptoms include fatigue, dizziness, headaches, cold hands and feet, jaundice, and unusually pale skin and mucous membranes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some pain symptoms associated with sickle cell anemia?', 'role': 'user'}, {'content': 'Individuals with sickle cell anemia often experience sudden, intense pain throughout the body, known as vaso-occlusive crises, which can affect areas such as the lungs, abdomen, bones, and joints.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some factors that can contribute to a sickle cell crisis?', 'role': 'user'}, {'content': 'Dehydration, infection, menstruation, and sudden changes in temperature', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some factors that can contribute to a sickle cell crisis?', 'role': 'user'}, {'content': 'Dehydration, infection, menstruation, and sudden changes in temperature', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the primary symptom of pulmonary hypertension in sickle cell disease patients?', 'role': 'user'}, {'content': 'Fatigue and shortness of breath', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some signs and symptoms of acute chest syndrome?', 'role': 'user'}, {'content': 'Some signs and symptoms of acute chest syndrome include chest pain, shortness of breath, fever, abnormal chest x-ray, and stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the two types of stroke that people with sickle cell disease are at risk for?', 'role': 'user'}, {'content': 'The two types of stroke that people with sickle cell disease are at risk for are when a blood vessel in the brain becomes damaged or blocked with sickle cells, and when a blood vessel in the brain ruptures.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can happen if priapism is left untreated?', 'role': 'user'}, {'content': 'Damage to penile tissue and permanent impotence', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a splenic crisis and what are the potential consequences of it?', 'role': 'user'}, {'content': 'A splenic crisis occurs when the spleen becomes blocked with sickle cells, leading to intense abdominal pain. Depending on the type of crisis, the spleen may swell full of blood or the blocked blood flow can cause damage and death to parts of the spleen. Loss of splenic function increases the risk of serious blood infections.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common symptoms of multiple organ failure in adults with sickle cell disease?', 'role': 'user'}, {'content': 'Some common symptoms of multiple organ failure in adults with sickle cell disease include labored breathing, tachycardia, fever, and changes in mental status.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of an echocardiogram in the UPMC Adult Sickle Cell Disease Program?', 'role': 'user'}, {'content': 'The echocardiogram is used to screen for pulmonary hypertension.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What does hemoglobin electrophoresis determine?', 'role': 'user'}, {'content': 'Hemoglobin electrophoresis determines the specific type of abnormal hemoglobin present and at what levels it exists in the blood stream.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is ongoing monitoring and treatment necessary for adult sickle cell disease?', 'role': 'user'}, {'content': 'Ongoing monitoring and treatment are necessary for adult sickle cell disease to control symptoms, reduce the number of pain crises, and manage the condition effectively.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the primary goals of adult sickle cell disease treatment?', 'role': 'user'}, {'content': 'The primary goals of adult sickle cell disease treatment are to control symptoms and reduce the number of pain crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to test the bilirubin and serum creatinine levels in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'It is important to test the bilirubin and serum creatinine levels in individuals with sickle cell disease to monitor for jaundice, gallstones, kidney function, and potential complications related to the disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can happen to kidney function in people with sickle cell disease?', 'role': 'user'}, {'content': 'People with sickle cell disease can experience diminished kidney function and intense pain when sickle cells block tiny blood vessels in the kidneys.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a new treatment that may help reduce the need for frequent blood transfusions and diminish the frequency of acute chest syndrome and pain crises in sickle cell disease?', 'role': 'user'}, {'content': 'Hydroxyurea', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatments and medical interventions mentioned for complications of sickle cell anemia in the text?', 'role': 'user'}, {'content': 'Some of the treatments and medical interventions mentioned include frequent blood transfusions, surgery to remove gallstones, wound care for sickle cell leg ulcers, kidney dialysis, kidney transplant therapies, hip replacement surgery for avascular necrosis of the hip, and laser surgery for eye problems.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some preventive measures recommended for managing adult sickle cell disease?', 'role': 'user'}, {'content': 'Some preventive measures recommended for managing adult sickle cell disease include taking prophylactic antibiotics, such as penicillin, and staying up to date on certain vaccinations like the Haemophilus influenzae vaccine (Hib) and the Pneumococcal conjugate vaccine (PCV).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some preventive measures for managing adult sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Some preventive measures for managing adult sickle cell disease mentioned in the text include taking prophylactic antibiotics, staying up to date on vaccinations, staying hydrated, and taking a folic acid vitamin supplement.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the sections available under 'About the Center' on the website?\", 'role': 'user'}, {'content': \"Some of the sections available under 'About the Center' are Center of Excellence, Board of Directors, Community Programs, Research, Partnerships, Team Bio, and News.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the conditions treated by the medical facility?', 'role': 'user'}, {'content': 'Hemophilia, von Willebrand Disease, Other Rare Bleeding Disorders, Thrombosis & Clotting, Sickle Cell Disease, Additional Blood Disorders', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which healthcare professionals are included in the Care Team mentioned in the text?', 'role': 'user'}, {'content': 'Pediatric Physicians, Adult Physicians, Hospitalists, Nurse Practitioners & Physician Assistants, Nurses, Physicial Therapists, Dental Hygienists, Pharmacy Team, Psychologist, Genetic Counselors', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which healthcare professional is responsible for providing therapy to help patients recover from injuries or illnesses?', 'role': 'user'}, {'content': 'Physicial Therapists', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which of the following is not a healthcare profession listed in the text?', 'role': 'user'}, {'content': 'School and Career Counselors', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the conditions treated at the Specialty Clinics mentioned in the text?', 'role': 'user'}, {'content': 'Some of the conditions treated at the Specialty Clinics mentioned in the text are Hemophilia, von Willebrand Disease, Other Rare Bleeding Disorders, Thrombosis & Clotting, and Sickle Cell Disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'At what age do babies with sickle cell disease usually start showing symptoms?', 'role': 'user'}, {'content': 'Babies with sickle cell disease usually do not have any symptoms until four to six months of age.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the extreme conditions that can worsen sickle cell disease symptoms?', 'role': 'user'}, {'content': 'High altitude, dehydration, illness, stress, sleep apnea, menstruation, exposure to cold temperatures, intense exercise, anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is dactylitis and why is it significant for babies and young children with sickle cell disease?', 'role': 'user'}, {'content': 'Dactylitis is painful swelling in the hands or feet, and it is often the first symptom exhibited by babies and young children with sickle cell disease. It is significant because it can help in identifying the presence of sickle cell disease in children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common symptoms of sickle cell disease in babies and young children?', 'role': 'user'}, {'content': 'Some common symptoms of sickle cell disease in babies and young children include dactylitis (painful swelling in hands or feet), increased fussiness, swelling, tenderness, or redness in hands or feet, avoiding grabbing or holding items, and avoiding walking or standing.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a vaso-occlusive crisis and how does it relate to sickle cell disease?', 'role': 'user'}, {'content': \"A vaso-occlusive crisis is a type of pain caused by low oxygen flow to the body's tissues, commonly experienced by individuals with sickle cell disease. During a vaso-occlusive crisis, sickled cells block blood vessels, reducing oxygen flow to surrounding tissues.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some possible complications associated with the conditions listed?', 'role': 'user'}, {'content': 'Possible complications include stroke, splenic sequestration, acute chest syndrome, aplastic crisis, cholecystitis, priapism, and vaso-occlusive crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What contact information is provided for the Indiana Hemophilia & Thrombosis Center?', 'role': 'user'}, {'content': '8326 Naab Road, Indianapolis, IN 46260; Phone: 317.871.0000; Emergency Phone: 877.CLOTTER (877.256.8837); Fax: 317.871.0010', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What does the HTTP status code '403 Forbidden' indicate?\", 'role': 'user'}, {'content': \"The HTTP status code '403 Forbidden' indicates that the server understood the request, but refuses to authorize it.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the services offered by iCliniq for consulting with a doctor?', 'role': 'user'}, {'content': 'Some of the services offered by iCliniq for consulting with a doctor include asking a doctor online, chatting with a doctor, video consultation, and phone consultation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the tools available on iCliniq for users?', 'role': 'user'}, {'content': 'Some of the tools available on iCliniq for users include a Symptom checker, Safe days calculator, and 40+ other tools.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"How many doctors are part of iCliniq's medical panel?\", 'role': 'user'}, {'content': '3500+ doctors', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can users do on the platform in terms of medical consultations?', 'role': 'user'}, {'content': 'Users can have on-demand or scheduled phone consultations with a doctor, choose a doctor for text, video, or phone consultations, and read medical articles and Q&A discussions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the Safe days calculator mentioned in the text?', 'role': 'user'}, {'content': 'The Safe days calculator is used to predict the fertile window based on menstrual cycle data.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the purpose of the article 'Sickle Cell Disease - Screening and Marital Decisions'?\", 'role': 'user'}, {'content': 'The article helps predict the genotypes of a baby with the hemoglobin electrophoresis result of its parents regarding sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the article regarding sickle cell disease?', 'role': 'user'}, {'content': 'The purpose of the article is to help predict the genotypes of a baby based on the hemoglobin electrophoresis result of its parents regarding sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are most couples concerned about during regular premarital consultations according to the text?', 'role': 'user'}, {'content': 'Most couples are concerned and anxious about sickle cell issues and often worried about what the results mean, their implications on their relationship, and especially their future babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common concerns that couples have during regular premarital consultations, according to the text?', 'role': 'user'}, {'content': 'Couples are often concerned about sickle cell issues, the implications on their relationship, and the health of their future babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell disease and who is most commonly affected by it?', 'role': 'user'}, {'content': 'Sickle cell disease is a genetic blood disorder that is very common among black descents. It can be inherited from either sickler parents or non-sickler parents.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to consult with a qualified health professional before doing the test?', 'role': 'user'}, {'content': 'It is important to consult with a qualified health professional before doing the test to ensure that you are referred to the right laboratory with a good track record and to avoid being given a false report.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who can be predicted certain future health outcomes based on the results of hemoglobin electrophoresis?', 'role': 'user'}, {'content': 'Either you or your baby', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is premarital health screening important?', 'role': 'user'}, {'content': 'Premarital health screening is important because it helps couples be aware of their hemoglobin electrophoresis status, which can help them choose the best genetic match for procreation and avoid giving birth to sick babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is premarital health screening important?', 'role': 'user'}, {'content': 'Premarital health screening is important to identify any genetic risks that could affect the health of future children and to help couples make informed decisions about their marriage.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some implications of marrying a good and bad genetic match?', 'role': 'user'}, {'content': 'Some implications include the increased likelihood of giving birth to a sickler baby, as well as other sociocultural, socioeconomic, and socio-psychological implications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What steps are involved during premarital testing according to the text?', 'role': 'user'}, {'content': 'According to the text, during premarital testing, a couple will need to be counseled, discuss with their healthcare provider, ask questions, be ready to answer questions, have a blood sample collected, analyzed, and reported, and may also be tested for other sexually transmitted diseases like HIV, syphilis, chlamydia, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the possible test results mentioned in the text and what do they indicate?', 'role': 'user'}, {'content': 'The possible test results mentioned are AA, AS, or SS. AA indicates a normal genotype, AS indicates a carrier of sickle cell trait, and SS indicates sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the chances of a couple who are both AS giving birth to a sickler (SS) according to the text?', 'role': 'user'}, {'content': '25%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the likelihood of a child being a sickler if both parents are AS according to the text?', 'role': 'user'}, {'content': '25%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, what is the recommendation for a couple if they find out their chances of having a sickler baby are high?', 'role': 'user'}, {'content': 'It is best for the couple to reconsider having babies and abstain from getting married altogether, especially if not having a baby after marriage is not an option.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the author trying to convey about the chances of having a sickler baby in the given text?', 'role': 'user'}, {'content': 'The author explains that the chances of having a sickler baby are not absolute predictions and can vary, with some cases resulting in all normal children or all sickler babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why did one of the twin males in the couple mentioned in the text have sickle cell disease while the other was healthy?', 'role': 'user'}, {'content': 'The twin males had different health statuses because they were non-identical twins. If they were identical twins, they would have both been either normal or sicklers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the body parts that can be harmed by sickle cell disease?', 'role': 'user'}, {'content': 'Sickle cell disease can harm the eyes, spleen, heart, brain, kidneys, lungs, liver, penis, joints, bones, or skin of a patient.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main cause of sickle cell anemia in children?', 'role': 'user'}, {'content': 'Sickle cell anemia is caused due to the mutation in the gene which commands to produce red blood cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can patients with sickle cell disease be cured?', 'role': 'user'}, {'content': 'Patients with sickle cell disease can be cured by stem cell transplantation without the necessity for chemotherapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can relieve you from Sickle Cell pain?', 'role': 'user'}, {'content': 'Administering suitable drugs may reduce the risks of vaso-occlusive events and chronic disorders.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is chronic pain in sickle cell anemia defined?', 'role': 'user'}, {'content': 'Pain in sickle cell disease is defined as chronic if it persists for three to six months or more.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for patients with sickle cell disease to stay hydrated?', 'role': 'user'}, {'content': 'Staying hydrated improves healthy blood flow, decreases the risk of red blood cells sickling and clinging together, and keeps the blood cells flexible for better flow inside the blood vessels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some good foods for Sickle Cell Patients?', 'role': 'user'}, {'content': 'Lean protein, fruits, vegetables, whole grains, lean chicken, fish, pork, lean beef, shrimps, sardine, beans, pumpkin seeds, cashew nuts, walnut, vegetable oil, peas, liver, and egg yolk are good foods for Sickle Cell Patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What vitamins are mentioned in the text as being good for controlling Homocysteine levels in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Vitamin B12, B6, and Folic Acid', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the tags related to the article on sickle cell tests?', 'role': 'user'}, {'content': 'hemoglobin electrophoresis, sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What specific blood parameters are mentioned as being elevated in the text?', 'role': 'user'}, {'content': 'Hematocrit, RBC, Hb, and mean cell volume', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the disclaimer mentioned at the end of the text?', 'role': 'user'}, {'content': 'No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the company's #1 priority?\", 'role': 'user'}, {'content': \"The company's #1 priority is your health.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the disclaimer mentioned at the end of the text?', 'role': 'user'}, {'content': 'No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the disclaimer mentioned on the website?', 'role': 'user'}, {'content': 'No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for individuals to know if they have sickle cell trait?', 'role': 'user'}, {'content': 'It is important for individuals to know if they have sickle cell trait because it puts them at risk of having a child with sickle cell disease and, in rare cases, puts themselves at risk.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for individuals to know if they are carriers of sickle cell trait?', 'role': 'user'}, {'content': 'It is important to know if you are a carrier of sickle cell trait because if both parents have the trait, their children could have sickle cell anemia, the most severe form of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common chronic complications of sickle cell disease?', 'role': 'user'}, {'content': 'Some common chronic complications of sickle cell disease include dactylitis, acute chest syndrome, chronic organ damage, stroke, and kidney failure.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some common chronic complications of sickle cell disease?', 'role': 'user'}, {'content': 'Some common chronic complications of sickle cell disease include dactylitis, acute chest syndrome, chronic organ damage, stroke, and kidney failure.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to know if you have sickle cell trait?', 'role': 'user'}, {'content': 'It is important to know if you have sickle cell trait for your own peace of mind, as there are rare cases when having the trait can be harmful in situations such as low oxygen levels, dehydration, high altitudes, and intense physical activity.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for individuals with sickle cell disease to pay attention to their diet and nutrition?', 'role': 'user'}, {'content': 'Individuals with sickle cell disease may need more energy than others to deal with the challenges of the disease, and eating properly can help boost their energy levels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why might individuals with sickle cell disease need more energy and protein in their diet?', 'role': 'user'}, {'content': 'Individuals with sickle cell disease may need more energy and protein in their diet because their body is working hard to deal with the crescent shaped red blood cells characteristic of the disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What types of foods are recommended for people with sickle cell disease?', 'role': 'user'}, {'content': 'Good quality protein and foods with lots of energy, such as animal-based foods like poultry, fish, eggs, and dairy, or plant-based proteins like nuts, beans, and lentils. Healthy sources of carbohydrates like whole grains, vegetables, and fruits are also recommended.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some healthy sources of protein for individuals following a vegan diet or preferring plant-based foods?', 'role': 'user'}, {'content': 'Nuts, beans, and lentils', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important for people with sickle cell disease to drink plenty of water?', 'role': 'user'}, {'content': 'Dehydration is a common trigger for pain crises in people with sickle cell disease, so drinking plenty of water helps to stay hydrated and prevent pain crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What vitamins and minerals may people with sickle cell disease have low blood levels of?', 'role': 'user'}, {'content': 'Vitamin D, folic acid, and zinc', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are probiotics and how can they help your digestive system?', 'role': 'user'}, {'content': 'Probiotics are good bacteria or yeasts found in foods such as yoghurt, which help your digestive system to function healthily, especially if you’re taking antibiotics.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to keep talking to your healthcare team about a diet plan and nutrition advice?', 'role': 'user'}, {'content': 'It is important to keep talking to your healthcare team about a diet plan and nutrition advice because what works for one person may not work for another, and they can help you find a diet that works for you.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the publication by Hyacinth HI, Adekeye OA, and Yilgwan CS that discusses malnutrition in sickle cell anemia?', 'role': 'user'}, {'content': 'Malnutrition in sickle cell anemia: implications for infection, growth, and maturation', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'The role of nutrition in sickle cell disease' by Hyacinth H, Gee BE, and Hibbert JM?\", 'role': 'user'}, {'content': 'The focus of the article is on the role of nutrition in sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What can be found in the 'Family Resources & Education' section?\", 'role': 'user'}, {'content': 'Family resources and education materials', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the blog 'Your Guide to Respiratory Season'?\", 'role': 'user'}, {'content': 'Health, Wellness and Safety Resources', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some examples of community resources available at Nationwide Children's?\", 'role': 'user'}, {'content': 'Mobile Apps, Social Media, Support Groups, Patient Stories, Classes for Parents and Kids', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the resources mentioned in the text for health, wellness, and safety?', 'role': 'user'}, {'content': 'Some of the resources mentioned are Helping Hands, Resources for Parents and Kids, Health e-Hints Newsletter, CAP4Kids, and Coronavirus (COVID-19) Information.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics such as abdominal pain, acetaminophen, advice for new moms and dads, aerosol therapy, and anal manometry.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the resource guide that provides information for new parents?', 'role': 'user'}, {'content': 'Infant, Maternity, and New Parent Resource Guide', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the resource guide mentioned in the text?', 'role': 'user'}, {'content': 'Infant, Maternity, and New Parent Resource Guide', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Behavior Support: Catching Your Child Being Good'?\", 'role': 'user'}, {'content': 'The focus is on catching and reinforcing positive behaviors in children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the text 'Behavior Support: Catching Your Child Being Good'?\", 'role': 'user'}, {'content': 'Behavior support and positive reinforcement for children', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the common theme among the topics listed in the text?', 'role': 'user'}, {'content': 'The common theme among the topics listed in the text is birth control methods.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of birth control methods mentioned in the text?', 'role': 'user'}, {'content': 'Depo Provera, Hormonal IUD, Nexplanon Implant, Non Hormonal IUD, Birth Control Pills, Vaginal Ring', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various birth control and medical treatment options related to birth control, blood counts, blood transfusion, and the cardiovascular system.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Which body system is associated with 'Blood Transfusion'?\", 'role': 'user'}, {'content': 'Cardiovascular', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some topics related to the Respiratory system mentioned in the text?', 'role': 'user'}, {'content': 'Some topics related to the Respiratory system mentioned in the text are Bronchoscopy and Laryngoscopy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'Breast/Chest Care, Expressing Milk, Breastfeeding/Chestfeeding, Bronchoscopy, Laryngoscopy, Bullying Information, Burn Prevention', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including burn prevention, button battery safety, calming a fussy baby, and cardiopulmonary resuscitation (CPR) for different age groups.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various topics related to first aid and medical care, such as CPR, cast care, and battery safety.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including Cardiopulmonary Resuscitation (CPR) for infants, cast and splint care, child care and illness, at-home safety guide for self-harm or suicide, and hospital safety guide for self-harm.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various topics related to child care and health, including self-harm, suicide, circulation checks, urine collection, and cleft lip procedures.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of procedures that may be found in a list of medical terms?', 'role': 'user'}, {'content': 'Clean Catch Urine Collection, Cleft Lip Adhesion, Cleft Lip Repair, Cleft Palate Repair, Closed Reduction of a Fracture, Collar and Cuff Sling', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What medical procedure is described as 'Closed Reduction of a Fracture'?\", 'role': 'user'}, {'content': 'Closed Reduction of a Fracture', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What does CRRT stand for in the context of medical procedures?', 'role': 'user'}, {'content': 'Continuous Renal Replacement Therapy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about various medical and dental topics such as cough and cold medicines, crutch walking, CT scans, cavities in baby teeth, dental home care goals, teeth and gum care, and wearing separators.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the fact sheets mentioned in the text?', 'role': 'user'}, {'content': 'The fact sheets cover topics such as dental care, wearing separators, diabetes, clear liquid diet, and digital blood pressure measurement.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various topics including diabetes, clear liquid diet, digital blood pressure measurement, discipline, divorce and children, earwax, and EEG (Electroencephalogram).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as earwax, EEG, emergency phone numbers, EMG and NCV tests, and epinephrine auto-injectors.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the tests and exercises mentioned in the text?', 'role': 'user'}, {'content': 'EMG and NCV tests, Epinephrine Auto-Injectors for Severe Allergic Reaction, Evaluation for Sepsis - Infant, Exercise Stress Test, Exercises for Breathing, Posture, Chest Mobility, and Left Torticollis Positioning for Play.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Breathing, posture, chest mobility, left torticollis positioning, right torticollis positioning, general eye care, safety for children, and eye socket care.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various exercises and tests related to eye care and health for children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What medical procedure involves the removal of breast tissue in males?', 'role': 'user'}, {'content': 'Gynecomastia Surgery', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as Gonorrhea, Gynecologic Laparoscopy, Gynecomastia Surgery, Hand Hygiene, Healthy Sleep Habits for Babies and Toddlers, and Healthy Sleep Habits for Older Children and Teens.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the section that provides guidance on helping very young children cope after a trauma?', 'role': 'user'}, {'content': 'Helping Very Young Children Cope after a Trauma', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various healthcare topics such as helping children cope after a trauma, home care for hemophilia joint and muscle bleeds, and home safety for infants and toddlers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical procedures and topics such as HIV Oral Point of Care Test, 24-Hour Holter Monitor, Home Safety for Infants and Toddlers, How and Why to Thicken Liquids, Hydrogen Breath Test, Hypnosis, and Hypospadias Repair.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the section that discusses 'Inhaled Corticosteroids for Asthma'?\", 'role': 'user'}, {'content': 'Inhaled Corticosteroids for Asthma', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics including Infant Vision, Inhaled Corticosteroids for Asthma, Inhalers, Innocent Heart Murmurs, and Intranasal Midazolam.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various topics related to health and medicine, such as inhalers, spacers, heart murmurs, midazolam, IV lines, lead poisoning prevention, and learning problems.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the section titled 'Medicine: Proper Disposal'?\", 'role': 'user'}, {'content': 'Medicine disposal', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including management of nonspecific back pain, mealtime success, giving medicine by mouth, proper disposal of medicine, chemotherapy medicine safety, MRI, and Nasoalveolar Molding (NAM).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'Medicine Safety - Chemotherapy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical procedures and care such as orthodontics, ostomy care, oxygen therapy, patient hair care, percutaneous pinning, and peripheral nerve catheter and pump for pain control.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various topics related to patient care, including percutaneous pinning, peripheral nerve catheter and pump for pain control, personal hygiene, poisonings and poison prevention, and prednisone and prednisolone.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including personal hygiene, poison prevention, medication (prednisone and prednisolone), rabies vaccine treatment, radiation therapy, rectal biopsy, and safe sleep practices.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including radiation therapy, rectal biopsy, safe sleep practices, scar management, school and illness, and secondhand smoke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': \"The text lists various topics including safe sleep practices for babies, scar management, school and illness, secondhand smoke, secondhand smoke and cystic fibrosis, service animals at Nationwide Children's Hospital, and splenectomy.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as secondhand smoke, cystic fibrosis, service animals, splenectomy, hard splints, stem cell transplant, HLA typing, stool collection guidelines, and smoking cessation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Some of the topics covered in the text include hard splints, stem cell transplant, stool collection guidelines, stop smoking, stop smoking programs, and suctioning the nose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some examples of topics covered in the 'Stop Smoking Programs'?\", 'role': 'user'}, {'content': 'Suctioning the Nose Human Powered Nasal Suction Tube, Suctioning the Nose with a Bulb Syringe, Sweat Chloride Test Collection Guidelines, Temperature: Digital and Glass Thermometers, Throat Culture', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the topics covered in the text?', 'role': 'user'}, {'content': 'The topics covered in the text are Sweat Chloride Test Collection Guidelines, Temperature: Digital and Glass Thermometers, Throat Culture, Tips and Suggestions for Taking Asthma Medicine, Toilet Training, Tonsillectomy and Adenoidectomy, and Treating Pain After Surgery.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of Universal Newborn Hearing Screening (UNHS)?', 'role': 'user'}, {'content': 'The purpose of Universal Newborn Hearing Screening (UNHS) is to identify hearing loss in newborns early on so that appropriate interventions can be implemented.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the U-Bag Urine Collection Guidelines for Males and Females document?', 'role': 'user'}, {'content': 'The topics covered include Ultrasound Scan, Universal Newborn Hearing Screening (UNHS), Use of Electronic Devices, Vagus Nerve Stimulation (VNS), and Videofluoroscopic Swallow Study.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Some of the topics covered in the text include Vagus Nerve Stimulation (VNS), Videofluoroscopic Swallow Study, Weaning Your Baby: Cup Feeding, and Well-Baby Visits at different ages.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the text 'Well-Baby Visits: 12 Months'?\", 'role': 'user'}, {'content': 'The focus of the text is on well-baby visits at 12 months of age.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Some of the topics covered in the text include Well-Baby Visits for newborns, 1 month, and 2 months, Well-Baby Visits for 15 months and 18 months, X-Ray, Adrenocorticotropin (ACTH) Stimulation Test, Advance Directives, Adenoid Removal (Adenoidectomy), and Hospital Admission for COVID-19.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the term for the surgical procedure to remove the adenoids?', 'role': 'user'}, {'content': 'Adenoidectomy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of Alveolar Bone Grafting Surgery?', 'role': 'user'}, {'content': 'Alveolar Bone Grafting Surgery is performed to repair cleft lip and palate defects by filling in the gaps in the alveolar ridge with bone grafts.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the second item listed in the text?', 'role': 'user'}, {'content': 'Aspen® Cervical Collar', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of 'Bone Health in Cerebral Palsy'?\", 'role': 'user'}, {'content': 'Bone health in individuals with cerebral palsy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the topics covered in the document 'Cochlear Implant: Care After Surgery'?\", 'role': 'user'}, {'content': 'Coping with Medicines, Creating a Purposeful Auditory Environment, Dental: Oral Sedation, Developmental Milestones: 0 to 6 Months, Developmental Milestones: 12 to 18 Months', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the medication mentioned in the text?', 'role': 'user'}, {'content': 'Diazepam Rectal Gel (Diastat)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the text 'Developmental Milestones: 18 to 24 Months'?\", 'role': 'user'}, {'content': 'The focus of the text is on the developmental milestones for children between 18 to 24 months of age.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the section that discusses 'Helping Children Cope After Trauma'?\", 'role': 'user'}, {'content': 'Helping Children Cope After Trauma', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the text 'Intranasal Diazepam Spray'?\", 'role': 'user'}, {'content': 'Intranasal Diazepam Spray', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about various medical topics such as Idiopathic Toe Walking, Intranasal Diazepam Spray, Intranasal Midazolam Spray, Iron Infusions, Kidney Injury, and Kidney Shields.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics including Intranasal Midazolam Spray, Iron Infusions, Kidney Injury, Kidney Shields, Liver Injury, Marijuana, Medicine Prior Authorization, and Medicine Safety - General.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including liver injury, marijuana, medicine prior authorization, medicine safety, menstrual period, MiraLAX, GlycoLax, and Pasteurized Donor Milk for hospitalized babies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'The topics covered in the text include Menstrual Period, Pasteurized Donor Milk for Your Hospitalized Baby, Patellar Tendonitis (Jumpers Knee), Preparing the Skin Before Surgery, and Protecting Babies and Young Children from Contagious Illnesses Without Masks.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the text?', 'role': 'user'}, {'content': 'The text focuses on various medical topics such as Patellar Tendonitis, Rapid Genome Sequencing, Sickle Cell Disease, and ways to protect babies and young children from contagious illnesses.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the section that discusses the relationship between Sickle Cell Disease and Stroke?', 'role': 'user'}, {'content': 'Sickle Cell Disease and Stroke', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What medical procedure involves using ultrasound to measure blood flow in the brain?', 'role': 'user'}, {'content': 'Transcranial Doppler (TCD) Ultrasound', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics including Speech and Communication Evaluations for Babies with Hearing Loss, Sports Medicine: Femoral Anteversion, Transcranial Doppler (TCD) Ultrasound, Vaping, Vitamin A and Eye Health, Antibiotic Resistance, and Antroduodenal Manometry.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics including vaping, Vitamin A and eye health, antibiotic resistance, and different types of appendectomies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the medical term for the surgical removal of the appendix?', 'role': 'user'}, {'content': 'Appendectomy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the text?', 'role': 'user'}, {'content': 'Elbow Immobilizers (Welcome Sleeves)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about various topics related to health and medicine, including bike safety, biosimilar medicines, biofeedback for constipation and pelvic floor dysfunction, emergency contraception, progestin-only contraceptive pills, and the gastrointestinal body system.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of birth control method is discussed in the text?', 'role': 'user'}, {'content': 'Emergency Contraception', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the body systems mentioned in the text?', 'role': 'user'}, {'content': 'Skeletal, Urinary (Female and Male), Reproductive (Female and Male)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the 'Bone Density Scanning (DEXA DXA)' procedure?\", 'role': 'user'}, {'content': \"The focus of the 'Bone Density Scanning (DEXA DXA)' procedure is to assess bone density.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What medical procedure involves the use of a bone scan in nuclear medicine?', 'role': 'user'}, {'content': 'Bone Scan: Nuclear Medicine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical procedures and topics such as bone scans, bronchoscopy, buccal medicines, BRUE, breast milk pumping, and nutrition for burns.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the document related to burns?', 'role': 'user'}, {'content': 'The topics covered in the document related to burns include nutrition, scar management, burn prevention activities, and split thickness skin grafts.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various topics related to burns, scar management, burn prevention, skin grafts, infant and toddler burn prevention, wearing pressure garments, capsule endoscopy, and cardiac catheterization care at home for adults.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'The topics covered in the text include wearing a pressure garment, capsule endoscopy, cardiac catheterization care at home for adults and pediatric patients, trusting health information on the web, and care conferences for families.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The topic of the text is about different aspects of cardiac catheterization care at home for pediatric patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of a Cecostomy Tube?', 'role': 'user'}, {'content': 'A Cecostomy Tube is used for decompression and irrigation of the cecum and ascending colon.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various medical procedures and safety measures for infants aged newborn to 12 months.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The topics covered in the text are Child Passenger Safety, Circumcision, and Children With Hearing Loss.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics related to child health and medical procedures.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the document that provides instructions after cleft palate repair surgery?', 'role': 'user'}, {'content': 'Cleft Palate Repair: Instructions After Surgery', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Cleft Palate Repair, Colonoscopy with General Anesthesia for adults, infants, and toddlers', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about various medical procedures and precautions related to infants, toddlers, and pediatric patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of study is mentioned in the text?', 'role': 'user'}, {'content': 'Colonic Marker Study', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics related to dental care and medical procedures.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various dental topics such as wearing a palatal expander, dental injury post-treatment instructions, teeth and gum care for infants and toddlers, and wearing a retainer.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical procedures and care instructions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of care is recommended after Ear Surgery, specifically Tympanoplasty and/or Mastoidectomy?', 'role': 'user'}, {'content': 'Care after Tympanoplasty and/or Mastoidectomy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered in the text?', 'role': 'user'}, {'content': 'Dry Skin Care, Ear Surgery care after Tympanoplasty and/or Mastoidectomy, Hand Exercises, ECMO (Extracorporeal Membrane Oxygenation), Lower Extremities Exercises for both active and passive movements.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of exercises are recommended for the lower extremities of an older child?', 'role': 'user'}, {'content': 'Passive exercises', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of exercises are mentioned in the text?', 'role': 'user'}, {'content': 'Exercises for Upper Extremities, Exercise for Fitness', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of therapy is mentioned in the text?', 'role': 'user'}, {'content': 'Epilepsy Diet Therapy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of 'Eye Surgery Under Anesthesia'?\", 'role': 'user'}, {'content': 'Eye surgery', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the Fiberoptic Endoscopic Evaluation of Swallowing (FEES) test?', 'role': 'user'}, {'content': 'The purpose of the Fiberoptic Endoscopic Evaluation of Swallowing (FEES) test is to evaluate swallowing function.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of a Fluorescein Angiography?', 'role': 'user'}, {'content': 'Fluorescein Angiography is a diagnostic test used to examine blood circulation in the back of the eye.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the Film Array Viral Panel (FARVPP)?', 'role': 'user'}, {'content': 'The purpose of the Film Array Viral Panel (FARVPP) is to test for various viral infections.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What medical procedure involves the removal of the gallbladder?', 'role': 'user'}, {'content': 'Gallbladder Removal (Cholecystectomy)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the text?', 'role': 'user'}, {'content': \"The title of the text is 'Growth Hormone Stimulation Test (Outpatient)'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical procedures and guidelines such as glucose tolerance test, drug facts label, growth hormone stimulation test, guided growth surgery, hymenectomy, impedance pH monitoring, and helping children cope during visits to the doctor.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text lists various medical topics including Hymenectomy, Impedance pH Monitoring, Helping Children Cope During Visits to the Doctor, High Fiber Diet, Hip Subluxation, Dislocation and Surveillance in Children with Cerebral Palsy (CP), and HIV Prevention.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics including Hip Subluxation, Dislocation and Surveillance in Children with Cerebral Palsy, HIV Prevention, Intrauterine Device Removal, Intraventricular Hemorrhage, and the Honda Center for Gait Analysis and Mobility Enhancement.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What procedure involves the removal of an intrauterine device?', 'role': 'user'}, {'content': 'Intrauterine Device Removal', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What procedure involves injecting a dye into the veins to visualize the kidneys, ureters, and bladder?', 'role': 'user'}, {'content': 'IVP (Intravenous Pyelogram)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics mentioned in the text?', 'role': 'user'}, {'content': 'Labiaplasty, Important Facts about Taking Opioids, Magnetic Resonance Enterography (MR-E), Medical Identification (ID), IV Central Line Preventing Bloodstream infections, Mepilex Ag Dressing', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What type of care does the article 'Moving from Pediatric to Adult Care: Finding a Doctor' discuss?\", 'role': 'user'}, {'content': 'Moving from pediatric to adult care and finding a doctor', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the section 'IV: Implanted Port Care at Home'?\", 'role': 'user'}, {'content': 'Implanted Port Care at Home', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of topics covered in the transition from pediatric to adult care?', 'role': 'user'}, {'content': 'Some examples of topics covered in the transition from pediatric to adult care include Jackson Pratt Drainage Tube, MRSA Decolonization, Nail Changes, Nasal Turbinate Reduction, Nephrostomy Tube, and Kangaroo Care for Your Infant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What medical procedure involves the reduction of nasal turbinates?', 'role': 'user'}, {'content': 'Nasal Turbinate Reduction', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the NTrainer® Pacifier System?', 'role': 'user'}, {'content': 'The NTrainer® Pacifier System is used for neurogenic bowel training.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical procedures and treatments such as Chelation Therapy, Orchidopexy, Mandibular Distraction Osteogenesis, and Patch Testing for Skin Allergies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'Management and Treatment of Neuromuscular Scoliosis in Spina Bifida', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the text?', 'role': 'user'}, {'content': 'The text focuses on various medical procedures and treatments such as mouth care for patients receiving chemotherapy, Mehta cast for early onset scoliosis, phototherapy for skin conditions, prescription medicines, microarray analysis test, and renal scan.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the Multi-View Videofluoroscopic Speech Study (MVSS)?', 'role': 'user'}, {'content': 'The focus of the Multi-View Videofluoroscopic Speech Study (MVSS) is on speech.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the Nasopharyngoscopic Evaluation of Velopharyngeal Closure During Speech?', 'role': 'user'}, {'content': 'The focus is on evaluating the closure of the velopharynx during speech.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the nasopharyngoscopic evaluation mentioned in the text?', 'role': 'user'}, {'content': 'The focus is on evaluating velopharyngeal closure during speech.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics including Obesity and Overweight Prevention, Social Security Disability Insurance (SSDI), Orthodontics, Osteopathic Manipulative Medicine, and Pain Management.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Patient Safety in the Health Care Setting'?\", 'role': 'user'}, {'content': 'Patient safety in the health care setting', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'Patient Safety in the Health Care Setting', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as surgery centers, pinworm test collection, PPF surgery, teenage pregnancy, teething, and radiology.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as teenage pregnancy, teething, radiology, tissue expansion, tissue expansion at home, and tracheostomy care.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the topics covered in the text?', 'role': 'user'}, {'content': 'Tissue Expansion, Tracheostomy Care, Saliva Cortisol Test Collection Guidelines, Scoliosis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various medical topics such as Tracheostomy, Scoliosis, and Transmission-Based Precautions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The topics covered in the text include Tracheostomy, Transmission-Based Precautions, Transtelephonic Monitor, Travel Bag for Trach Care, Sibling Rivalry, and Sleep Study.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the section that discusses 'Sibling Rivalry'?\", 'role': 'user'}, {'content': 'Travel Bag for Trach Care', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the text 'All About Surgeries and Procedures'?\", 'role': 'user'}, {'content': 'The focus of the text is on various surgeries and procedures such as Upper Endoscopy with General Anesthesia, Urine Dip Tests, Sphincter Pharyngoplasty Surgery, Spinal Fusion, Spinal Tap, and Warts: Liquid Nitrogen Treatment.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the text 'Talking to a Child About Racism'?\", 'role': 'user'}, {'content': \"The topic of the text is 'Talking to a Child About Racism'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics related to health and medical procedures, such as yoga exercises, swaddling, talking to children about racism, tongue-lip adhesion, urodynamics, uroflow and electromyography tests, and urology biofeedback therapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the procedures or tests related to urology mentioned in the text?', 'role': 'user'}, {'content': 'Tongue-Lip Adhesion, Uroflow and Electromyography Tests, Urology Biofeedback Therapy', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some possible symptoms of a sickle cell disease pain episode?', 'role': 'user'}, {'content': 'Possible symptoms of a sickle cell disease pain episode include something hurts, behavior changes, appetite changes, not using the leg, arm, or body part that hurts, being fussy and hard to comfort, swollen and painful areas on the body, and being less active than usual.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some ways to help ease a child's pain at home according to the text?\", 'role': 'user'}, {'content': \"Some ways to help ease a child's pain at home include applying a warm, moist towel or heating pad, having them drink fluids, massaging the painful area, getting extra rest, and focusing on activities other than the pain.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some ways to help ease a child's sickle cell pain?\", 'role': 'user'}, {'content': \"Some ways to help ease a child's sickle cell pain include applying a warm, moist towel or heating pad, having them drink fluids, massaging the painful area, getting extra rest, focusing on activities other than the pain, and giving pain medicines as directed by their doctor.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some daily habits and medicines that can help prevent or reduce sickle cell pain?', 'role': 'user'}, {'content': 'Some daily habits and medicines that can help prevent or reduce sickle cell pain include getting enough sleep, following the green section of the Sickle Cell Action Plan, eating a healthy diet, daily physical activity, drinking enough water, psychosocial support, and taking prescribed medicines like hydroxyurea, Endari®, voxelotor (Oxybryta®), or crizanlizumab (Adakveo®).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some signs that indicate it is time to call the doctor for a sickle cell patient?', 'role': 'user'}, {'content': 'Some signs that indicate it is time to call the doctor for a sickle cell patient include pain that is too intense to manage at home, pain that has not gone away after 2 days of treatment at home, stiff neck, severe headache, dizziness, chest or back pain with a constant cough or trouble breathing, refusal to eat, drink, or take medicine, and severe stomach pain or swelling with pale skin or being more sleepy than usual.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When should you call 911 for emergency help for your child?', 'role': 'user'}, {'content': 'You should call 911 for emergency help if your child is breathing slowly or stops breathing, is unresponsive and cannot talk to you, cannot wake after a nap, or has sudden weakness, loss of feeling, or cannot move a body part.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the purpose of the 'Le Rofsed' section on the menu?\", 'role': 'user'}, {'content': \"The 'Le Rofsed' section provides information about who they are.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les différents sujets abordés dans la rubrique 'Autres informations médicales' ?\", 'role': 'user'}, {'content': \"Les différents sujets abordés dans la rubrique 'Autres informations médicales' sont : Se faire dépister, Transfusion, L'éducation thérapeutique, Nos conseils, Sport, Orientation professionnelle, Scolarité, Voyages, Le jeu - le film, Pour les jeunes, Le jeu, Le film, Contact, Mentions légales, FAQ, A propos, Je n'ai pas de compte, Je m'identifie, Le Rofsed, Qui sommes nous ?, Actualités, Contact, Présentation.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the sections listed on the website?', 'role': 'user'}, {'content': \"Some of the sections listed on the website are Actualités, Contact, Présentation, L'équipe, Adhérer au ROFSED, Créer mon espace perso, and Liens utiles.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The topic of the text is about the disease called sickle cell anemia (drépanocytose in French).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': \"The topic of the text is 'Formations' and specifically discusses 'La drépanocytose' (sickle cell disease).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the section that discusses the mechanisms of the disease?', 'role': 'user'}, {'content': 'Les mécanismes de la maladie', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que l'éducation thérapeutique ?\", 'role': 'user'}, {'content': \"L'éducation thérapeutique est un processus qui vise à aider les patients à acquérir ou maintenir les compétences dont ils ont besoin pour gérer au mieux leur vie avec une maladie chronique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is being discussed in the text?', 'role': 'user'}, {'content': 'The text is discussing therapeutic education and its various aspects such as sports, career guidance, education, and travel.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about different sections related to career orientation, education, travel, games, movies, sickle cell disease, adolescent questions, and medical information.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi être drépanocytaire ne vous empêche-t-il pas d'avoir des enfants ?\", 'role': 'user'}, {'content': \"Être drépanocytaire ne vous empêche pas d'avoir des enfants car le corps change au moment de la puberté pour permettre la procréation, comme pour toute personne en bonne santé.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Qu’est ce que la contraception ?', 'role': 'user'}, {'content': 'La contraception est un ensemble de moyens visant à empêcher une grossesse non désirée lors de rapports sexuels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont quelques moyens de contraception mentionnés dans le texte?', 'role': 'user'}, {'content': 'Le préservatif, la pilule, le stérilet', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can high school students get a consultation with a doctor and a prescription for contraception anonymously and for free?', 'role': 'user'}, {'content': \"High school students can get a consultation with a doctor and a prescription for contraception anonymously and for free by asking the school nurse for the 'pass contraception' or by visiting the centers for family planning.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Que doit-on faire pour obtenir la pilule contraceptive selon le texte ?', 'role': 'user'}, {'content': 'Il faut en parler à son médecin qui pourra la prescrire en fonction du mode de vie et des souhaits de la personne.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la pilule du lendemain et dans quelles circonstances doit-elle être utilisée ?\", 'role': 'user'}, {'content': \"La pilule du lendemain est une méthode de rattrapage qui doit être utilisée de façon exceptionnelle pour éviter une grossesse non désirée après un accident tel qu'une rupture de préservatif ou un oubli de pilule. Elle est efficace dans 75 à 80 % des cas.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important que le médecin soit informé de la drépanocytose d'une personne avant une interruption volontaire de grossesse (IVG) ?\", 'role': 'user'}, {'content': \"Il est important que le médecin soit informé de la drépanocytose d'une personne avant une IVG car des précautions spécifiques doivent être prises, telles qu'un échange transfusionnel, en fonction des antécédents de la personne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de consulter un conseiller génétique si votre conjoint est porteur du trait drépanocytaire?', 'role': 'user'}, {'content': 'Il est recommandé de consulter un conseiller génétique pour déterminer le choix de recourir ou non au dépistage prénatal et pour prendre des décisions éclairées concernant la grossesse en cas de drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi la grossesse d'une femme drépanocytaire est-elle considérée comme une grossesse à risque?\", 'role': 'user'}, {'content': \"La grossesse d'une femme drépanocytaire est considérée comme une grossesse à risque en raison des risques de complications maternelles (anémie, crise vaso-occlusive, hypertension artérielle, infection) et des risques de complications pour le bébé (fausse couche, prématurité, retard de croissance).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Combien de personnes, en France, vivent avec la drépanocytose ?', 'role': 'user'}, {'content': 'Il y aurait environ 12 000 personnes en France qui seraient atteintes de la drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Combien de personnes, en France, vivent avec la drépanocytose ?', 'role': 'user'}, {'content': 'Environ 12 000 personnes en France seraient atteintes de la drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont quelques-unes des mesures simples de prévention recommandées pour éviter les crises selon le texte?', 'role': 'user'}, {'content': 'Boire fréquemment de l’eau, rester au chaud, manger des aliments riches en fer, ne pas s’enrhumer, porter des vêtements amples, ne pas s’essouffler, éviter d’aller à plus de 1 500 mètres d’altitude, ne pas s’exposer à de fortes chaleurs, éviter de croiser les jambes, éviter les courants d’air, faire attention aux variations de températures, éviter le stress, consulter régulièrement son médecin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines des bonnes pratiques recommandées pour prévenir les complications liées à la drépanocytose?', 'role': 'user'}, {'content': \"Porter des vêtements amples, éviter de s'exposer à de fortes chaleurs, éviter de se croiser les jambes, éviter les courants d'air, faire attention aux variations de températures, éviter le stress, consulter régulièrement son médecin.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels facteurs peuvent favoriser les complications aiguës de la maladie?', 'role': 'user'}, {'content': 'Un temps froid, une variation de température ou un manque d’oxygène peuvent favoriser les complications aiguës de la maladie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il important de discuter avec votre médecin spécialiste si vous êtes atteint de drépanocytose?', 'role': 'user'}, {'content': \"Il est important de discuter avec votre médecin spécialiste pour comprendre votre cas particulier, car la drépanocytose s'exprime de manière variable en fonction des individus et toutes les complications ne se manifestent pas chez toutes les personnes touchées.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes majeurs de la drépanocytose?', 'role': 'user'}, {'content': 'Les crises vaso-occlusives, caractérisées par des épisodes de douleurs intenses causées par le blocage de la circulation sanguine par les globules rouges en forme de croissant de lune.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la comparaison faite entre la douleur ressentie par les personnes atteintes de drépanocytose et celle d'un infarctus cardiaque?\", 'role': 'user'}, {'content': \"La douleur ressentie par les personnes atteintes de drépanocytose est comparable à celle d'un infarctus cardiaque.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Que doivent faire les patients en cas de douleurs avec un niveau d'intensité élevé ou si les douleurs ne disparaissent pas après la réalisation du premier protocole?\", 'role': 'user'}, {'content': \"Les patients doivent se rendre à l'hôpital.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'un des symptômes les plus fréquents de la drépanocytose?\", 'role': 'user'}, {'content': \"L'anémie\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of anemia in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some symptoms of anemia in individuals with sickle cell disease include fatigue, rapid shortness of breath, and low resistance to physical exertion.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi les personnes touchées par la drépanocytose sont-elles plus vulnérables aux infections?', 'role': 'user'}, {'content': \"Les personnes touchées par la drépanocytose sont plus vulnérables aux infections en raison d'un système immunitaire plus faible, notamment en lien avec une rate souvent non fonctionnelle.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'une des complications chroniques de la drépanocytose mentionnée dans le texte?\", 'role': 'user'}, {'content': \"L'ostéonécrose est une des complications chroniques de la drépanocytose, caractérisée par la destruction progressive de certains os.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les examens radiologiques qui permettent de contrôler les complications cérébrales chez les patients drépanocytaires?', 'role': 'user'}, {'content': \"Les examens radiologiques tels que le doppler transcranien et l'IRM permettent de contrôler les complications cérébrales chez les patients drépanocytaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les deux organes les plus fréquemment affectés par la drépanocytose selon le texte?', 'role': 'user'}, {'content': 'Les organes les plus fréquemment affectés par la drépanocytose sont les reins (insuffisance rénale) et le foie (insuffisance hépatique).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le priapisme et comment affecte-t-il les hommes atteints de drépanocytose?\", 'role': 'user'}, {'content': \"Le priapisme est une complication sévère de la drépanocytose qui touche uniquement les patients de sexe masculin. Il s'agit d'une crise qui survient dans le penis et entraine une érection très douloureuse persistante non induite par une stimulation sexuelle. Des épisodes répétés peuvent affecter la fonction érectile et les possibilités d'avoir des enfants pour les hommes drépanocytaires car ils affectent le nombre de spermatozoïdes.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le priapisme et comment affecte-t-il les hommes atteints de drépanocytose?\", 'role': 'user'}, {'content': \"Le priapisme est une crise d'érection douloureuse persistante non provoquée par une stimulation sexuelle qui affecte les hommes atteints de drépanocytose en pouvant altérer leur fonction érectile et leurs chances de procréer en réduisant le nombre de spermatozoïdes.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les mesures de traitement standard pour l'ulcère de jambe?\", 'role': 'user'}, {'content': 'Le traitement standard pour l’ulcère de jambe est le port d’un collant/chaussette de contention, la limitation des mouvements et les soins infirmiers jusqu’à cicatrisation de la plaie. Dans les cas sévères, la greffe de peau peut-être proposée afin de faciliter la cicatrisation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main focus of the text?', 'role': 'user'}, {'content': 'The main focus of the text is on the editors of medical journals in French-speaking Africa and the Maghreb region who closely follow health news in those countries.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de suivre les liens placés à la fin des articles?', 'role': 'user'}, {'content': \"Il est recommandé de suivre les liens placés à la fin des articles pour lire le document original et contacter l'auteur ou le responsable de la publication, si nécessaire.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de suivre les liens placés à la fin des articles?', 'role': 'user'}, {'content': \"Il est recommandé de suivre les liens placés à la fin des articles pour lire le document original et contacter l'auteur ou le responsable de la publication.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Où s'est tenu le deuxième Congrès de lutte contre la drépanocytose?\", 'role': 'user'}, {'content': \"Le deuxième Congrès de lutte contre la drépanocytose s'est tenu à Cotonou, au Bénin.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la maladie génétique la plus répandue dans les milieux tropicaux, principalement en Afrique?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la conséquence de l'anomalie de l'hémoglobine sur le globule rouge?\", 'role': 'user'}, {'content': 'Le globule rouge drépanocytaire prend un aspect de faucille.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose?', 'role': 'user'}, {'content': \"La drépanocytose provoque une anémie chronique, des crises extrêmement douloureuses et des complications qui touchent la rate et, à l'âge adulte, les vaisseaux.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements recommandés pour les enfants drépanocytaires?', 'role': 'user'}, {'content': 'La supplémentation en vitamine B9, un traitement à base de pénicilline, des traitements antidouleurs et des anti-inflammatoires.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains signes que le drépanocytaire doit reconnaître pour consulter un médecin?', 'role': 'user'}, {'content': 'Le blanc des yeux devient jaune, la rate gonfle', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est-elle mal appréciée en Afrique subsaharienne?', 'role': 'user'}, {'content': \"La drépanocytose est mal appréciée en Afrique subsaharienne en raison du manque de dépistage systématique à la naissance, ce qui entraîne des décès d'enfants et rend la prise en charge coûteuse et difficile.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi le dépistage à la naissance est-il une étape essentielle dans l'approche médicale adaptée aux réalités africaines?\", 'role': 'user'}, {'content': \"Le dépistage à la naissance est une étape essentielle car il peut être réalisé grâce à un test facile à réaliser et bon marché, permettant ainsi d'informer les parents sur la maladie et ses traitements, ainsi que sur les précautions à prendre au quotidien.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est-elle avant tout une maladie de la douleur?', 'role': 'user'}, {'content': \"La drépanocytose est avant tout une maladie de la douleur car la mutation génétique affecte la constitution de l'hémoglobine, rendant les globules rouges sanguins incapables de transporter convenablement l'oxygène dans les plus petits vaisseaux sanguins, ce qui entraîne des douleurs terribles.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les effets de la drépanocytose sur les globules rouges sanguins?', 'role': 'user'}, {'content': \"La drépanocytose rend la circulation des globules rouges sanguins impossible dans les plus petits vaisseaux sanguins, privant ainsi les tissus d'oxygène et entraînant des douleurs terribles.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi la faute est-elle souvent rejetée sur la mère de l'enfant malade en Afrique?\", 'role': 'user'}, {'content': \"La faute est souvent rejetée sur la mère de l'enfant malade en Afrique en raison d'une fausse représentation de la conception qui serait assumée seulement par la mère.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les effets de la drépanocytose sur l'organisme selon le texte?\", 'role': 'user'}, {'content': \"La drépanocytose peut causer d'autres dégâts sur l'organisme tels que l'anémie, les infections virales ou bactériennes. Ces effets peuvent être aggravés par des facteurs tels que la malnutrition, le paludisme, le climat froid et l'insalubrité du logis.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont certains facteurs qui peuvent aggraver les effets de la drépanocytose sur l'organisme?\", 'role': 'user'}, {'content': \"La malnutrition, le paludisme, le climat froid, l'insalubrité du logis\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Selon le Pr Gil Tchernia, pourquoi la drépanocytose est-elle souvent mal prise en charge dans les pays où elle est la plus fréquente?', 'role': 'user'}, {'content': 'La drépanocytose est souvent mal prise en charge dans les pays où elle est la plus fréquente en raison de raisons essentiellement économiques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who holds the copyright for the text?', 'role': 'user'}, {'content': 'NG COM Santé tropicale', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the categories available on the website related to medications and health?', 'role': 'user'}, {'content': 'Categories include medications by brand name, specialty name, active substance, laboratory, therapeutic domain, ATC class, indication, prescription analysis, calculators and converters, proper medication use, and news.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Maladies de A à Z, Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, and Sport.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, Sport, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the symptoms of drépanocytose?', 'role': 'user'}, {'content': 'The symptoms of drépanocytose include fatigue, shortness of breath, dizziness, pale skin, and jaundice.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quand a été mise à jour l'article sur les symptômes de la drépanocytose?\", 'role': 'user'}, {'content': '02 décembre 2021', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les trois symptômes les plus fréquents de la drépanocytose selon le texte ?', 'role': 'user'}, {'content': 'Les trois symptômes les plus fréquents de la drépanocytose sont l’anémie chronique, la fièvre liée à une plus grande susceptibilité aux infections, et les crises vaso-occlusives.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les trois symptômes de la drépanocytose les plus fréquents mentionnés dans le texte?', 'role': 'user'}, {'content': 'Les trois symptômes de la drépanocytose les plus fréquents sont l’anémie chronique, la fièvre liée à une plus grande susceptibilité aux infections, et les crises vaso-occlusives.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes de l'anémie chronique dans la drépanocytose?\", 'role': 'user'}, {'content': \"Les symptômes de l'anémie chronique dans la drépanocytose incluent la fatigue, la faiblesse, l'essoufflement, une accélération des battements du cœur, une couleur jaune des yeux et de la peau, et une fatigabilité.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes de l'anémie sévère selon le texte?\", 'role': 'user'}, {'content': \"L'anémie sévère se traduit par un essoufflement et une accélération des battements du cœur.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la méthode utilisée pour éviter les infections chez les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': 'Les enfants atteints de drépanocytose sont non seulement vaccinés mais également traités par antibiotique sans interruption jusqu’à l’âge d’au moins 5 ans.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui provoque les crises vaso-occlusives dans la drépanocytose?\", 'role': 'user'}, {'content': \"Les crises vaso-occlusives sont dues à l'obstruction des petits vaisseaux sanguins par des globules rouges déformés.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains facteurs qui favorisent les crises vaso-occlusives?', 'role': 'user'}, {'content': 'La déshydratation, la chaleur, les efforts intenses, le froid, l’altitude, le stress, la fièvre et les infections', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes d'une crise vaso-occlusive touchant le cerveau chez les enfants atteints de drépanocytose?\", 'role': 'user'}, {'content': 'Les symptômes sont similaires à ceux des AIT (accidents ischémiques transitoires) ou des AVC (accidents vasculaires cérébraux), tels que des maux de tête, des troubles neurologiques soudains, des pertes d’attention, des problèmes d’apprentissage, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi les enfants atteints de drépanocytose sont-ils régulièrement surveillés par des échographies doppler transcrâniennes?', 'role': 'user'}, {'content': 'Ils sont surveillés pour détecter précocement des signes d’AIT ou d’AVC.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les conditions requises pour ajouter un commentaire dans l'espace participatif 'Commentaires'?\", 'role': 'user'}, {'content': \"Il faut être âgé(e) d'au moins 16 ans et avoir lu et accepté les règles et conditions d'utilisation.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the alert concerning DOLIPRANE 2,4 % buvable mentioned in the text?', 'role': 'user'}, {'content': 'The alert concerns pipettes without graduation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What will soon be prohibited in terms of advertising to the general public regarding Ibuprofen 400 mg?', 'role': 'user'}, {'content': 'Any advertising to the general public', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is VIDAL a signatory of?', 'role': 'user'}, {'content': 'VIDAL is a signatory of the charter of E-HEALTH.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Que se passe-t-il si vous cliquez sur 'Je paramètre les cookies'?\", 'role': 'user'}, {'content': \"Si vous cliquez sur 'Je paramètre les cookies', vous pouvez réaliser un choix granulaire concernant l'utilisation des cookies sur le site.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What will happen if you are logged into your VIDAL user account when making a choice regarding cookies?', 'role': 'user'}, {'content': 'Your choice will be applied across all terminals you use.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can you do on the present module mentioned in the text?', 'role': 'user'}, {'content': \"The present module allows you to configure your cookie settings and choose how you want VIDAL to perform operations of reading and/or writing information on the devices you use to visit VIDAL's websites and applications.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of measuring the audience of the website mentioned in the text?', 'role': 'user'}, {'content': 'The purpose of measuring the audience of the website is to respond to various needs such as measuring performance, detecting navigation issues, optimizing technical performance or ergonomics, estimating server power requirements, analyzing viewed content, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of using cookies to personalize the content on the VIDAL websites?', 'role': 'user'}, {'content': \"The purpose of using cookies to personalize the content on the VIDAL websites is to tailor editorial content and self-promotional content based on the user's usage of the sites, such as pages visited, in order to better meet the user's expectations and needs.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi sont utilisés les cookies mentionnés dans le texte?', 'role': 'user'}, {'content': \"Les cookies sont utilisés pour personnaliser les communications adressées par VIDAL en fonction de l'utilisation des sites et applications édités par VIDAL, et pour afficher des publicités personnalisées en fonction du profil et des activités de l'utilisateur.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why are cookies used by VIDAL and third-party companies?', 'role': 'user'}, {'content': \"Cookies are used to improve the relevance of advertising and content displayed on VIDAL's websites and applications, as well as on third-party sites and applications.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of data can cookies process according to the text?', 'role': 'user'}, {'content': 'Cookies can process data related to personal preferences, interests in products/services, professional practices, consumption habits, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What types of data sources are mentioned in the text for processing in order to offer personalized advertisements?', 'role': 'user'}, {'content': 'The text mentions that data sources such as user and/or client databases, browsing data, and data from third parties can be processed to offer personalized advertisements.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the impact of refusing cookies on the advertisements displayed to the user?', 'role': 'user'}, {'content': 'Refusing cookies will result in non-personalized advertisements that may be less relevant and less valued by advertising partners.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose affecte dans le corps humain?\", 'role': 'user'}, {'content': 'La drépanocytose affecte l’hémoglobine des globules rouges.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et comment est-elle caractérisée?\", 'role': 'user'}, {'content': 'La drépanocytose, aussi appelée anémie falciforme, est une maladie génétique héréditaire touchant les globules rouges. Elle est caractérisée par une anomalie de l’hémoglobine, principale protéine du globule rouge.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et comment affecte-t-elle les globules rouges?\", 'role': 'user'}, {'content': \"La drépanocytose, aussi appelée anémie falciforme, est une maladie génétique héréditaire caractérisée par une anomalie de l’hémoglobine. Cette anomalie provoque des déformations des globules rouges, les rendant fragiles et rigides, ce qui entraîne des complications telles que l'anémie, des crises vaso-occlusives douloureuses et un risque accru d'infections.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que l'hémoglobine transporte depuis les poumons vers les tissus?\", 'role': 'user'}, {'content': \"L'hémoglobine transporte l'oxygène depuis les poumons vers les tissus.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la prévalence de la drépanocytose en France en 2015?', 'role': 'user'}, {'content': \"Une prévalence d'un enfant atteint pour 1 736 naissances.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la cause de la drépanocytose selon le texte?', 'role': 'user'}, {'content': 'Une altération génétique de l’hémoglobine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la cause de la drépanocytose selon le texte?', 'role': 'user'}, {'content': 'La drépanocytose est due à une mutation unique et ponctuelle dans l’ADN du gène codant pour la bêta-globine, situé sur le chromosome 11.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la forme la plus fréquente de la drépanocytose et qu'est-ce qui la distingue des autres formes de la maladie?\", 'role': 'user'}, {'content': 'La forme la plus fréquente de la drépanocytose est associée à la présence de deux copies du gène codant pour l’hémoglobine S, une sur chaque chromosome 11 (forme homozygote SS). Les autres formes de la maladie sont caractérisées par le fait que les patients ne sont porteurs que d’une seule copie du gène codant pour l’hémoglobine S.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est souvent le premier signe de la maladie de la drépanocytose?', 'role': 'user'}, {'content': \"L'anémie est souvent le premier signe de la maladie. Elle se traduit par une pâleur et une fatigue chronique, parfois par une jaunisse (ictère).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes de l'anémie mentionnés dans le texte?\", 'role': 'user'}, {'content': \"Les symptômes de l'anémie mentionnés dans le texte sont la pâleur, la fatigue chronique, parfois une jaunisse (ictère), et une possible aggravation brusque en cas de suractivité de la rate.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui peut aggraver l'anémie de façon importante en cas de drépanocytose?\", 'role': 'user'}, {'content': \"L'infection par le parvovirus B19 peut aggraver l'anémie de façon importante en cas de drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui déclenche les crises vaso-occlusives chez les patients drépanocytaires?\", 'role': 'user'}, {'content': 'Les crises vaso-occlusives sont déclenchées par les globules rouges rigidifiés par les polymères d’hémoglobine S, qui finissent par obstruer la circulation sanguine dans les petits vaisseaux sanguins.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la principale cause de décès des patients atteints de drépanocytose?', 'role': 'user'}, {'content': 'Le syndrome thoracique aigu est la première cause de décès des patients atteints de drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains des symptômes des accidents vasculaires cérébraux (AVC) chez les drépanocytaires?', 'role': 'user'}, {'content': \"Les AVC chez les drépanocytaires peuvent se manifester par des symptômes tels que la paralysie, les maux de tête, l'aphasie et les troubles de l'équilibre.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les effets de la répétition des vaso-occlusions sur la rate des patients drépanocytaires?', 'role': 'user'}, {'content': \"La répétition des vaso-occlusions peut lésée la rate des patients drépanocytaires, la rendant moins efficace dans l'hémolyse des hématies falciformes et favorisant ainsi la survenue d'infections bactériennes.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les risques associés aux infections chez les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Les infections exacerbent les autres manifestations de la drépanocytose comme l’anémie et les occlusions vasculaires, et représentent un risque de mortalité, en particulier chez les enfants aux mécanismes de défense affaiblis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la précocité du diagnostic est-elle importante pour les patients atteints de drépanocytose?', 'role': 'user'}, {'content': 'La précocité du diagnostic conditionne le pronostic des patients, ce qui peut influencer leur quotidien et leur espérance de vie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Comment est réalisé le diagnostic de la drépanocytose aujourd'hui?\", 'role': 'user'}, {'content': \"Le diagnostic de la drépanocytose est aujourd'hui réalisé en premier lieu à partir d'un simple échantillon de sang analysé par différentes méthodes aptes à distinguer l'hémoglobine S de l'hémoglobine normale et des autres variants de l'hémoglobine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quand est réalisé le dépistage néonatal en France et comment est-il effectué?', 'role': 'user'}, {'content': \"Le dépistage néonatal est réalisé en France à la 72ème heure de vie du nourrisson, à partir d'un échantillon sanguin prélevé au niveau du talon du nouveau-né.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la méthode de diagnostic prénatal non invasif récemment développée?', 'role': 'user'}, {'content': \"La méthode de diagnostic prénatal non invasif récemment développée consiste à rechercher la mutation dans l'ADN fœtal circulant en petite quantité dans le sang de la mère à partir d'une simple prise de sang.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pour quelles raisons le diagnostic préimplantatoire (DPI) est-il envisagé pour les couples selon le texte?', 'role': 'user'}, {'content': \"Le DPI est envisagé pour les couples présentant une forte probabilité de donner naissance à un enfant atteint d'une maladie génétique d'une particulière gravité reconnue comme incurable au moment du diagnostic.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'outil indispensable pour la prévention des complications de la drépanocytose selon le texte?\", 'role': 'user'}, {'content': 'Le dépistage néonatal', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux aspects de la prise en charge de la drépanocytose pour la plupart des patients?', 'role': 'user'}, {'content': \"La prise en charge de la drépanocytose pour la plupart des patients s'articule autour d'une prévention des complications et d'un suivi médical régulier.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les conseils donnés pour diminuer le risque de crises douloureuses chez les patients drépanocytaires?', 'role': 'user'}, {'content': \"Une bonne hydratation, éviter l'exposition à des températures extrêmes, éviter les efforts trop intenses, éviter les pièces mal aérées et les séjours à plus de 1 500 mètres d'altitude, et porter des vêtements amples ne coupant pas la circulation sanguine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels organes sont particulièrement suivis lors d'un suivi médical régulier pour évaluer l'évolution de la maladie?\", 'role': 'user'}, {'content': \"Les fonctions rénale et respiratoire ainsi que l'état de l'œil sont particulièrement suivis lors d'un suivi médical régulier pour évaluer l'évolution de la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la transfusion sanguine et en quoi est-elle importante pour les patients drépanocytaires?\", 'role': 'user'}, {'content': \"La transfusion sanguine consiste à transfuser le malade avec le sang d’un donneur sain compatible, permettant ainsi de rétablir un taux acceptable de globules rouges en cas d’anémie aggravée et de «\\xa0diluer\\xa0»\\xa0les globules rouges falciformes avec des globules rouges normaux. Elle est importante pour réduire le risque d'AVC chez les patients drépanocytaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que l'alloimmunisation érythrocytaire et comment peut-elle affecter l'effet bénéfique des transfusions sanguines?\", 'role': 'user'}, {'content': \"L'alloimmunisation érythrocytaire est une réaction du système immunitaire du malade contre le sang du donneur considéré comme étranger. Cela peut compromettre l'effet bénéfique des transfusions sanguines, car le corps du malade réagit contre le sang du donneur.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'effet de l'hydroxycarbamide dans la prévention des vaso-occlusions chez les patients drépanocytaires?\", 'role': 'user'}, {'content': \"L'hydroxycarbamide permet notamment d'augmenter la production de l'hémoglobine fœtale exempte de mutation et de réduire la polymérisation de l'hémoglobine S.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le seul traitement curatif actuellement disponible contre la drépanocytose?', 'role': 'user'}, {'content': 'La greffe de moelle osseuse', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les enjeux de la recherche mentionnés dans le texte?', 'role': 'user'}, {'content': 'Les enjeux de la recherche mentionnés dans le texte sont de trouver des alternatives thérapeutiques pour les malades drépanocytaires, malgré les traitements limités actuellement disponibles.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les mécanismes importants dans la physiopathologie de la drépanocytose selon le texte?', 'role': 'user'}, {'content': \"La destruction des globules rouges malformés conduisant à la présence d’hémoglobine libre et de ses produits de dégradation dans le sang, la dégradation du monoxyde d’azote (NO), la libération d'hème et l'implication de l'endothélium vasculaire, des globules blancs et des plaquettes dans les phénomènes d'occlusion vasculaire.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels autres éléments en plus des globules rouges sont impliqués dans les phénomènes d'occlusion vasculaire liés à la drépanocytose?\", 'role': 'user'}, {'content': \"L'endothélium vasculaire, les globules blancs (notamment les neutrophiles) et les plaquettes sont aussi impliqués dans les phénomènes d'occlusion vasculaire liés à la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main focus of the research mentioned in the text?', 'role': 'user'}, {'content': 'The main focus of the research mentioned in the text is the development of new drugs or the evaluation of prescribed drugs for various indications related to hemoglobin and red blood cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les trois nouveaux médicaments qui ont fait l'objet d'études cliniques probantes selon le texte?\", 'role': 'user'}, {'content': 'Les trois nouveaux médicaments sont le voxelotor, le crizanlizumab et la L-glutamine.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'objectif de la L-glutamine dans le traitement de la drépanocytose?\", 'role': 'user'}, {'content': 'La L-glutamine vise à réduire le stress oxydatif.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main objective of the CADRE project mentioned in the text?', 'role': 'user'}, {'content': 'The main objective of the CADRE project is to study the epidemiology of cardiovascular complications of sickle cell disease in several African countries.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which countries are involved in the epidemiological study of cardiovascular complications of sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Cameroun, Sénégal, Mali, Côte d’Ivoire, and République Démocratique du Congo', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui est en cours d'étude pour identifier les particularités génétiques responsables des variations de la drépanocytose?\", 'role': 'user'}, {'content': 'Des études sont en cours pour identifier des particularités génétiques responsables de ces variations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le rôle du gène BCL11A dans la production d'hémoglobine fœtale?\", 'role': 'user'}, {'content': \"Le gène BCL11A joue un rôle majeur dans l'arrêt de la production d'hémoglobine fœtale peu après la naissance.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels gènes pourraient représenter des cibles intéressantes pour développer des alternatives thérapeutiques à l’hydroxycarbamide?', 'role': 'user'}, {'content': 'Les gènes BCL11A et MYB', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main idea behind using genome editing tools like CRISPR-Cas9 in the text?', 'role': 'user'}, {'content': 'The main idea is to use these tools to correct genetic mutations responsible for diseases or to modify regulatory regions, such as the BCL11A gene, to inhibit the production of sickle cell hemoglobin in favor of fetal hemoglobin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle maladie est mentionnée dans les différents articles sur la thérapie génique?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des documents mentionnés dans le texte?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et quel impact peut-elle avoir sur la qualité de vie des patients?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique du sang qui peut entraîner des crises douloureuses. Elle peut avoir un impact sur la qualité de vie des patients en raison de ses symptômes, complications et de sa nature chronique.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose, également connue sous le nom d'anémie falciforme?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie héréditaire qui altère la forme des globules rouges, chargés de transporter l'oxygène vers toutes les parties du corps.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose affecte dans le corps humain?\", 'role': 'user'}, {'content': \"La drépanocytose affecte les cellules sanguines en provoquant une anomalie sur l'hémoglobine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the characteristics of red blood cells in an individual without the sickle cell gene?', 'role': 'user'}, {'content': 'In an individual without the sickle cell gene, red blood cells are smooth, round, and flexible, allowing them to circulate easily in the blood vessels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la durée de vie des globules rouges falciformes par rapport à celle des globules rouges normaux?', 'role': 'user'}, {'content': 'La durée de vie des globules rouges falciformes est de 10 à 20 jours, contre 120 jours pour des globules rouges normaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment la drépanocytose est-elle transmise selon un schéma autosomique récessif ?', 'role': 'user'}, {'content': \"La drépanocytose est transmise selon un schéma autosomique récessif, ce qui signifie qu'un individu naîtra avec la maladie uniquement s'il hérite de deux gènes défectueux, un de la mère et un du père.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes les plus fréquents de la drépanocytose?', 'role': 'user'}, {'content': 'Les symptômes les plus fréquents de la drépanocytose sont des crises douloureuses.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes les plus fréquents de la drépanocytose?', 'role': 'user'}, {'content': \"Les symptômes les plus fréquents de la drépanocytose sont des crises douloureuses, de l'anémie, une inflammation et un gonflement des articulations, les yeux jaunes, un jaunissement de la peau, et des blocages sanguins dans le foie et la rate.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel test est utilisé pour diagnostiquer la drépanocytose?', 'role': 'user'}, {'content': 'Une simple analyse de sang.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': \"Les traitements de la drépanocytose peuvent inclure la prise de médicaments pour soulager la douleur, la prise d'antibiotiques pour prévenir les infections, la transfusion sanguine pour augmenter le taux d'hémoglobine, et la greffe de moelle osseuse dans certains cas.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'Pour la plupart des personnes atteintes de drépanocytose, le traitement et la prise en charge de la maladie consiste principalement à atténuer la gravité de la maladie et à soulager les symptômes, en particulier les douleurs dues à la drépanocytose. Il n’existe, en effet, pas de traitement curatif permettant de soigner les cas de drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'Les traitements de la drépanocytose peuvent inclure un suivi médical pour prévenir les complications, des transfusions sanguines, une greffe de moelle osseuse et des thérapies géniques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les méthodes recommandées pour prévenir la drépanocytose selon le texte ?', 'role': 'user'}, {'content': 'Les méthodes recommandées pour prévenir la drépanocytose selon le texte sont des transfusions sanguines, une greffe de moelle osseuse et des thérapies géniques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the medical article mentioned in the text?', 'role': 'user'}, {'content': 'The purpose of the medical article is solely informative and does not replace the advice of a doctor.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie d'une personne drépanocytaire en France ?\", 'role': 'user'}, {'content': \"L'espérance de vie des personnes atteintes de drépanocytose en France est de plus de 40 ans en moyenne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie moyenne des personnes drépanocytaires selon les statistiques mentionnées dans le texte ?\", 'role': 'user'}, {'content': \"L'espérance de vie des personnes atteintes est de plus de 40 ans en moyenne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est une maladie génétique ?', 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique car elle est causée par une mutation génétique qui est transmise par les parents aux enfants.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est une maladie génétique ?', 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique car elle est causée par une mutation génétique qui se transmet de génération en génération.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the term for a condition characterized by a deficiency of red blood cells or hemoglobin in the blood?', 'role': 'user'}, {'content': 'Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the medical condition that is characterized by a swollen abdomen and bloating?', 'role': 'user'}, {'content': 'Ventre gonflé, ballonnements', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How many doctors are mentioned in the text?', 'role': 'user'}, {'content': '7,500 doctors', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il important de réfléchir à la façon dont vous souhaitez vivre avec la drépanocytose?', 'role': 'user'}, {'content': 'Il est important de réfléchir à la façon dont vous souhaitez vivre avec la drépanocytose pour vous permettre de prendre votre vie en main et devenir maître de votre vie, plutôt que de laisser la maladie en prendre le contrôle.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important d'établir une relation de confiance avec les personnes qui vous aident à gérer vos symptômes de la drépanocytose?\", 'role': 'user'}, {'content': \"Il est important d'établir une relation de confiance avec les personnes qui vous aident à gérer vos symptômes de la drépanocytose afin qu'elles puissent vous expliquer la conduite à tenir de façon compréhensible et vous aider à garder une vision positive de la situation.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels professionnels de la santé sont en charge du suivi d'une personne atteinte de drépanocytose selon le texte?\", 'role': 'user'}, {'content': \"Un hématologue, un pédiatre (dans le cas d'un enfant) et un spécialiste en médecine interne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important de parler régulièrement de l'impact de la drépanocytose sur votre vie quotidienne?\", 'role': 'user'}, {'content': \"Il est important de parler régulièrement de l'impact de la drépanocytose sur votre vie quotidienne pour avoir une vision générale des retentissements de la maladie et pouvoir évoquer des solutions pour améliorer votre quotidien.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les conseils généraux pour vivre avec la drépanocytose mentionnés dans le texte?', 'role': 'user'}, {'content': \"Les conseils généraux pour vivre avec la drépanocytose mentionnés dans le texte sont de respecter les règles hygiéno-diététiques, de boire abondamment au moins deux litres d'eau par jour, d'avoir un rythme de vie régulier, de dormir suffisamment, d'éviter les efforts intenses et de ne pas s'exposer au froid.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les recommandations pour prévenir les crises dépranocytaires selon le texte?', 'role': 'user'}, {'content': \"Les recommandations pour prévenir les crises dépranocytaires sont : boire au moins deux litres d'eau par jour, avoir un rythme de vie régulier, éviter les efforts intenses, ne pas s'exposer au froid, ne pas faire d'effort violent, éviter le port de vêtements serrés, avoir un suivi dentaire régulier, et ne pas consommer d'alcool ou de tabac.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some recommendations given to prevent infections for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'Some recommendations include avoiding exposure to cold, avoiding strenuous activities, wearing loose clothing, having regular dental check-ups, avoiding alcohol and tobacco, and gradually returning to sports activities.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important de prévenir les infections lorsque l'on est atteint de drépanocytose?\", 'role': 'user'}, {'content': \"Il est important de prévenir les infections lorsque l'on est atteint de drépanocytose pour éviter des complications de santé supplémentaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pour éviter les intoxications alimentaires, que devriez-vous faire en particulier lors du réchauffage et de la consommation des restes alimentaires?', 'role': 'user'}, {'content': 'Assurez-vous que les aliments soient cuits et stockés dans le respect des mesures d’hygiène recommandées.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de demander conseil à son équipe soignante avant de commencer une activité physique?', 'role': 'user'}, {'content': \"Pour savoir comment initier et poursuivre l'activité choisie en toute sécurité.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important d'éviter les températures extrêmes et surtout le froid lors de l'activité physique?\", 'role': 'user'}, {'content': \"Il est important d'éviter les températures extrêmes et surtout le froid lors de l'activité physique pour maintenir une température corporelle équilibrée.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to regularly share your experiences with your healthcare team and other supportive individuals?', 'role': 'user'}, {'content': 'Sharing your experiences can help you cope with the daily challenges faced by patients with chronic illnesses.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of an emergency card mentioned in the text?', 'role': 'user'}, {'content': 'The emergency card contains information to immediately alert emergency services about certain patient characteristics.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important d'informer votre équipe soignante des conséquences de la drépanocytose sur tous les aspects de votre vie?\", 'role': 'user'}, {'content': \"Il est important d'informer votre équipe soignante des conséquences de la drépanocytose sur tous les aspects de votre vie pour signaler tout événement nouveau induit par la maladie sur votre organisme ou votre quotidien.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can you find French guidelines for the management of adult sickle cell disease?', 'role': 'user'}, {'content': 'French guidelines for the management of adult sickle cell disease can be found in the article by Habibi A et al. in Rev Med Interne, 2015.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the document that provides advice on hygiene in the kitchen to prevent microbiological risks?', 'role': 'user'}, {'content': 'Conseils d’hygiène dans la cuisine : dix gestes simples pour prévenir les risques microbiologiques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': 'La drépanocytose de l’enfant', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of services and specialties are mentioned in the text?', 'role': 'user'}, {'content': 'The text mentions pediatric emergencies, healthcare services, access to care services, rare diseases, cancer institute, appointments, patient space, children and teenagers, women and mothers, contact persons, medical records request, and patient engagement.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What options are available for making a donation to the hospital?', 'role': 'user'}, {'content': 'The options available for making a donation to the hospital include making a general donation, making a targeted donation, making a monthly regular donation, making a donation for IFI, and making a donation in kind.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important que l'enfant drépanocytaire boive suffisamment d'eau chaque jour?\", 'role': 'user'}, {'content': \"Il est important que l'enfant drépanocytaire boive suffisamment d'eau chaque jour car la déshydratation est un facteur de risque de déclenchement des crises vaso-occlusives.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important que l'enfant drépanocytaire boive suffisamment d'eau chaque jour?\", 'role': 'user'}, {'content': \"Il est important que l'enfant drépanocytaire boive suffisamment d'eau chaque jour car la déshydratation est un facteur de risque de déclenchement des crises vaso-occlusives.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui facilite la scolarisation des enfants drépanocytaires selon le texte?\", 'role': 'user'}, {'content': \"La scolarisation des enfants drépanocytaires est facilitée par l'établissement d'un PAI (protocole d'accueil individuel) signé par les parents, le médecin de l'éducation nationale et le directeur de l'établissement scolaire, avec l'aide du médecin spécialiste et/ou du médecin traitant.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le PAI (protocole d’accueil individuel) permet de mettre en place pour les enfants atteints de maladies chroniques à l'école?\", 'role': 'user'}, {'content': 'Le PAI permet à l’enfant de boire suffisamment en milieu scolaire et de prendre ses médicaments antalgiques en cas de besoin.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les activités sportives contre-indiquées pour le sujet en question?', 'role': 'user'}, {'content': 'Les sports de compétition ou d’endurance, les baignades en eau froide (< 25°C), les séjours en altitude > 1500 m', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to prepare for trips in advance according to the text?', 'role': 'user'}, {'content': 'It is important to prepare for trips in advance to consult with the treating physician and/or specialist, complete the necessary vaccinations, and receive anti-malarial prophylaxis if needed in order to minimize the risk of complications during the trip.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'objet du suivi médical de l'enfant drépanocytaire?\", 'role': 'user'}, {'content': \"L'objet du suivi médical de l'enfant drépanocytaire est de détecter et de traiter rapidement les complications de la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les cookies considérés comme indispensables pour utiliser les principales fonctionnalités du site?', 'role': 'user'}, {'content': 'Les cookies techniques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les cookies qui sont indispensables pour utiliser les principales fonctionnalités du site et ne peuvent donc pas être désactivés?', 'role': 'user'}, {'content': 'Les cookies techniques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels cookies ne peuvent pas être désactivés selon le texte?', 'role': 'user'}, {'content': 'Les cookies techniques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les deux maladies du sang abordées dans le texte?', 'role': 'user'}, {'content': 'La drépanocytose et la thalassémie', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les thèmes abordés dans la série 'La drépanocytose, une maladie du sang'?\", 'role': 'user'}, {'content': \"Les thèmes abordés dans la série sont : l'origine et diffusion de la drépanocytose, le dépistage, vivre avec la maladie, l'enfant atteint de drépanocytose et l'école, travailler avec la drépanocytose, la prévention des crises, la greffe de moelle osseuse et la thérapie génique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les sujets abordés dans la série 'La drépanocytose, une maladie du sang'?\", 'role': 'user'}, {'content': \"La série aborde des sujets tels que l'origine et la diffusion de la drépanocytose, le dépistage, vivre avec la maladie, les soins et la prévention au quotidien, l'enfant atteint de drépanocytose et l'école, travailler avec la drépanocytose, la prévention des crises, la greffe de moelle osseuse et la thérapie génique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la maladie génétique la plus répandue dans le monde selon le texte ?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Combien de personnes sont porteuses du gène de la drépanocytose selon l'Organisation Mondiale de la Santé?\", 'role': 'user'}, {'content': \"Selon l'Organisation Mondiale de la Santé, on compte 500 millions de personnes porteuses du gène de la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la substance affectée par la drépanocytose dans les globules rouges?', 'role': 'user'}, {'content': \"L'hémoglobine\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le risque d'avoir un enfant drépanocytaire SS lorsque les deux parents sont AS?\", 'role': 'user'}, {'content': \"Il y a un risque de 25% d'avoir un enfant drépanocytaire SS lorsque les deux parents sont AS.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la différence entre une personne AS et une personne SS en ce qui concerne la drépanocytose?', 'role': 'user'}, {'content': \"Une personne AS est porteuse du gène de l'hémoglobine S mais n'est pas atteinte de la maladie, tandis qu'une personne SS a deux gènes S et est atteinte de l'anémie falciforme.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les signes précoces de la maladie chez les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': 'Les signes précoces de la maladie chez les enfants atteints de drépanocytose sont la fatigue, la pâleur, un ictère au niveau des yeux, un retard de croissance et une puberté tardive.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il essentiel d'effectuer un dépistage précoce de la drépanocytose?\", 'role': 'user'}, {'content': \"Il est essentiel d'effectuer un dépistage précoce de la drépanocytose pour permettre la mise en place d'une prise en charge adaptée à la maladie, tout au long de la vie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et quelles sont ses conséquences principales?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique des globules rouges qui transportent moins bien l’oxygène dans le sang. Ses conséquences principales peuvent être une anémie et des crises douloureuses pouvant toucher différents organes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose ?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique du sang qui affecte les globules rouges.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose ?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie génétique héréditaire qui touche autant les femmes que les hommes et se caractérise par l'altération de l'hémoglobine, la protéine qui transporte l'oxygène et le gaz carbonique dans le sang.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et comment se manifeste-t-elle?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie génétique héréditaire qui touche autant les femmes que les hommes. Elle se caractérise par l'altération de l'hémoglobine, la protéine qui transporte l'oxygène et le gaz carbonique dans le sang. La maladie se manifeste par une anémie, une sensibilité aux infections et des poussées douloureuses dues à la mauvaise circulation sanguine et au déficit d'oxygénation des tissus.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la protéine affectée par la maladie décrite dans le texte?', 'role': 'user'}, {'content': \"L'hémoglobine\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les différentes formes de drépanocytose ?', 'role': 'user'}, {'content': 'Il existe deux formes de drépanocytose : la drépanocytose homozygote et la drépanocytose hétérozygote.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la différence entre la drépanocytose homozygote et la drépanocytose hétérozygote en termes de transmission génétique et de manifestation de la maladie?', 'role': 'user'}, {'content': \"La drépanocytose homozygote se manifeste lorsque deux exemplaires du gène portent l'anomalie et est transmise par les deux parents, tandis que la drépanocytose hétérozygote se déclare lorsque l'hémoglobine S n'est transmise que par un parent et la personne porte le gène sans développer la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main cause of sickle cell anemia?', 'role': 'user'}, {'content': 'Sickle cell anemia is mainly caused by an abnormality in the hemoglobin, specifically the presence of abnormal beta chains which lead to the formation of hemoglobin S.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la conséquence de l'agglomération de l'hémoglobine S sur les globules rouges dans le cas de la drépanocytose?\", 'role': 'user'}, {'content': \"Les globules rouges prennent la forme d'une faucille ou d'un croissant lorsque la quantité d'oxygène est plus faible.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What chromosome is involved in the manifestation of sickle cell anemia?', 'role': 'user'}, {'content': 'Chromosome 11', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui détermine la fabrication de la chaîne b de l’hémoglobine selon le texte?\", 'role': 'user'}, {'content': 'La fabrication de la chaîne b de l’hémoglobine dépend des gènes « bêtaglobine » (β-globine) localisés sur le chromosome 11.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les personnes à risque de drépanocytose selon le texte?', 'role': 'user'}, {'content': 'Les personnes à risque de drépanocytose sont celles qui ont deux parents originaires d’une région à risque, ont un seul parent originaire d’une région à risque si le deuxième parent n’est pas connu, ou ont des antécédents familiaux de syndrome drépanocytaire majeur.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux symptômes de la drépanocytose?', 'role': 'user'}, {'content': 'Les principaux symptômes de la drépanocytose sont la douleur par crises inopinées dues à des accidents ischémiques vaso-occlusifs et une anémie hémolytique chronique causée par la destruction des globules rouges anormaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux symptômes de la maladie décrite dans le texte?', 'role': 'user'}, {'content': \"Les principaux symptômes de la maladie sont la douleur par crises, l'anémie hémolytique chronique, les crises d'anémie aiguë et leurs conséquences telles que la fatigue, la pâleur de la peau, la jaunisse, les urines foncées, les essoufflements, la tachycardie, le retard de puberté et de poids, et l'altération de l'état général.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les complications de la drépanocytose ?', 'role': 'user'}, {'content': 'Les complications de la drépanocytose peuvent inclure des crises d’anémie aiguë, fatigue, pâleur de la peau, coloration jaune du blanc de l’œil et de la peau, urines foncées, essoufflements, fréquence cardiaque augmentée, retard de puberté et de poids, altération de l’état général, et une vulnérabilité accrue aux infections bactériennes comme le pneumocoque.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines complications de la drépanocytose selon le Dr Frédéric Galacteros ?', 'role': 'user'}, {'content': \"Selon le Dr Frédéric Galacteros, certaines complications de la drépanocytose peuvent inclure des sepsis à pneumocoques ou à méningocoques, des manifestations anémiques aiguës, une vasculopathie cérébrale, des crises vaso-occlusives osseuses, un syndrome pieds-mains chez les tout-petits, des crises osseuses extrêmement douloureuses chez les adultes, et toute une série d'atteintes organiques chez les sujets âgés.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la séquestration splénique selon le texte?', 'role': 'user'}, {'content': 'Les symptômes de la séquestration splénique selon le texte sont des douleurs abdominales, une augmentation du volume de la rate (splénomégalie), une pâleur et une aggravation de l’anémie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains symptômes des crises aplasiques liées à la drépanocytose?', 'role': 'user'}, {'content': 'Certains symptômes des crises aplasiques liées à la drépanocytose sont la fièvre, des maux de tête et de ventre, des vomissements et une perte d’appétit.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les signes évocateurs qui nécessitent une consultation en urgence pour les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Des accidents ischémiques transitoires (AIT) voire des accidents vasculaires cérébraux (AVC)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie moyenne des personnes atteintes de drépanocytose aujourd'hui ?\", 'role': 'user'}, {'content': 'Plus de 40 ans', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie moyenne des personnes atteintes de drépanocytose aujourd'hui?\", 'role': 'user'}, {'content': 'Plus de 40 ans', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment peut-on prévenir la drépanocytose chez les parents à risque?', 'role': 'user'}, {'content': \"On peut prévenir la drépanocytose chez les parents à risque en réalisant un dépistage prénatal au début de chaque grossesse pour rechercher l'anomalie génétique en étudiant l'ADN du fœtus.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la différence entre la choriocentèse et l'amniocentèse en termes de prélèvement des cellules du futur placenta?\", 'role': 'user'}, {'content': \"La choriocentèse permet le prélèvement de cellules du futur placenta par voie vaginale ou à travers la paroi abdominale de la mère, tandis que l'amniocentèse permet d'obtenir des cellules flottant dans le liquide amniotique à travers la paroi abdominale de la mère.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le dépistage pré-implantatoire et à qui est-il accessible en France?\", 'role': 'user'}, {'content': \"Le dépistage pré-implantatoire (DPI) consiste à rechercher l'anomalie génétique responsable de la maladie sur des embryons obtenus par fécondation in vitro. En France, seuls les couples ayant déjà eu un enfant atteint de drépanocytose ou les couples sans enfants, dont les deux partenaires sont porteurs sains, y ont accès.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les maladies rares qui peuvent être dépistées lors du dépistage néonatal au troisième jour de la naissance?', 'role': 'user'}, {'content': 'Treize maladies rares peuvent être dépistées lors du dépistage néonatal au troisième jour de la naissance.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les mesures préventives qui peuvent être mises en place pour limiter les poussées aiguës de la drépanocytose?', 'role': 'user'}, {'content': \"Les mesures préventives pour limiter les poussées aiguës de la drépanocytose incluent : réduire l'exposition au froid, éviter les efforts intenses, éviter la déshydratation, éviter l'altitude au-dessus de 1 500 mètres, et réaliser scrupuleusement les vaccinations.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment est établi le diagnostic de la drépanocytose ?', 'role': 'user'}, {'content': 'Le diagnostic est posé grâce à des examens sanguins : analyse de la forme des globules rouges, de l’hémoglobine, et tests génétiques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment est établi le diagnostic de la drépanocytose ?', 'role': 'user'}, {'content': 'Le diagnostic est posé grâce à des examens sanguins : analyse de la forme des globules rouges, de l’hémoglobine, et tests génétiques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'La prise en charge des personnes atteintes de la drépanocytose comprend dès la naissance la prévention des infections, de la douleur et des complications, mais aussi la dimension psychologique d’accompagnement du malade.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les objectifs des traitements pour la drépanocytose ?', 'role': 'user'}, {'content': \"Les traitements pour la drépanocytose visent à diminuer la douleur, prévenir les crises, prévenir les infections et complications, et inclure une dimension psychologique d'accompagnement du malade.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements actuels pour la drépanocytose?', 'role': 'user'}, {'content': 'Les traitements actuels ne servent qu’à diminuer la douleur et à prévenir les crises. Des antalgiques peuvent être prescrits en fonction de l’intensité de la douleur, de même que des antibiotiques en cas d’infection.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la transfusion sanguine peut-elle entraîner une réaction du système immunitaire?', 'role': 'user'}, {'content': 'La transfusion sanguine peut entraîner une réaction du système immunitaire car celui-ci peut réagir contre le sang du donneur, considéré comme étranger, ce qui peut conduire à une allo-immunisation érythrocytaire.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel médicament a obtenu une autorisation de mise sur le marché européen pour améliorer la circulation sanguine dans les formes graves de la maladie?', 'role': 'user'}, {'content': 'Un médicament à base d’hydroxycarbamide', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le seul traitement curatif actuellement disponible pour la drépanocytose?', 'role': 'user'}, {'content': 'La transplantation de moelle osseuse', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les domaines de recherche actuels sur la drépanocytose mentionnés dans le texte?', 'role': 'user'}, {'content': \"Les domaines de recherche actuels sur la drépanocytose mentionnés dans le texte sont l'amélioration des traitements via la thérapie génique, l'étude des mécanismes moléculaires de la maladie et le comportement de l'hémoglobine anormale.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le nom de l'expert mentionné dans le texte et dans quel hôpital exerce-t-il ?\", 'role': 'user'}, {'content': \"Dr Frédéric Galacteros, hématologue à l'hôpital Henri-Mondor à Créteil (94)\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les sujets associés mentionnés dans le texte?', 'role': 'user'}, {'content': 'Maladies génétiques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique du sang qui se caractérise par une déformation des globules rouges en forme de faucille.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What services and specialties are offered at the Institut du cancer AP-HP. Nord – Université Paris Cité?', 'role': 'user'}, {'content': 'The services and specialties offered include Enfants et ados, Femmes et mères, Vos interlocuteurs, Demande de dossier médical, and Engagement Patient.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What options are available for making a donation to the hospital?', 'role': 'user'}, {'content': 'The options available for making a donation to the hospital include making a general donation, making a targeted donation, making a monthly regular donation, making a donation for IFI, and making a donation in kind.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the Institut Robert-Debré du Cerveau de l’Enfant?', 'role': 'user'}, {'content': 'The focus of the Institut Robert-Debré du Cerveau de l’Enfant is on research and innovation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et quel est son autre nom?\", 'role': 'user'}, {'content': \"La drépanocytose, également appelée anémie falciforme, est une maladie génétique grave due à une anomalie de l'hémoglobine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'anomalie de l'hémoglobine associée à la drépanocytose?\", 'role': 'user'}, {'content': \"L'anomalie de l'hémoglobine associée à la drépanocytose est l'hémoglobine S.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les deux conséquences directes de la déformation des globules rouges dans la drépanocytose?', 'role': 'user'}, {'content': 'Les deux conséquences directes sont une destruction anormalement rapide des globules rouges, entraînant une anémie, et une obstruction des petits vaisseaux sanguins provoquant des douleurs dans les organes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la troisième manifestation de la maladie mentionnée dans le texte?', 'role': 'user'}, {'content': 'Une sensibilité anormalement élevée à certains microbes, surtout le pneumocoque, qui peut être responsable d’infections très graves.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are cookies techniques and why are they important for the website?', 'role': 'user'}, {'content': 'Cookies techniques are cookies necessary for the proper functioning of the website, used by the host for the technical management of the network. They are essential to use the main features of the site and therefore cannot be disabled.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les cookies techniques et pourquoi ne peuvent-ils pas être désactivés?', 'role': 'user'}, {'content': 'Les cookies techniques sont les cookies nécessaires au bon fonctionnement du site. Ils ne peuvent pas être désactivés car ils sont indispensables pour utiliser les principales fonctionnalités du site.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of cookies cannot be disabled according to the text?', 'role': 'user'}, {'content': 'Les cookies techniques (technical cookies)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et comment est-elle liée aux globules rouges du sang?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie du sang liée à la présence d'une hémoglobine S dans les globules rouges. L'hémoglobine est le constituant principal du globule rouge et sert à transporter l'oxygène nécessaire à tous les organes du corps.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la principale différence entre l'hémoglobine normale et l'hémoglobine anormale chez un enfant drépanocytaire ?\", 'role': 'user'}, {'content': \"L'enfant drépanocytaire ne fabrique pas d'hémoglobine A mais une hémoglobine anormale, l'hémoglobine S.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes d'une anémie chez un enfant drépanocytaire?\", 'role': 'user'}, {'content': \"Les symptômes d'une anémie chez un enfant drépanocytaire peuvent inclure une fatigabilité, un essoufflement et une lenteur.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes des crises vaso-occlusives chez les enfants drépanocytaires?', 'role': 'user'}, {'content': \"Les crises vaso-occlusives se traduisent par des douleurs et un manque d'oxygène, car les globules rouges drépanocytaires se coincent dans les petits vaisseaux sanguins.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important que l'enfant drépanocytaire soit pris en charge par une équipe spécialisée?\", 'role': 'user'}, {'content': \"Il est important que l'enfant drépanocytaire soit pris en charge par une équipe spécialisée pour proposer des traitements préventifs et éviter certaines complications de la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements préventifs recommandés pour les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': \"Les traitements préventifs recommandés pour les enfants atteints de drépanocytose sont l'Hydroxyurée (Hydréa ou Siklos) et les programmes d'échanges transfusionnels réguliers.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les objectifs des programmes d'échanges transfusionnels réguliers mentionnés dans le texte?\", 'role': 'user'}, {'content': \"Les programmes d'échanges transfusionnels réguliers visent à remplacer les globules rouges malades par des globules rouges normaux provenant de donneurs de sang sains, pour protéger le cerveau de l'enfant et éviter que les crises douloureuses se répètent.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la proportion de guérison obtenue par la greffe de moelle osseuse ou de sang de cordon lorsqu'elle est réalisée à partir d'un frère ou d'une sœur compatible?\", 'role': 'user'}, {'content': '95 % des cas', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la cause de la drépanocytose chez un enfant ?', 'role': 'user'}, {'content': \"La drépanocytose chez un enfant est causée par le fait que ses deux parents sont porteurs de l'hémoglobine S, ce qui signifie qu'il a reçu de chacun d'eux de l'hémoglobine S mais pas d'hémoglobine A.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel type d'examen est nécessaire pour savoir si vous pouvez transmettre la drépanocytose?\", 'role': 'user'}, {'content': 'Une prise de sang', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et comment se caractérise-t-elle?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique héréditaire qui touche l’hémoglobine et se caractérise par la présence conjointe de globules rouges en forme de faucille et d’une anémie chronique due à la destruction excessive des globules rouges anormaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel examen sanguin permet d'établir la présence de la drépanocytose?\", 'role': 'user'}, {'content': \"L'électrophorèse\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la population principalement touchée par la drépanocytose?', 'role': 'user'}, {'content': 'La drépanocytose touche presque exclusivement les personnes d’origine africaine ou afro-américaine.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la principale cause de la forme en faucille des globules rouges dans la drépanocytose?', 'role': 'user'}, {'content': \"La forme anormale d'hémoglobine appelée hémoglobine S\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi les globules en faucille peuvent-ils causer des problèmes de circulation sanguine?', 'role': 'user'}, {'content': \"Les globules en faucille sont rigides et ont du mal à se déplacer dans les capillaires, ce qui obstrue la circulation sanguine et réduit l'alimentation en oxygène vers les tissus.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose?', 'role': 'user'}, {'content': \"Les personnes atteintes de drépanocytose ont toujours une anémie et parfois un ictère modéré, ainsi que d'autres symptômes graves et récurrents dans certains cas.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les risques associés aux personnes porteuses du trait drépanocytaire?', 'role': 'user'}, {'content': \"Les risques associés aux personnes porteuses du trait drépanocytaire incluent un risque accru d'insuffisance rénale chronique, d'embolie pulmonaire, de saignements dans les urines et de développement d'une forme rare de cancer rénal.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains facteurs qui peuvent déclencher une crise drépanocytaire?', 'role': 'user'}, {'content': \"Certains facteurs qui peuvent déclencher une crise drépanocytaire sont une consommation accrue d'oxygène, comme de l'exercice physique intense, l'alpinisme, le vol en altitude sans suffisamment d'oxygène, ou une maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes caractéristiques du syndrome thoracique aigu?', 'role': 'user'}, {'content': 'Le syndrome thoracique aigu se caractérise généralement par des douleurs intenses et des difficultés respiratoires.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi les personnes atteintes de drépanocytose sont-elles plus susceptibles de développer des infections?', 'role': 'user'}, {'content': \"Les personnes atteintes de drépanocytose sont plus susceptibles de développer des infections car la rate, qui contribue à lutter contre les infections, est endommagée et finit par s'atrophier chez les adolescents atteints de cette maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes physiques courants chez les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': 'Les enfants atteints de drépanocytose ont souvent le tronc court, mais des bras, des jambes, des doigts et des orteils longs. Ils peuvent également souffrir de troubles osseux et de la moelle osseuse, entraînant des douleurs osseuses, principalement des mains et des pieds.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes potentiels de la drépanocytose mentionnés dans le texte?', 'role': 'user'}, {'content': 'Les symptômes potentiels de la drépanocytose mentionnés dans le texte incluent le tronc court, des bras, des jambes, des doigts et des orteils longs, des douleurs osseuses, des accès de douleurs articulaires accompagnées de fièvre, des ulcères dans les membres inférieurs, des érections persistantes et douloureuses, des accidents vasculaires cérébraux, des lésions du système nerveux, et la détérioration des poumons et des reins chez les personnes âgées.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes qui peuvent indiquer une crise drépanocytaire chez une personne jeune d'origine africaine ou afro-américaine?\", 'role': 'user'}, {'content': \"Une anémie, des douleurs au niveau de l'estomac et des os, et des nausées.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que l'électrophorèse de l’hémoglobine?\", 'role': 'user'}, {'content': \"L'électrophorèse de l’hémoglobine est un examen qui consiste à utiliser un courant électrique pour séparer les différents types d’hémoglobine et détecter celui qui est anormal.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il important de pratiquer des examens sanguins chez les proches des personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Il est important de pratiquer des examens sanguins chez les proches des personnes atteintes de drépanocytose car ils peuvent également être porteurs de la maladie ou du trait drépanocytaire, ce qui permet de déterminer le risque de donner naissance à un enfant porteur de la maladie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les objectifs du traitement de la drépanocytose?', 'role': 'user'}, {'content': \"Les objectifs du traitement de la drépanocytose sont de prévenir les crises, contrôler l'anémie, soulager les symptômes, et parfois guérir la maladie par une greffe de cellules souches ou une thérapie génique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels vaccins doivent être administrés aux personnes atteintes de drépanocytose pour prévenir les infections?', 'role': 'user'}, {'content': 'Des vaccins pneumococciques, méningococciques, antigrippaux, et contre Haemophilus influenzae type b doivent être administrés.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels vaccins sont recommandés pour les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Des vaccins pneumococciques, méningococciques, antigrippaux, et contre Haemophilus influenzae type b doivent être administrés.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains médicaments qui peuvent aider à contrôler la drépanocytose selon le texte?', 'role': 'user'}, {'content': \"L'hydroxyurée, la L-glutamine, le crizanlizumab et le voxélotor\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle vitamine est administrée pour permettre à l'organisme de fabriquer de nouveaux globules rouges?\", 'role': 'user'}, {'content': 'de l’acide folique', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of support does the Sickle Cell Disease Association of America provide?', 'role': 'user'}, {'content': 'The Sickle Cell Disease Association of America provides comprehensive educational materials and support, including mentoring, for individuals with sickle cell disease and their caregivers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la maladie génétique la plus répandue en France selon le texte?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le principal symptôme de la drépanocytose?', 'role': 'user'}, {'content': 'Le principal symptôme de la drépanocytose est la douleur.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le but de l'association Drepan-Hope par rapport à la drépanocytose?\", 'role': 'user'}, {'content': \"Le but de l'association Drepan-Hope est de mettre à disposition de tous, par divers moyens médiatiques modernes, l'information au sujet de la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle association a été choisie comme partenaire de l'Etablissement français du Sang pour mener des actions de sensibilisation sur le don du sang et la drépanocytose?\", 'role': 'user'}, {'content': \"L'association Drepan-Hope\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel sujet est abordé dans la vidéo de l’Inserm et de l’APIPD mentionnée dans le texte?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the topics covered on the website related to fertility treatments?', 'role': 'user'}, {'content': 'Some of the topics covered on the website related to fertility treatments include infertility, female infertility, male infertility, IVF failures, miscarriages, improving fertility, and fertility treatment options.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatments mentioned in the text for infertility?', 'role': 'user'}, {'content': 'Some of the treatments mentioned include IUI, Mini FIV, FIV + ICSI, FIV cytoplasmic, tandem IVF cycle, egg donation, embryo donation, sperm donation, gender selection, gestational surrogacy, surgical sperm retrieval, Preimplantation Genetic Diagnosis (PGD), egg freezing, and sex selection using donor eggs.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the treatment called for mitochondrial replacement therapy?', 'role': 'user'}, {'content': 'Thérapie de remplacement mitochondrial', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the topics covered under 'Traitements de FIV' on the website?\", 'role': 'user'}, {'content': \"Some of the topics covered under 'Traitements de FIV' are Nouvelles avancées FIV, Traitement Prp, Thérapie par cellules souches pour l'azoospermie, Sélection de sperme avancée, Embryoscope, and Thérapie intralipidique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatments mentioned in the text for infertility?', 'role': 'user'}, {'content': 'Some of the treatments mentioned include IUI, Mini FIV, FIV + ICSI, FIV cytoplasmic, tandem IVF cycle, egg donation, embryo donation, sperm donation, gender selection, gestational surrogacy, surgical sperm retrieval, Pre-Implantation Genetic Diagnosis (PGD), egg freezing, and prevention of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses various fertility treatments and related procedures such as mitochondrial replacement therapy, IVF, IUI, egg donation, sperm donation, gender selection, and genetic testing.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell anemia and what causes it?', 'role': 'user'}, {'content': 'Sickle cell anemia is a type of inherited anemia where red blood cells have a sickle shape. It is caused by an abnormal hemoglobin called hemoglobin S.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la conséquence de l'obstruction des vaisseaux sanguins par les globules rouges en forme de faucille?\", 'role': 'user'}, {'content': \"L'obstruction des vaisseaux sanguins par les globules rouges en forme de faucille peut entraîner des épisodes de douleur intense et une pénurie de globules rouges, provoquant ainsi une anémie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose chez les enfants?', 'role': 'user'}, {'content': 'Un faible nombre de globules rouges, un essoufflement, une croissance et un retard de développement chez les enfants et une pression artérielle élevée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la conséquence de la substitution d'acide aminé de Glu à Val à la sixième position d'acide aminé dans la protéine d'hémoglobine de la chaîne bêta?\", 'role': 'user'}, {'content': \"La substitution provoque une mutation (anomalie) qui fait que l'hémoglobine déforme les globules rouges en forme de faucille.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le mode de transmission de l'anémie falciforme?\", 'role': 'user'}, {'content': \"Le mode de transmission de l'anémie falciforme est autosomique récessif, ce qui signifie que le patient doit acquérir l'allèle du gène portant la mutation des deux parents.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la différence entre le trait drépanocytaire et la drépanocytose?', 'role': 'user'}, {'content': \"Le trait drépanocytaire indique qu'une personne est porteuse de la mutation génétique, tandis que la drépanocytose est une maladie génétique qui peut se manifester chez les individus porteurs des deux copies du gène muté.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi le corps essaie-t-il de compenser l'inefficacité du transport de l'oxygène chez les personnes atteintes de drépanocytose?\", 'role': 'user'}, {'content': \"Le corps essaie de compenser en produisant de l'hémoglobine supplémentaire et de la moelle osseuse supplémentaire.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of sickle cell disease?', 'role': 'user'}, {'content': 'Symptoms of sickle cell disease can vary from very mild to very severe and affect different people differently. Some symptoms include anemia, repeated infections, and periodic episodes of pain.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main reason why symptoms of sickle cell disease do not appear at birth but rather around 6 months of age?', 'role': 'user'}, {'content': 'The hemoglobin of the baby or fetus has the ability to prevent red blood cells from sickling.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Comment la technologie et la médecine permettent-elles d'éviter de transmettre la drépanocytose à vos enfants ?\", 'role': 'user'}, {'content': \"La technologie du diagnostic génétique préimplantatoire permet de dépister les embryons porteurs de la mutation génétique de la drépanocytose et de ne transférer que les embryons sains dans l'utérus pour la grossesse.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la technique proposée dans le cadre d'un programme de traitement de FIV pour prévenir la transmission de la drépanocytose à la progéniture?\", 'role': 'user'}, {'content': 'La technique proposée est la PGD (diagnostic génétique préimplantatoire).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi un couple qui souhaite suivre un traitement DPI pour la prévention de l'anémie falciforme doit-il fournir ses échantillons de sang?\", 'role': 'user'}, {'content': 'Le couple doit fournir ses échantillons de sang afin de concevoir la sonde PGD pour le dépistage des embryons.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les tubes appropriés pour placer les échantillons de sang à des fins de dépistage de la drépanocytose?', 'role': 'user'}, {'content': 'Les échantillons doivent être placés dans des tubes K3 Edta avec le bouchon violet.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi certains patients trouvent-ils avantageux de venir à Chypre pour donner leurs échantillons de sang?', 'role': 'user'}, {'content': \"Certains patients trouvent avantageux de venir à Chypre pour donner leurs échantillons de sang car cela leur permet d'avoir une première consultation avec le personnel médical, de faire leurs premiers tests dans la clinique et d'acheter leurs médicaments à moindre coût.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il essentiel pour le succès des traitements de FIV d'avoir plusieurs ovules?\", 'role': 'user'}, {'content': \"Avoir plusieurs ovules est essentiel pour le succès des traitements de FIV car plus le nombre d'ovules et la qualité de ces ovules sont élevés, plus il est probable d'avoir des embryons de bonne qualité plus tard pour le transfert dans l'utérus.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the proposed treatment for the prevention of sickle cell anemia mentioned in the text?', 'role': 'user'}, {'content': 'The proposed treatment for the prevention of sickle cell anemia mentioned in the text is a treatment of In Vitro Fertilization (FIV) where embryos are screened for sickle cell anemia before being transferred into the uterus.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important d'obtenir le plus d'embryons possible avant de commencer le traitement de FIV?\", 'role': 'user'}, {'content': \"Il est important d'obtenir le plus d'embryons possible avant de commencer le traitement de FIV afin qu'une fois les embryons malades éliminés, il reste un bon nombre d'embryons sains à transférer.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il recommandé aux patientes de plus de 35 ans d'envisager d'avoir deux cycles de FIV?\", 'role': 'user'}, {'content': \"Il est recommandé aux patientes de plus de 35 ans d'envisager d'avoir deux cycles de FIV afin de combiner deux ensembles d'embryons obtenus à partir des deux cycles, ce qui permet d'avoir plus d'embryons à dépister et d'offrir un plus grand nombre d'embryons sains à transférer, maintenant ainsi leurs chances de succès élevées avec la procédure.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le DPI dans le cadre de la prévention de la drépanocytose?\", 'role': 'user'}, {'content': 'Le DPI est le Diagnostic Génétique Pré-Implantation sur les embryons créés in vitro après le protocole de FIV.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is the Fertility Center of Northern Cyprus located?', 'role': 'user'}, {'content': \"The Fertility Center of Northern Cyprus is located in Nicosia, Cyprus, within the 'Elite Research and Surgery Hospital'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the contact options provided for the Cyprus IVF center?', 'role': 'user'}, {'content': 'The contact options provided for the Cyprus IVF center include phone numbers for English, Turkish, Arabic, and German languages, as well as an email address.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the email address provided for contact?', 'role': 'user'}, {'content': 'info@northcyprusivf.net', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the topics covered under 'Nouvelles avancées' on the website?\", 'role': 'user'}, {'content': \"Traitement Prp, Thérapie par cellules souches pour l'azoospermie, Sélection de sperme avancée, Embryoscope, Thérapie intralipidique\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of technology is mentioned in the text?', 'role': 'user'}, {'content': 'In vitro fertilization (FIV)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are the different categories available under 'Médicaments' on the website?\", 'role': 'user'}, {'content': \"The different categories available under 'Médicaments' are: Par nom de gamme, Par nom de spécialité, Par substance active, Par laboratoire, Par domaine thérapeutique, Par classe ATC, Par indication, Analyse d'ordonnance, Calculateurs et convertisseurs, Bien utiliser ses médicaments, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'DM & Parapharmacie' on the website?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'DM & Parapharmacie' are Par nom commercial, Par fabricant & distributeur, Par domaine d'utilisation, Phytothérapie, Compléments alimentaires, Bien utiliser ses produits de parapharmacie, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, Sport, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text is about the complications of sickle cell disease (drépanocytose) and their prevention.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the potential consequences of not promptly addressing the complications of sickle cell disease?', 'role': 'user'}, {'content': 'If the complications of sickle cell disease are not addressed promptly, they can have serious consequences.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la séquestration splénique et quelles en sont les conséquences pour les enfants atteints de drépanocytose?\", 'role': 'user'}, {'content': \"La séquestration splénique est une complication de l'anémie chronique chez les enfants atteints de drépanocytose, où les globules rouges s'accumulent dans la rate et peuvent entraîner une augmentation soudaine de volume de la rate, de la douleur, une grande pâleur et une insuffisance d'oxygénation des organes pouvant provoquer le décès sans transfusion sanguine rapide.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les signes de la crise aplasique chez les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': \"Les signes de la crise aplasique chez les personnes atteintes de drépanocytose incluent essoufflement, fatigue, pâleur, rythme du cœur augmenté, maux de tête, maux de ventre, fièvre, perte d'appétit et vomissements.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les deux principales causes de la crise aplasique chez les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': 'Une infection par le parvovirus B19 (la « cinquième maladie » infantile) ou une carence en folates (vitamine B9)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les signes d'arthrose qui peuvent apparaître au niveau des articulations?\", 'role': 'user'}, {'content': \"Des signes d'arthrose peuvent apparaître avec usure des cartilages.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the complications that can arise from sickle cell disease?', 'role': 'user'}, {'content': 'Complications can include pulmonary hypertension, chronic anemia affecting the heart, progressive kidney failure, priapism in males, leg ulcers, gallstones, liver dysfunction, and growth delays in children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains exemples de complications liées aux crises vaso-occlusives chez les enfants souffrant de drépanocytose?', 'role': 'user'}, {'content': 'Des complications telles que ulcères des jambes, calculs de la vésicule biliaire, mauvais fonctionnement du foie peuvent être observées chez les enfants souffrant de drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes du syndrome thoracique aigu lié à la drépanocytose ?', 'role': 'user'}, {'content': 'Les symptômes du syndrome thoracique aigu lié à la drépanocytose sont une gêne respiratoire, de la fièvre, des douleurs dans la poitrine et le ventre.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains signes pouvant suggérer une complication chez les patients atteints de la drépanocytose?', 'role': 'user'}, {'content': \"Certains signes pouvant suggérer une complication chez les patients atteints de la drépanocytose sont : douleur rebelle aux traitements classiques, fièvre supérieure à 38,5°C, augmentation soudaine du volume du ventre ou de la rate, érection persistante, gêne respiratoire soudaine, vomissements répétés, maux de tête soudains et violents, difficultés à parler, troubles de la vision ou d'un autre sens, troubles soudains de l'équilibre, anomalie neurologique d'apparition soudaine, tout symptôme soudain et inhabituel.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to maintain good hydration to prevent vaso-occlusive crises?', 'role': 'user'}, {'content': 'It is important to maintain good hydration to prevent vaso-occlusive crises because dehydration can lead to complications and trigger sudden and unusual symptoms.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What age do you need to be to confirm your comment according to the text?', 'role': 'user'}, {'content': 'At least 16 years old', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the alert regarding DOLIPRANE 2,4% buvable?', 'role': 'user'}, {'content': 'The alert concerns pipettes without graduation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of advertising will soon be prohibited for Ibuprofen 400 mg?', 'role': 'user'}, {'content': 'Advertising to the general public', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article 'COVID-19 : quelles priorités pour les pays du Sud ?'\", 'role': 'user'}, {'content': \"Le sujet principal de l'article est les priorités des pays du Sud face à la pandémie de COVID-19.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article mentionné dans le texte?\", 'role': 'user'}, {'content': \"Les différents sujets de santé abordés dans l'article sont la drépanocytose, les infections, la maladie de Lyme, l'appendicite, le noma, les infections, la vaccination, la préparation de la 'farine composée', les antibiotiques, les hépatites, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des textes mentionnés?', 'role': 'user'}, {'content': 'Les textes abordent des sujets liés à la santé, tels que la vaccination, les urgences médicales et les traitements médicaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets liés à la santé, tels que la drépanocytose, les vaccinations, la rougeole, la génétique, la chirurgie, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle maladie est principalement associée au papillomavirus (HPV) selon le texte?', 'role': 'user'}, {'content': \"Le cancer du col de l'utérus\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal du texte 'Campagne de vaccination MenAfriVac'?\", 'role': 'user'}, {'content': \"Le sujet principal du texte 'Campagne de vaccination MenAfriVac' est la vaccination contre la méningite en Afrique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the text primarily about?', 'role': 'user'}, {'content': 'The text covers a variety of medical topics and issues, such as tungiasis, respiratory problems in children, domestic nuisances, fractures, bat ecology, insulin use, female genital mutilation, malnutrition, rabies, tuberculosis, drug interactions, Ebola virus infection, ulcers, obesity, vaccination, tropical diseases, and more.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': \"Le texte aborde divers sujets tels que les interactions médicamenteuses, l'infection à virus Ebola, les ulcères gastriques, la grossesse, l'obésité, la vaccination, les viroses tropicales, les hémorragies, les convulsions du nourrisson, l'excision, les mutilations sexuelles féminines, l'accouchement humanisé et la lutte contre les mutilations génitales féminines.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des textes mentionnés?', 'role': 'user'}, {'content': 'Les mutilations sexuelles féminines et les efforts pour les éliminer.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le sujet principal du texte est les mutilations sexuelles féminines et leur impact sur la société, ainsi que les efforts pour les prévenir et les traiter.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'La prévention des mutilations sexuelles féminines', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article intitulé 'ALERTE : virus Ebola' ?\", 'role': 'user'}, {'content': 'Le virus Ebola', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte aborde différents sujets liés à la santé tels que le diabète, le cancer, la douleur chronique, les maladies tropicales, les interactions médicamenteuses, les vaccins, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': \"Le texte aborde différents sujets liés à la santé et aux maladies, tels que la poliomyélite, l'hépatite C, l'hypertension artérielle, le cosleeping, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des conférences de Dakar sur les hépatites mentionnées dans le texte?', 'role': 'user'}, {'content': 'Les hépatites virales', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel sujet est abordé dans la conférence de Dakar sur les hépatites?', 'role': 'user'}, {'content': 'Les hépatites virales', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal abordé dans le texte?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets de santé tels que les hépatites virales, le VIH, la grossesse, les médicaments, les insecticides, la dengue, le tabagisme, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte mentionne une liste de sujets médicaux variés, tels que la grossesse, les maladies infectieuses, les médicaments, les vaccinations, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des textes mentionnés?', 'role': 'user'}, {'content': 'Les différents sujets abordés concernent la santé, la médecine et les pratiques médicales.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des soins mentionnés dans le texte?', 'role': 'user'}, {'content': \"Les soins de santé et les mesures d'hygiène à appliquer pour prévenir les infections et maladies transmissibles.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte aborde divers sujets liés à la santé et à la médecine, tels que les infections nosocomiales, l'hygiène, les voies de transmission des infections, les vaccinations, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste des thèmes liés à la grossesse et à la naissance?\", 'role': 'user'}, {'content': 'La chirurgie cardiaque', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various aspects related to childbirth and neonatal care, such as emergency procedures during birth, breastfeeding, hygiene in maternity wards, common neonatal infections, and care for fragile newborns.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the text 'Soins du nouveau-né de la naissance à six heures'?\", 'role': 'user'}, {'content': 'The care of the newborn from birth to six hours.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the text provided?', 'role': 'user'}, {'content': 'The text provided focuses on various topics related to HIV/AIDS, including prevention, treatment, and epidemiology.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main topic discussed in the text?', 'role': 'user'}, {'content': 'The text covers a variety of topics related to public health issues, such as HIV, herpes, prevention strategies, and global health concerns.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet est abordé dans le texte 'Baisse de la séroprévalence à Lusaka chez les femmes enceintes'?\", 'role': 'user'}, {'content': 'La baisse de la séroprévalence chez les femmes enceintes à Lusaka est abordée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi le diabète est-il considéré comme dangereux ?', 'role': 'user'}, {'content': \"Le diabète est considéré comme dangereux en raison des risques encourus par l'enfant, des difficultés de prise en charge, des complications oculaires et des risques pour la santé en général.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal abordé dans le texte?', 'role': 'user'}, {'content': \"Le texte aborde divers aspects liés à la vaccination, la pratique des vaccinations en Afrique, les vaccins du futur, la conservation des vaccins, et les accidents domestiques chez l'enfant.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text covers various topics related to vaccination, nursing practices, childhood accidents, and emergency medical situations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal abordé dans le texte fourni?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets liés à la santé tels que la vaccination, la drépanocytose, les urgences épidémiques, les algorithmes liés au VIH, la tuberculose, le paludisme, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal abordé dans le texte donné ?', 'role': 'user'}, {'content': 'Le texte aborde principalement la tuberculose et le paludisme, ainsi que les mesures de prévention et de traitement associées à ces maladies.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte parle de divers sujets liés à la santé, tels que le paludisme, la gestion des médicaments, les urgences traumatiques, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sujets sont abordés dans le texte concernant la prise en charge des urgences en ophtalmologie?', 'role': 'user'}, {'content': 'La prise en charge des urgences traumatiques en ophtalmologie est abordée dans le texte.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main topic discussed in the text?', 'role': 'user'}, {'content': 'The main topic discussed in the text is therapeutic education for various medical conditions such as asthma, malaria, tuberculosis, and HIV/AIDS.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'objectif principal de l'article mentionné dans le texte?\", 'role': 'user'}, {'content': \"L'article traite de l'éducation thérapeutique des enfants infectés par le VIH/SIDA et de son impact sur l'observance du traitement.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'expérience partagée dans le texte concernant l'éducation thérapeutique de l'enfant ?\", 'role': 'user'}, {'content': \"L'expérience de l'Hôpital d'Instruction des Armées de Cotonou est partagée dans le texte concernant l'éducation thérapeutique de l'enfant.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les enjeux de l'éducation thérapeutique en PTME et pédiatrie identifiés au CTA de Brazzaville?\", 'role': 'user'}, {'content': \"Les enjeux de l'éducation thérapeutique en PTME et pédiatrie identifiés au CTA de Brazzaville ne sont pas spécifiés dans le texte.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the text about?', 'role': 'user'}, {'content': \"The text discusses the development of a formative evaluation approach for therapeutic education activities implemented within Médecins Sans Frontières' access to antiretroviral programs, as well as various topics related to patient education, parasitic diseases, water issues in developing countries, and medication management.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte ?', 'role': 'user'}, {'content': \"Le texte aborde divers sujets tels que les parasitoses digestives, l'eau de boisson dans les pays en développement, la gestion des médicaments, la circoncision pour la prévention du VIH, les algorithmes IST, la stigmatisation et discrimination liées au SIDA, la défense et immunité anti infectieuse, la prise en charge du SIDA, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': \"Le texte présente une liste de sujets liés à la gestion des médicaments, la circoncision pour la prévention du VIH, la stigmatisation liée au SIDA, la défense immunitaire, la prise en charge du SIDA, et d'autres sujets médicaux.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal du texte 'Anesthésie chez un malade porteur d'une drépanocytose'?\", 'role': 'user'}, {'content': \"Le sujet principal du texte est l'anesthésie chez un patient atteint de drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'objectif de l'article 'Pourquoi et comment se laver les mains ?'\", 'role': 'user'}, {'content': \"L'objectif de l'article est d'expliquer l'importance de se laver les mains et de détailler la bonne technique pour le faire.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article mentionné?\", 'role': 'user'}, {'content': 'La santé et les différentes pratiques médicales et préventives associées.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte parle de divers sujets liés à la santé, tels que l'extraction dentaire, la potabilité de l'eau, les maladies liées à l'eau, le VIH/SIDA, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le rôle d'une psychologue auprès de femmes et d'enfants concernés par le VIH/SIDA?\", 'role': 'user'}, {'content': \"Aide à l'observance des traitements ARV et soutien aux patients\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le rôle essentiel de l'infirmier dans l'aide à l'observance, en particulier pour le traitement par ARV\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte parle d'outils pour l'éducation thérapeutique des patients vivant avec le VIH et aborde différents sujets liés à la santé et aux traitements médicaux.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets liés à la santé tels que le SIDA, les infections respiratoires, la proctologie, la thrombose veineuse, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article 'Intérêt du dépistage VIH dans un hôpital rural au Nord-Cameroun'?\", 'role': 'user'}, {'content': 'Le dépistage du VIH dans un hôpital rural au Nord-Cameroun', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal du texte 'Recommandations de Gorée 2001'?\", 'role': 'user'}, {'content': 'Le texte présente une liste de sujets médicaux variés sur lesquels des recommandations ont été faites lors de la conférence de Gorée en 2001.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte parle de différents sujets liés à la santé communautaire et à la médecine, tels que le diagnostic, le traitement et la prévention de diverses maladies et affections.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte mentionne différents sujets médicaux et de santé tels que la méningite, les infections après l'accouchement, les maladies sexuellement transmissibles, la réanimation, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle maladie est en voie de disparition selon le texte?', 'role': 'user'}, {'content': 'La dracunculose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans le texte mentionné?\", 'role': 'user'}, {'content': 'Les maladies du péril fécal et leur prévention', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet est abordé dans le texte 'Du bon usage des antibiotiques' ?\", 'role': 'user'}, {'content': 'Le bon usage des antibiotiques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte mentionne une liste de sujets médicaux variés, tels que la toux, l'hypertension artérielle et grossesse, la cataracte, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal des actualités mentionnées dans le texte ?', 'role': 'user'}, {'content': 'Les actualités médicales et les différentes prises en charge de diverses pathologies et situations médicales.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal abordé dans le texte donné ?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets médicaux tels que le paludisme, la rougeole, les douleurs abdominales, les infections à gonocoque, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte aborde différents sujets médicaux tels que le traitement chirurgical du kyste hydatique du foie, la prévention de la diarrhée chez les jeunes enfants, le diagnostic des infections à gonocoque, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': 'Le texte aborde différents sujets liés à la santé et aux soins médicaux, tels que les envenimations par les serpents, les traumatisés crâniens, les ulcères de jambe, les brûlures, les pénicillines, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste des titres de cet article?\", 'role': 'user'}, {'content': 'La cuisine française', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte donné ?', 'role': 'user'}, {'content': 'Le texte traite de divers sujets médicaux et de santé, tels que la douleur, les maladies, les traitements et les examens médicaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte donné ?', 'role': 'user'}, {'content': 'Le texte aborde différents sujets médicaux et de santé, tels que la chirurgie de la main, les diarrhées bactériennes, la drépanocytose, le diabète, etc.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte donné ?', 'role': 'user'}, {'content': 'Le texte aborde divers sujets liés à la santé, tels que les maladies, les traitements et les stratégies de prévention.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte ?', 'role': 'user'}, {'content': \"Le texte aborde divers sujets liés à la santé, tels que la prévention des complications infectieuses, l'infection à VIH, la tuberculose-sida, la transmission du VIH de la mère à l'enfant, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste des thèmes médicaux mentionnés ?\", 'role': 'user'}, {'content': 'La cuisine française', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste des thèmes de santé mentionnés?\", 'role': 'user'}, {'content': 'La cuisine traditionnelle africaine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le sujet principal du texte mentionné?', 'role': 'user'}, {'content': \"Le texte mentionne une variété de sujets liés à la santé et aux soins médicaux, tels que le traitement de l'asthme, la kinésithérapie, la fécondité, la transfusion sanguine, les soins dermatologiques, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel type de vaccination est mentionné dans le texte?', 'role': 'user'}, {'content': 'La vaccination rabique', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste de thèmes médicaux mentionnés?\", 'role': 'user'}, {'content': 'La cuisine française', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste des thèmes médicaux mentionnés?\", 'role': 'user'}, {'content': 'La cuisine française', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel sujet n'est pas abordé dans la liste de sujets médicaux mentionnés?\", 'role': 'user'}, {'content': 'La cuisine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'article 'Drépanocytose' par Philippe Reinert?\", 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la principale fonction du globule rouge dans le corps humain?', 'role': 'user'}, {'content': \"La principale fonction du globule rouge est de transporter l'oxygène des poumons vers les tissus grâce à l'hémoglobine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la principale cause de la drépanocytose?', 'role': 'user'}, {'content': \"La drépanocytose est causée par une mutation génétique qui remplace l'hémoglobine normale par une hémoglobine S, provoquant la déformation des globules rouges en forme de faucille.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What happens to the red blood cells in a person with sickle cell anemia?', 'role': 'user'}, {'content': 'The red blood cells become deformed into a sickle shape, leading to fragility, shortened lifespan, and frequent obstructions in the capillaries.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi le drépanocytaire est-il menacé de thromboses selon le texte?', 'role': 'user'}, {'content': \"Le drépanocytaire est menacé de thromboses car les globules en forme de faucille s'accrochent entre eux dans les capillaires, entraînant des obstructions fréquentes.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la différence entre la forme légère AS de la drépanocytose et la forme sévère SS?', 'role': 'user'}, {'content': \"La forme légère AS de la drépanocytose se caractérise par une petite quantité d'Hb S anormale dans les globules rouges, tandis que la forme sévère SS ne contient que de l'hémoglobine anormale (Hb S) et peut être fatale avant l'âge adulte.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Comment la production de l'hémoglobine est-elle influencée par les chromosomes?\", 'role': 'user'}, {'content': \"La production de l'hémoglobine dépend d'un couple de chromosomes, l'un d'origine paternelle et l'autre maternelle. Chez le sujet normal, cela donne le même ordre pour la synthèse de l'Hb A. En cas d'anomalie chromosomique, l'un des chromosomes peut donner l'ordre pour la synthèse de l'Hb S.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les différentes formes d'hémoglobine mentionnées dans le texte et quelles sont les pourcentages de répartition de la maladie à Kinshasa pour chacune de ces formes?\", 'role': 'user'}, {'content': \"Les différentes formes d'hémoglobine mentionnées sont Hb S et Hb A. Les pourcentages de répartition de la maladie à Kinshasa sont A A 72%, A S 25,3%, et S S 2,7%.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les pourcentages de répartition de la maladie à Kinshasa selon le texte?', 'role': 'user'}, {'content': 'A A 72%, A S 25,3%, S S 2,7%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes associés à la forme grave de la drépanocytose chez les enfants?', 'role': 'user'}, {'content': 'Les symptômes associés à la forme grave de la drépanocytose chez les enfants incluent une anémie permanente, une pâleur des conjonctives, un subictère, une augmentation de la rate, des poussées de déglobulisation, des infections, des carences diverses, un gonflement chaud et douloureux des pieds et des mains, une petite taille avec une grosse tête, des accidents douloureux ou crises drépanocytaires, des crises osseuses, des crises articulaires, et des crises douloureuses abdominales.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les manifestations fréquentes chez les enfants atteints de drépanocytose?', 'role': 'user'}, {'content': 'Les manifestations fréquentes chez les enfants atteints de drépanocytose incluent les crises osseuses, les crises articulaires, les crises douloureuses abdominales, ainsi que des thromboses dans divers organes comme la rate, les reins, les poumons et le cerveau.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les symptômes courants chez les sujets porteurs de l'anomalie sanguine drépanocytose?\", 'role': 'user'}, {'content': \"Les symptômes courants chez les sujets porteurs de l'anomalie sanguine drépanocytose sont les maux de tête, les douleurs osseuses, articulaires ou vertébrales, les douleurs du flanc gauche et la fatigabilité à l'effort.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les signes cliniques les plus courants chez les sujets porteurs de la forme légère du trait drépanocytaire?', 'role': 'user'}, {'content': \"Les signes cliniques les plus courants chez les sujets porteurs de la forme légère du trait drépanocytaire sont les maux de tête, les douleurs osseuses, articulaires ou vertébrales, les douleurs du flanc gauche et la fatigabilité à l'effort.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le vrai traitement de la drépanocytose grave selon le texte?', 'role': 'user'}, {'content': 'La transfusion de sang', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le vrai traitement de la drépanocytose grave selon le texte?', 'role': 'user'}, {'content': 'La transfusion de globules rouges normaux constitue le vrai traitement de la drépanocytose grave.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the Emmel test mentioned in the text?', 'role': 'user'}, {'content': 'The purpose of the Emmel test is to recognize individuals affected by sickle cell disease in a simple way.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le but du test d'Emmel mentionné dans le texte?\", 'role': 'user'}, {'content': \"Le but du test d'Emmel est de reconnaître de manière simple les sujets atteints de drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la forme que prennent les globules rouges dans la drépanocytose en cas de manque d'oxygène?\", 'role': 'user'}, {'content': \"Les globules rouges prennent l'aspect de croissants, de quartier de lune, de faux ou de faucille.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle substance peut être ajoutée au sang pour des techniques plus rapides et pratiques lors des enquêtes de masse?', 'role': 'user'}, {'content': 'Le métabisulfite de soude', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the categories available on the website related to medications and health?', 'role': 'user'}, {'content': \"Categories include medications by brand name, specialty name, active substance, laboratory, therapeutic domain, ATC class, indication, prescription analysis, calculators and converters, proper medication use, as well as news updates. There are also categories related to over-the-counter products, including by commercial name, manufacturer & distributor, usage domain, phytotherapy, dietary supplements, proper parapharmacy product use, and news updates. Additionally, there are categories related to diseases, such as VIDAL recommendations, diseases from A to Z, adult diseases, childhood diseases, pregnancy-related ailments, specific pain or illness concerns, children's health issues, and COVID-19 news updates.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Maladies de A à Z, Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, Sport, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, Sport, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses the causes and prevention of sickle cell disease (drépanocytose).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the causes of drépanocytose?', 'role': 'user'}, {'content': 'The causes of drépanocytose are genetic mutations in the hemoglobin gene, specifically a mutation in the beta-globin gene.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la cause de la drépanocytose ?', 'role': 'user'}, {'content': 'La drépanocytose est due à la mutation d’un gène impliqué dans la synthèse de l’hémoglobine, la protéine des globules rouges chargée de transporter l’oxygène dans le corps.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les causes de la drépanocytose ?', 'role': 'user'}, {'content': 'La drépanocytose est due à la mutation d’un gène impliqué dans la synthèse de l’hémoglobine, la protéine des globules rouges chargée de transporter l’oxygène dans le corps.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui peut causer les crises douloureuses caractéristiques de la drépanocytose?\", 'role': 'user'}, {'content': \"Les globules rouges contenant de l’hémoglobine S peuvent gêner la circulation du sang à travers les plus petits vaisseaux sanguins et diminuer l'oxygénation des tissus, ce qui est à l'origine des crises vaso-occlusives.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are 'hémoglobinopathies' and 'major sickle cell syndromes'?\", 'role': 'user'}, {'content': \"'Hémoglobinopathies' refer to diseases related to mutated forms of hemoglobin, while 'major sickle cell syndromes' are hémoglobinopathies where at least one S mutation is present.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que signifie le terme 'syndromes drépanocytaires majeurs'?\", 'role': 'user'}, {'content': \"Le terme 'syndromes drépanocytaires majeurs' regroupe les hémoglobinopathies où au moins une mutation S est présente sur chaque chromosome 11.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Combien de personnes en France souffrent d'une hémoglobinopathie?\", 'role': 'user'}, {'content': \"Environ 19 000 personnes en France souffrent d'une hémoglobinopathie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle condition est nécessaire pour qu'une personne développe les symptômes de la drépanocytose ?\", 'role': 'user'}, {'content': 'Il faut que les deux copies du gène touché soient mutées dans la forme S sur chaque chromosome 11.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment la drépanocytose est-elle transmise aux enfants selon le texte?', 'role': 'user'}, {'content': 'La drépanocytose est transmise aux enfants lorsque les deux parents ont au moins une copie de la mutation S et la transmettent à leur enfant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le risque de transmission de la drépanocytose si l'un des parents est S/S et l'autre parent est S/A ?\", 'role': 'user'}, {'content': \"Le risque de transmission de la drépanocytose est de 50 % (une chance sur deux) si l'un des parents est S/S et l'autre parent est S/A.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment peut-on prévenir la drépanocytose dans les familles à risque ?', 'role': 'user'}, {'content': \"Les futurs parents peuvent bénéficier de conseil génétique avant de concevoir leur premier enfant pour savoir s'ils sont porteurs de la mutation S, et un diagnostic prénatal peut être proposé lorsque le risque génétique est important.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que le diagnostic préimplantatoire (DPI) permet de faire sur des embryons obtenus par fécondation in vitro?\", 'role': 'user'}, {'content': \"Le DPI permet de n'implanter que les embryons qui ne sont pas S/S.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les conditions requises pour ajouter un commentaire dans l'espace participatif 'Commentaires'?\", 'role': 'user'}, {'content': \"Il faut être âgé(e) d'au moins 16 ans et avoir lu et accepté les règles et conditions d'utilisation.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the alert regarding DOLIPRANE 2,4 % buvable mentioned in the text?', 'role': 'user'}, {'content': 'The alert concerns pipettes without graduation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of advertising will soon be prohibited for Ibuprofen 400 mg?', 'role': 'user'}, {'content': 'Advertising to the general public', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les deux types d'épisodes douloureux mentionnés dans le texte pour les patients atteints de drépanocytose?\", 'role': 'user'}, {'content': \"Les deux types d'épisodes douloureux mentionnés sont les crises vaso-occlusives et la douleur chronique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les noms donnés aux épisodes douloureux aigus chez les patients atteints de drépanocytose?', 'role': 'user'}, {'content': \"Les épisodes douloureux aigus sont appelés 'crises douloureuses aiguës' ou 'crises vaso-occlusives'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la complication aiguë la plus fréquente de la drépanocytose?', 'role': 'user'}, {'content': 'La douleur', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la cause des crises vaso-occlusives dans la drépanocytose?', 'role': 'user'}, {'content': 'Les crises vaso-occlusives sont causées par l’obstruction des vaisseaux sanguins.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qui cause les crises drépanocytaires selon le texte?\", 'role': 'user'}, {'content': 'Les crises drépanocytaires sont causées par l’obstruction des vaisseaux sanguins.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels facteurs peuvent déclencher les crises douloureuses selon le texte?', 'role': 'user'}, {'content': 'Un manque de sommeil, une déshydratation ou encore les conditions météorologiques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains facteurs qui peuvent déclencher des crises douloureuses selon le texte?', 'role': 'user'}, {'content': 'Un manque de sommeil, une déshydratation ou encore les conditions météorologiques', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont quelques conseils donnés pour aider à prévenir les épisodes douloureux liés à la drépanocytose?', 'role': 'user'}, {'content': 'Effectuer des bilans de santé réguliers, rester hydraté(e), éviter les températures extrêmes, avoir un rythme de vie régulier, manger de façon équilibrée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Que pouvez-vous faire pour atténuer la douleur pendant une crise selon le texte?', 'role': 'user'}, {'content': 'Pour atténuer la douleur pendant une crise, vous pouvez vous renseigner sur les traitements antalgiques à disposition, pratiquer des techniques de relaxation, vous reposer dans un lieu calme et chaud, arrêter toute activité physique, et vous hydrater.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Que devez-vous faire en cas de crise douloureuse sévère selon le texte?', 'role': 'user'}, {'content': 'Rendez-vous à l’hôpital', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Que devez-vous faire en cas de crise douloureuse sévère selon le texte?', 'role': 'user'}, {'content': 'Rendez-vous à l’hôpital.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines mesures qui peuvent aider à mieux vivre avec la douleur chronique chez les personnes vivant avec la drépanocytose?', 'role': 'user'}, {'content': 'Écouter son corps et apprendre à le connaître, en savoir plus sur la maladie et sa physiopathologie, adopter un mode de vie sain (par exemple ne pas consommer d’alcool ou de tabac).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines mesures qui peuvent aider à mieux vivre avec la douleur chronique selon le texte?', 'role': 'user'}, {'content': \"Écouter son corps et apprendre à le connaître, en savoir plus sur la maladie et sa physiopathologie, adopter un mode de vie sain, utiliser d'autres approches pour la prise en charge de la douleur, et construire un réseau de soutien.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines approches recommandées pour la prise en charge de la douleur chronique selon le texte?', 'role': 'user'}, {'content': \"Des techniques de relaxation, des massages, de l'exercice physique, la construction d'un réseau de soutien, et parler avec l'équipe soignante des techniques pour atténuer la douleur.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de parler avec votre équipe soignante des techniques pour atténuer la douleur chronique?', 'role': 'user'}, {'content': 'Il est recommandé de parler avec votre équipe soignante des techniques pour atténuer la douleur chronique car les mesures efficaces pour la prise en charge des épisodes de douleur aiguë peuvent également aider à gérer la douleur chronique.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les recommandations pour atténuer la douleur chez les patients atteints de drépanocytose?', 'role': 'user'}, {'content': 'Les patients atteints de drépanocytose peuvent atténuer leur douleur en utilisant des stratégies de gestion de la douleur. Ils peuvent en apprendre davantage en parlant à leur équipe soignante.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Ballas SK, Gupta K, and Adams-Graves P?', 'role': 'user'}, {'content': 'Sickle cell pain: a critical reappraisal', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Brandow AM, Carroll CP, Creary S, et al.?', 'role': 'user'}, {'content': 'American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Brandow AM, Carroll CP, Creary S, et al. that provides guidelines for the management of acute and chronic pain in sickle cell disease?', 'role': 'user'}, {'content': 'American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the article by Osunkwo I, O'Connor HF, and Saah E?\", 'role': 'user'}, {'content': 'Optimizing the management of chronic pain in sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose mentionnés dans le texte?', 'role': 'user'}, {'content': \"Les symptômes de la drépanocytose mentionnés dans le texte sont une anémie, des crises douloureuses, un risque d'infections bactériennes sévères, des risques d'accidents vasculaires cérébraux, des risques rénaux, et des risques de rétinopathie et biliaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal de l'émission MIDI PILE du LUNDI 23 JANVIER 2017 sur France 3 Aquitaine?\", 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la pathologie abordée dans l'émission MIDI PILE du LUNDI 23 JANVIER 2017?\", 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose selon le texte?', 'role': 'user'}, {'content': \"Les symptômes de la drépanocytose incluent une anémie, des crises douloureuses, un risque d'infections bactériennes sévères, des risques d'accidents vasculaires cérébraux, des risques rénaux, et des risques de rétinopathie et biliaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes de la drépanocytose selon le texte?', 'role': 'user'}, {'content': \"Les symptômes de la drépanocytose incluent une anémie, des crises douloureuses, un risque d'infections bactériennes sévères, des risques d'accidents vasculaires cérébraux, des risques rénaux, et des risques de rétinopathie et biliaires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles populations sont particulièrement touchées par la drépanocytose selon le texte?', 'role': 'user'}, {'content': 'Les populations d’origine antillaise, africaine, méditerranéenne, indienne et sud-américaine (surtout au Brésil).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le seul traitement curatif actuel pour la drépanocytose dans les formes sévères de la maladie?', 'role': 'user'}, {'content': 'La greffe de moelle osseuse intrafamiliale est le seul traitement curatif actuel pour la drépanocytose dans les formes sévères de la maladie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le nombre actuel de patients pédiatriques pris en charge par le centre de compétences pédiatrique au CHU de Bordeaux?', 'role': 'user'}, {'content': 'Le centre de compétences pédiatrique au CHU de Bordeaux prend actuellement en charge 120 patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la fréquence des consultations pour le suivi des patients pédiatriques dans le texte?', 'role': 'user'}, {'content': 'Les patients sont suivis en consultations tous les 3 à 4 mois.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel type de rendez-vous mensuel les enfants atteints de vasculopathies cérébrales ont-ils à l'hôpital de jour?\", 'role': 'user'}, {'content': 'Les enfants atteints de vasculopathies cérébrales ont des rendez-vous mensuels en hôpital de jour pour des échanges transfusionnels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux services offerts aux patients adultes par le centre de compétence mentionné dans le texte?', 'role': 'user'}, {'content': 'Les patients adultes sont suivis en hospitalisation de jour pour les bilans annuels, en consultation pour leur traitement de fond, et en hospitalisation conventionnelle si nécessaire pour calmer la douleur ou les autres symptômes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What does the team currently contribute to in addition to their therapeutic education program?', 'role': 'user'}, {'content': 'The team currently contributes to two multicenter research programs and is part of the national network of care, in constant connection with the national reference centers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi votre organisme peut avoir besoin d'une plus grande quantité d'énergie lorsque vous vivez avec la drépanocytose?\", 'role': 'user'}, {'content': \"Votre organisme peut avoir besoin d'une plus grande quantité d'énergie pour faire face aux défis de la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle alimentation est recommandée pour les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Il est recommandé de manger des protéines et des aliments de bonne qualité énergétique avec un apport suffisant en calorie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les types d'aliments recommandés pour les personnes atteintes de drépanocytose?\", 'role': 'user'}, {'content': \"Les protéines et les aliments de bonne qualité énergétique avec un apport suffisant en calorie, tels que les aliments d'origine animale (volaille, poisson, oeufs, produits laitiers) ou d'origine végétale (légumes, légumineuses, tofu, lentilles, haricots, fruits, céréales).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les conseils donnés pour un régime alimentaire sain selon le texte?', 'role': 'user'}, {'content': 'Les conseils incluent de trouver des aliments que vous aimez tout en ajoutant des laitages, des fruits, des fruits secs et des légumes à votre alimentation, ainsi que de limiter la viande riche en fer, les repas aux fast-foods et les aliments industriels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il recommandé aux personnes atteintes de drépanocytose de boire au moins deux litres d'eau par jour?\", 'role': 'user'}, {'content': \"Il est recommandé de boire au moins deux litres d'eau par jour pour éviter la déshydratation, qui est un déclencheur fréquent des crises douloureuses chez les personnes atteintes de drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il recommandé de consommer davantage de laitages et de fromages à pâte dure?', 'role': 'user'}, {'content': 'Il est recommandé de consommer davantage de laitages et de fromages à pâte dure pour assurer un apport alimentaire en calcium suffisant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important d'être attentif à son alimentation si l'on vit avec la drépanocytose?\", 'role': 'user'}, {'content': \"Il est important d'être attentif à son alimentation si l'on vit avec la drépanocytose pour adopter un régime alimentaire adapté et équilibré.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il important pour une personne vivant avec la drépanocytose d'être attentif à son alimentation?\", 'role': 'user'}, {'content': \"Il est important pour une personne vivant avec la drépanocytose d'être attentif à son alimentation car ce qui est bénéfique pour une personne peut ne pas l’être pour une autre, et un régime alimentaire adapté et équilibré peut aider à gérer la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can you find information about proteins and sugars in the diet according to the text?', 'role': 'user'}, {'content': 'You can find information about proteins at https://www.anses.fr/fr/content/les-protéines and information about sugars at https://www.anses.fr/fr/content/sucres-dans-l%E2%80%99alimentation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the categories available on the website related to medications and health?', 'role': 'user'}, {'content': \"Categories include medications by brand name, specialty name, active substance, laboratory, therapeutic domain, ATC class, indication, prescription analysis, calculators and converters, proper medication use, as well as news updates. There are also categories related to over-the-counter products, including by commercial name, manufacturer & distributor, usage domain, phytotherapy, dietary supplements, proper parapharmacy product use, and news updates. Additionally, there are categories related to diseases, such as VIDAL recommendations, diseases from A to Z, adult diseases, children's diseases, pregnancy-related ailments, 'I have pain in', 'My child has', and COVID-19 news updates.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Maladies de A à Z, Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, and Sport.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the categories listed under 'Santé des patients'?\", 'role': 'user'}, {'content': \"Some of the categories listed under 'Santé des patients' include Agir pour ma santé, Examens, tests et analyses, Médecine thermale, SantéBD, Grossesse, Enfants, Voyage, Nutrition, Sport, and Actualités.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'The text discusses the medical management and treatment of sickle cell disease (drépanocytose).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la date de la dernière mise à jour de l'article sur la drépanocytose ?\", 'role': 'user'}, {'content': '02 décembre 2021', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le traitement de la drépanocytose ?', 'role': 'user'}, {'content': \"La prise en charge médicale de la drépanocytose s'est considérablement améliorée depuis que la majorité des diagnostics se font à la naissance. Néanmoins, la drépanocytose est directement responsable d'une cinquantaine de décès chaque année en France.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les objectifs de la prise en charge médicale de la drépanocytose ?', 'role': 'user'}, {'content': \"Les objectifs de la prise en charge médicale de la drépanocytose sont de surveiller l'anémie, prévenir les crises douloureuses et les infections, et détecter rapidement les complications pour les traiter au plus vite.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels professionnels de santé peuvent être impliqués dans le traitement de la drépanocytose chez les enfants selon le texte?', 'role': 'user'}, {'content': 'pédiatre ou médecin généraliste, médecin hospitalier spécialiste de la drépanocytose, médecin ou puéricultrice de PMI, aide-soignante, infirmière scolaire, assistant social ou travailleur social', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What type of information is provided in the 'Soins' section of the document?\", 'role': 'user'}, {'content': \"The 'Soins' section provides contact information for the doctor and emergency contacts, information on where to find resources, and personal data for emergencies.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont certaines des mesures mises en place pour le suivi médical des enfants atteints de drépanocytose?', 'role': 'user'}, {'content': \"Certaines des mesures mises en place pour le suivi médical des enfants atteints de drépanocytose incluent la vaccination selon le calendrier vaccinal obligatoire, la prise d'un antibiotique pendant au moins 5 ans, la supplémentation en vitamine B9, la surveillance régulière avec des bilans sanguins et des échographies, l'éducation des parents sur les signaux d'alerte et les mesures d'hygiène de vie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the recommended medical interventions and precautions for a child with sickle cell anemia?', 'role': 'user'}, {'content': 'Some of the recommended interventions and precautions include vaccination against hepatitis A and typhoid for travel, continuous antibiotic intake for at least 5 years, supplementation with vitamin B9, regular monitoring with blood tests, ultrasounds, X-rays, transcranial Doppler from 12 to 18 months of age, education of parents on signs warranting emergency consultation, and education of parents on adopting healthy lifestyle measures.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les médicaments antalgiques généralement prescrits pour la prise en charge d'une crise vaso-occlusive douloureuse chez les personnes atteintes de drépanocytose?\", 'role': 'user'}, {'content': \"Les médicaments antalgiques généralement prescrits sont le paracétamol ou l'ibuprofène, avec ou sans codéine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux éléments de la prise en charge du syndrome thoracique aigu?', 'role': 'user'}, {'content': \"Les principaux éléments de la prise en charge du syndrome thoracique aigu sont l'hydratation par voie intraveineuse, la prescription d'antibiotiques et de médicaments antalgiques, éventuellement la mise sous oxygène et l'administration de transfusions sanguines.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the purpose of an 'échange transfusionnel' in the treatment of complications of drépanocytose?\", 'role': 'user'}, {'content': \"The purpose of an 'échange transfusionnel' is to decrease the concentration of mutated hemoglobin S in the blood and replace it with normal hemoglobin.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is an exchange transfusion systematically implemented for a person with sickle cell disease undergoing surgery lasting more than 60 minutes?', 'role': 'user'}, {'content': 'An exchange transfusion is implemented to ensure optimal oxygenation of the organs and to prevent an anesthesia accident.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel est le traitement de fond utilisé pour certains patients adultes atteints de drépanocytose?', 'role': 'user'}, {'content': \"Le traitement de fond repose sur les transfusions et/ou les échanges transfusionnels, ainsi que sur la prescription d'un médicament appelé hydroxycarbamide (SIKLOS).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la procédure médicale parfois nécessaire dans les formes les plus graves de drépanocytose?', 'role': 'user'}, {'content': \"La greffe de cellules souches dites 'hématopoïétiques'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'objectif de la thérapie génique dans le contexte de la drépanocytose?\", 'role': 'user'}, {'content': \"L'objectif de la thérapie génique dans le contexte de la drépanocytose est d'insérer le gène codant pour l'hémoglobine normale dans les cellules de la moelle osseuse d'un patient, de manière à ce que ce gène devienne fonctionnel de manière durable.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of patients are similar studies being conducted on?', 'role': 'user'}, {'content': 'Patients with sickle cell disease (drépanocytose)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What type of information can be found under the 'Actualités liées' section?\", 'role': 'user'}, {'content': 'News related to medications and health alerts', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is soon to be prohibited in terms of advertising to the general public regarding Ibuprofen 400 mg?', 'role': 'user'}, {'content': 'Any advertising', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the main topic of the article 'Traitement de fond et suivi de la drépanocytose'?\", 'role': 'user'}, {'content': 'The main topic of the article is the treatment and monitoring of sickle cell disease (drépanocytose).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le sujet principal du dossier abordé dans l'article?\", 'role': 'user'}, {'content': 'Le traitement de fond et le suivi de la drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les formes génétiques de la drépanocytose qui restent associées à des complications sévères et récurrentes, ainsi qu'à une mortalité précoce chez l'adulte?\", 'role': 'user'}, {'content': 'Les formes génétiques homozygotes SS et Sβ°.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les deux types de traitement de fond mentionnés dans le texte pour les patients atteints de drépanocytose?', 'role': 'user'}, {'content': 'Le traitement de fond peut être médicamenteux par l’hydroxycarbamide (HC) ou peut consister en un programme transfusionnel (PT) régulier.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le principal mode d'action de l'hydroxycarbamide dans le traitement de la drépanocytose?\", 'role': 'user'}, {'content': \"Le principal mode d'action de l'hydroxycarbamide est d'augmenter la synthèse de l'hémoglobine fœtale (HbF), ce qui réduit la polymérisation des molécules d'HbS et les événements physiopathologiques délétères qui en résultent.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont certains des effets bénéfiques de l'HC mentionnés dans le texte?\", 'role': 'user'}, {'content': 'Diminution de la leucocytose, de l’adhésivité des globules rouges, augmentation de la disponibilité du monoxyde d’azote.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les indications discordantes entre l'autorisation de mise sur le marché (AMM) et les résultats des études concernant l'hydroxyurée (HC) selon le texte?\", 'role': 'user'}, {'content': \"Les indications de l'AMM sont restrictives, tandis que les résultats des études vont dans le sens d'une prescription large, voire universelle.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la discordance mentionnée dans le texte entre l'autorisation de mise sur le marché (AMM) et les résultats des études?\", 'role': 'user'}, {'content': \"La discordance mentionnée est que les indications de l'AMM sont restrictives, tandis que les résultats des études suggèrent une prescription plus large, voire universelle.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'âge recommandé pour commencer la prophylaxie par hydroxyurée (HC) chez les enfants?\", 'role': 'user'}, {'content': \"L'âge recommandé pour commencer la prophylaxie par hydroxyurée (HC) chez les enfants est dès l'âge de 9 mois.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les indications principales de l'hydroxyurée chez les adultes selon le texte?\", 'role': 'user'}, {'content': \"Les indications principales de l'hydroxyurée chez les adultes sont les CVO hospitalisées répétées et le STA.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les effets indésirables cutanés les plus fréquents associés à l'utilisation de l'HC?\", 'role': 'user'}, {'content': 'Les effets indésirables cutanés les plus fréquents sont habituellement une sécheresse cutanée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les effets indésirables cutanés les plus fréquents associés à l'hydroxychloroquine?\", 'role': 'user'}, {'content': 'Les effets indésirables cutanés les plus fréquents sont habituellement peu gênants, sous forme d’une sécheresse cutanée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les effets indésirables cutanés les plus fréquents associés à l'hydroxychloroquine?\", 'role': 'user'}, {'content': 'Les effets indésirables cutanés les plus fréquents sont habituellement une sécheresse cutanée.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one of the factors that can lead to hematologic toxicity according to the text?', 'role': 'user'}, {'content': 'High dosages, iron deficiency, or a need for dose adjustment in case of renal insufficiency', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la posologie initiale recommandée pour l'enfant prenant de l'hydroxyurée?\", 'role': 'user'}, {'content': 'La posologie initiale recommandée est de 20 mg/kg/j en une prise orale quotidienne.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la posologie initiale recommandée chez l'enfant pour ce traitement?\", 'role': 'user'}, {'content': \"La posologie initiale recommandée chez l'enfant est de 20 mg/kg/j en une prise orale quotidienne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les critères principaux pour déterminer la dose de médicament chez l'adulte?\", 'role': 'user'}, {'content': \"La dose minimale efficace en commençant par 15 mg/kg, puis en augmentant si nécessaire, avec le critère principal étant l'amélioration clinique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les examens cliniques et biologiques nécessaires avant l'initiation du traitement par HC selon le texte?\", 'role': 'user'}, {'content': 'Une évaluation clinique et biologique, comportant hémo\\xadgramme, réticulocytes, taux de LDH, bilan hépatique avec bilirubinémie, créatininémie, taux d’HbF, bilan martial avec coefficient de saturation de la transferrine.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les signes d'efficacité biologique de l'hydroxyurée (HC) mentionnés dans le texte?\", 'role': 'user'}, {'content': \"Les signes d'efficacité biologique de l'hydroxyurée (HC) mentionnés dans le texte sont l'augmentation du taux d'hémoglobine, la réduction des réticulocytes, de la LDH et de la bilirubinémie, ainsi que l'augmentation de l'HbF.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi le suivi d'observance est-il un enjeu central de la consultation pour les patients atteints de drépanocytose?\", 'role': 'user'}, {'content': \"Le suivi d'observance est un enjeu central de la consultation pour les patients atteints de drépanocytose car l'effet bénéfique du traitement est majeur, ce qui nécessite une prise en charge spécifique et continue, incluant l'évaluation et la promotion de l'adhésion au traitement.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les risques associés à la transfusion sanguine dans le traitement de la drépanocytose?', 'role': 'user'}, {'content': \"Les risques associés à la transfusion sanguine dans le traitement de la drépanocytose sont l'allo-immunisation et l'hyperhémolyse, qui sont élevés dans la population atteinte de cette maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les indications de la transfusion ponctuelle chez un enfant atteint de drépanocytose?', 'role': 'user'}, {'content': 'Le PT régulier reste indiqué en première intention dès la détection de vitesses cérébrales pathologiques et après survenue d’un premier infarctus artériel cérébral, notamment s’il est lié à une vasculopathie cérébrale. Il est indiqué en seconde ligne après l’HC, pour prévenir la récurrence des complications vaso-occlusives (CVO/STA), des épisodes de priapisme et d’ostéonécrose de hanche.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main indication for regular blood transfusions in adults?', 'role': 'user'}, {'content': 'The main indication for regular blood transfusions in adults is cerebral vasculopathy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les indications du traitement par transfusion (PT) chez les patients atteints de drépanocytose selon le texte?', 'role': 'user'}, {'content': 'Le PT est indiqué pour réduire le risque d’anémie sévère lié à la récidive de séquestration splénique aiguë, avant une greffe de cellules souches ou d’organe pour réduire les complications aiguës drépanocytaires en prégreffe, et lors du conditionnement. Chez l’adulte, la vasculopathie cérébrale est l’indication principale.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Dans quelles circonstances la mise en place d'un PT est-elle indiquée pendant la grossesse selon le texte?\", 'role': 'user'}, {'content': \"La mise en place d'un PT pendant la grossesse est indiquée dans des circonstances précises telles que chez les femmes aux antécédents de complications sévères de la drépanocytose, présentant des comorbidités, en cas de survenue de CVO non liées à un facteur curable lors de la grossesse en cours, ou pour des indications obstétricales.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les circonstances précises dans lesquelles la mise en place d'un PT est indiquée pendant la grossesse?\", 'role': 'user'}, {'content': \"La mise en place d'un PT pendant la grossesse est indiquée chez les femmes aux antécédents de complications sévères de la drépanocytose, présentant des comorbidités, en cas de survenue de CVO non liées à un facteur curable lors de la grossesse en cours, ou pour des indications obstétricales (antécédent de retard de croissance, par exemple).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les complications majeures de la transfusion dans la population drépanocytaire?', 'role': 'user'}, {'content': 'Les complications majeures de la transfusion dans la population drépanocytaire sont l’allo-immunisation et les accidents hémolytiques post-transfusionnels retardés.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is it important to inform the transfusion biologist about the sickle cell disease and previous transfusions?', 'role': 'user'}, {'content': 'It is important to inform the transfusion biologist about the sickle cell disease and previous transfusions in order to search for previous irregular antibodies and prevent hemolytic transfusion reactions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'objectif d'HbS à viser sous PT pour vasculopathie cérébrale?\", 'role': 'user'}, {'content': \"Un objectif d'HbS inférieur à 30%\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is being proposed to reduce the indications of blood transfusions for patients with severe forms of sickle cell disease?', 'role': 'user'}, {'content': 'The introduction of hydroxycarbamide (HC) at an earlier stage and its wider use.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the article by Brousse et al.?', 'role': 'user'}, {'content': 'The study focuses on evaluating outcomes and quality of care in children with sickle cell disease diagnosed by newborn screening.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Ware RE that discusses the use of hydroxyurea to treat young patients with sickle cell anemia?', 'role': 'user'}, {'content': 'How I use hydroxyurea to treat young patients with sickle cell anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the study by John CC, Opoka RO, and colleagues regarding sickle cell anemia treatment in Sub-Saharan Africa?', 'role': 'user'}, {'content': 'Hydroxyurea dose escalation for sickle cell anemia in Sub-Saharan Africa', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Ataga, Saraf, and Derebail published in 2022?', 'role': 'user'}, {'content': 'The nephropathy of sickle cell trait and sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the text by Sahoo LK et al.?', 'role': 'user'}, {'content': 'The study focuses on seminal fluid parameters and fertility of male sickle cell disease patients and the potential impact of hydroxyurea treatment.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main focus of the study by Gille AS et al. mentioned in the text?', 'role': 'user'}, {'content': 'The study by Gille AS et al. focuses on the effect of hydroxyurea on the spermatogonial pool in prepubertal patients with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the study mentioned in reference 20?', 'role': 'user'}, {'content': 'Increased risk of leukemia among sickle cell disease patients in California', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Adams RJ et al. published in the New England Journal of Medicine in 1998?', 'role': 'user'}, {'content': 'Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the text by Adams et al.?', 'role': 'user'}, {'content': 'The prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is highlighted as a key element despite its risks in the treatment of sickle cell disease?', 'role': 'user'}, {'content': 'Treatment by blood transfusion or exchange transfusions', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les deux principaux traitements de fond de la drépanocytose mentionnés dans le texte?', 'role': 'user'}, {'content': 'Les deux principaux traitements de fond de la drépanocytose mentionnés dans le texte sont le traitement médicamenteux par hydroxycarbamide (HC) et les transfusions régulières de globules rouges.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What factors are closely related to the effectiveness of the treatment with HC mentioned in the text?', 'role': 'user'}, {'content': 'The dose (usually between 15 and 35 mg/kg/day) and adherence to the daily oral intake.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the website mentioned in the text?', 'role': 'user'}, {'content': 'La Revue du Praticien', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les deux maladies du sang abordées dans le texte?', 'role': 'user'}, {'content': 'La drépanocytose et la thalassémie', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sujets sont abordés dans la série 'La drépanocytose, une maladie du sang'?\", 'role': 'user'}, {'content': \"La série aborde des sujets tels que l'origine et la diffusion de la drépanocytose, le dépistage, vivre avec la maladie, l'enfant atteint de drépanocytose et l'école, travailler avec la drépanocytose, la prévention des crises, la greffe de moelle osseuse et la thérapie génique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les sujets abordés dans la série 'La drépanocytose, une maladie du sang'?\", 'role': 'user'}, {'content': \"La série aborde des sujets tels que l'origine et la diffusion de la drépanocytose, le dépistage, vivre avec la maladie, les soins et la prévention au quotidien, l'enfant atteint de drépanocytose et l'école, travailler avec la drépanocytose, la prévention des crises, la greffe de moelle osseuse et la thérapie génique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la maladie génétique la plus répandue dans le monde selon le texte ?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Combien de personnes sont porteuses du gène de la drépanocytose selon l'Organisation Mondiale de la Santé?\", 'role': 'user'}, {'content': \"Selon l'Organisation Mondiale de la Santé, on compte 500 millions de personnes porteuses du gène de la drépanocytose.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la substance affectée par la drépanocytose dans les globules rouges?', 'role': 'user'}, {'content': \"L'hémoglobine\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le risque d'avoir un enfant drépanocytaire SS lorsque les deux parents sont AS?\", 'role': 'user'}, {'content': \"Il y a un risque de 25% d'avoir un enfant drépanocytaire SS lorsque les deux parents sont AS.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la différence entre une personne AS et une personne SS en ce qui concerne la drépanocytose?', 'role': 'user'}, {'content': \"Une personne AS est porteuse du gène de l'hémoglobine S mais n'est pas atteinte de la maladie, tandis qu'une personne SS a deux gènes S et est atteinte de l'anémie falciforme.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les signes précoces de la drépanocytose chez les enfants?', 'role': 'user'}, {'content': 'Les signes précoces de la drépanocytose chez les enfants sont la fatigue, la pâleur, un ictère au niveau des yeux, un retard de croissance et une puberté tardive.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi est-il essentiel d'effectuer un dépistage précoce de la drépanocytose?\", 'role': 'user'}, {'content': \"Il est essentiel d'effectuer un dépistage précoce de la drépanocytose pour permettre la mise en place d'une prise en charge adaptée à la maladie, tout au long de la vie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose et quel impact peut-elle avoir sur la qualité de vie des patients?\", 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique du sang qui peut entraîner des crises douloureuses. Elle peut avoir un impact sur la qualité de vie des patients en raison de ses symptômes, complications et de sa nature chronique.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose, également connue sous le nom d'anémie falciforme?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie héréditaire qui altère la forme des globules rouges, chargés de transporter l'oxygène vers toutes les parties du corps.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la drépanocytose affecte dans le corps humain?\", 'role': 'user'}, {'content': \"La drépanocytose affecte les cellules sanguines en provoquant une anomalie sur l'hémoglobine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the characteristics of red blood cells in an individual without the sickle cell gene?', 'role': 'user'}, {'content': 'In an individual without the sickle cell gene, red blood cells are smooth, round, and flexible, allowing them to circulate easily in the blood vessels.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la durée de vie des globules rouges falciformes par rapport à celle des globules rouges normaux?', 'role': 'user'}, {'content': 'La durée de vie des globules rouges falciformes est de 10 à 20 jours, contre 120 jours pour des globules rouges normaux.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment la drépanocytose est-elle transmise selon un schéma autosomique récessif ?', 'role': 'user'}, {'content': \"Un individu naîtra avec la drépanocytose uniquement s’il hérite de deux gènes, de la part de ses parents, l’un de la mère et l’autre du père. Un individu qui hérite d’un seul gène est en bonne santé et est dit 'porteur sain' de la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes les plus fréquents de la drépanocytose?', 'role': 'user'}, {'content': 'Les symptômes les plus fréquents de la drépanocytose sont des crises douloureuses.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les symptômes les plus fréquents de la drépanocytose?', 'role': 'user'}, {'content': \"Les symptômes les plus fréquents de la drépanocytose sont des crises douloureuses, de l'anémie, une inflammation et un gonflement des articulations, les yeux jaunes, un jaunissement de la peau, et des blocages sanguins dans le foie et la rate.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel test est utilisé pour diagnostiquer la drépanocytose?', 'role': 'user'}, {'content': 'Une simple analyse de sang.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'Les traitements de la drépanocytose peuvent inclure la prise de médicaments pour soulager la douleur, la prévention des infections, la transfusion sanguine et la greffe de moelle osseuse.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'Pour la plupart des personnes atteintes de drépanocytose, le traitement et la prise en charge de la maladie consiste principalement à atténuer la gravité de la maladie et à soulager les symptômes, en particulier les douleurs dues à la drépanocytose. Il n’existe, en effet, pas de traitement curatif permettant de soigner les cas de drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les traitements de la drépanocytose ?', 'role': 'user'}, {'content': 'Les traitements de la drépanocytose peuvent inclure un suivi pour prévenir les complications, des transfusions sanguines, une greffe de moelle osseuse et des thérapies géniques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les méthodes recommandées pour prévenir la drépanocytose?', 'role': 'user'}, {'content': \"Les méthodes recommandées pour prévenir la drépanocytose incluent des transfusions sanguines, une greffe de moelle osseuse par un donneur compatible, et des thérapies géniques en cours d'évaluation.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the medical article mentioned in the text?', 'role': 'user'}, {'content': 'The purpose of the medical article is solely informative and does not replace the advice of a doctor.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie d'une personne drépanocytaire en France ?\", 'role': 'user'}, {'content': \"L'espérance de vie des personnes atteintes de drépanocytose en France est de plus de 40 ans en moyenne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'espérance de vie moyenne des personnes atteintes de drépanocytose selon les statistiques mentionnées dans le texte ?\", 'role': 'user'}, {'content': \"L'espérance de vie des personnes atteintes de drépanocytose est de plus de 40 ans en moyenne.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est une maladie génétique ?', 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique car elle est causée par une mutation génétique qui est transmise par les parents aux enfants.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la drépanocytose est une maladie génétique ?', 'role': 'user'}, {'content': 'La drépanocytose est une maladie génétique car elle est causée par une mutation génétique qui se transmet de génération en génération.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the term for a condition characterized by a deficiency of red blood cells or hemoglobin in the blood?', 'role': 'user'}, {'content': 'Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the medical condition that involves inflammation of the voice box?', 'role': 'user'}, {'content': 'Laryngite', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How many doctors are mentioned in the text?', 'role': 'user'}, {'content': '7,500 doctors', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell disease and how does it affect individuals?', 'role': 'user'}, {'content': 'Sickle cell disease is an inherited red blood cell disorder characterized by sickle-shaped red blood cells. It causes complications such as episodic pain, susceptibility to infections, swelling in the hands and feet, and damage to blood vessels impacting multiple organs. Individuals with sickle cell disease also have an increased risk for strokes and problems during pregnancy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the curative therapies available for individuals with sickle cell disease?', 'role': 'user'}, {'content': 'The curative therapies available for individuals with sickle cell disease include hematopoietic stem cell transplant and gene therapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the clinical datasets related to sickle cell disease hosted by BDC?', 'role': 'user'}, {'content': 'Some of the clinical datasets related to sickle cell disease hosted by BDC include Cooperative Study of Sickle Cell Disease (CSSCD), Hematopoietic Cell Transplant for Sickle Cell Disease (HCT for SCD), Multicenter Study of Hydroxyurea (MSH), Optimizing Primary Stroke Prevention in Children with Sickle Cell Anemia (STOP II), Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy (Walk-PHaSST), and Hydroxyurea to Prevent Organ Damage in Children with Sickle Cell Anemia (Baby Hug).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What program has made these datasets available for researchers to download redacted versions of the data?', 'role': 'user'}, {'content': \"NHLBI's BioLINCC program\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What new opportunities does the ingestion of data into BDC open up for researchers working in sickle cell disease research?', 'role': 'user'}, {'content': 'The ingestion of data into BDC opens up new opportunities for researchers, including conducting dynamic cohort generation with data from both people with and without sickle cell disease, working with genomic and other clinical data using deep learning tools and workflows, and the potential for more robust analysis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What does BDC offer to the sickle cell research community?', 'role': 'user'}, {'content': 'BDC offers an improved ability to browse data, facilitates reproducibility, allows researchers to collaborate in cloud-based workspaces, create cohorts, use a variety of tools and workflows, conduct secondary analyses of existing data, combine BDC-hosted data with their own data (BYOD).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who is the Chief of the Scientific Solutions Delivery Branch in the Information Technology and Applications Center at NHLBI and the Data Management Lead for BDC?', 'role': 'user'}, {'content': 'Sweta Ladwa', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What did Gillaspy state about the new inclusions related to sickle cell disease?', 'role': 'user'}, {'content': 'Gillaspy stated that the new inclusions relate to sickle cell disease, but there are many clinical study datasets from current and historical NHLBI-funded research that NHLBI is working to make available within BDC.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of BDC in relation to sickle cell disease research?', 'role': 'user'}, {'content': \"BDC is increasing researchers' access to key sickle cell data and providing them with enhanced analysis and collaboration capabilities to advance the research for improved treatments and additional cures.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who provided information for the article about sickle cell disease datasets and research?', 'role': 'user'}, {'content': 'Sweta Ladwa', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is Sweta Ladwa's current role at the NHLBI Information Technology and Applications Center (ITAC)?\", 'role': 'user'}, {'content': 'Sweta Ladwa currently serves as Chief, Scientific Solutions Delivery Branch in the NHLBI Information Technology and Applications Center (ITAC) and is the Data Management Lead for BDC’s data science ecosystem.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is Allison Gillaspy's role in the Cure Sickle Cell Initiative (CureSCi)?\", 'role': 'user'}, {'content': 'Allison Gillaspy is the Data Strategy Scientific Program Lead for the Cure Sickle Cell Initiative (CureSCi).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is Lisbeth A. Welniak's role at the National Institutes of Health (NIH)?\", 'role': 'user'}, {'content': 'Lisbeth A. Welniak is a program director in the Translational Biology Branch of the Division of Blood Diseases and Resources (DBDR) at NHLBI, part of the National Institutes of Health (NIH).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of section 1 in the table of contents?', 'role': 'user'}, {'content': 'Symptômes', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the different sections discussed in the text?', 'role': 'user'}, {'content': 'The text discusses sections on Physiopathology, Genetics, Hereditary transmission and composite forms, Molecular and cellular impacts, Heterozygous advantage, Examinations and diagnosis, Treatments, Background treatment, Treatment of complications, Bone marrow transplant, Gene therapies, and Best practices to prevent complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the treatments mentioned in the text?', 'role': 'user'}, {'content': 'Some of the treatments mentioned in the text include: Treatment of the underlying condition, Treatment of complications, Bone marrow transplant, Gene therapies, and Best practices to prevent complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are the different sub-sections under the section 'Épidémiologie, écoépidémiologie'?\", 'role': 'user'}, {'content': \"The different sub-sections under the section 'Épidémiologie, écoépidémiologie' are: Afrique, Moyen-Orient, Inde et Népal, Amériques, Europe, and France.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the different sections mentioned in the text?', 'role': 'user'}, {'content': \"The text mentions sections such as 'Dépistage', 'États-Unis et Royaume-Uni', 'France', 'Autres pays développés', 'Pays en voie de développement', 'Histoire', 'Élucidation de la maladie', 'Données cliniques et biologiques', 'Données génétiques', 'Aspects politiques et sociaux', 'En Afrique', 'En Occident', 'Prise en charge médico-sociale', 'Filmographie', and 'Malades célèbres'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the section that includes 'Notes' and 'Références'?\", 'role': 'user'}, {'content': 'Notes et références', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What language is listed between '한국어' and 'Lingua Franca Nova'?\", 'role': 'user'}, {'content': 'Kurdî', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What language is the text written in?', 'role': 'user'}, {'content': 'The text is written in French.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the genetic disorder discussed in the text?', 'role': 'user'}, {'content': 'Drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la prévalence de la drépanocytose en 2015?', 'role': 'user'}, {'content': '4,4 millions en 2015', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la particularité de la transmission de la drépanocytose?', 'role': 'user'}, {'content': 'La drépanocytose est une maladie à transmission autosomique récessive, ce qui signifie que seuls les homozygotes porteurs de deux allèles mutés sont affectés par la maladie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la transmission de la drépanocytose et comment se manifeste-t-elle chez les porteurs d'un seul allèle muté ?\", 'role': 'user'}, {'content': \"La drépanocytose est une maladie à transmission autosomique récessive. Chez les porteurs d'un seul allèle muté, la maladie ne se manifeste pas ou peu, on dit qu'ils ont le trait drépanocytaire ou qu'ils sont des porteurs sains.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the three main clinical manifestations of the disease described in the text?', 'role': 'user'}, {'content': 'The three main clinical manifestations are chronic hemolytic anemia with acute exacerbations, susceptibility to bacterial infections, and vaso-occlusive crises.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les différentes méthodes de prise en charge de la drépanocytose mentionnées dans le texte?', 'role': 'user'}, {'content': \"Les différentes méthodes de prise en charge de la drépanocytose mentionnées dans le texte sont la prévention des infections à l'aide de vaccins et d'antibiotiques, une bonne hydratation de l'organisme, le traitement des douleurs induites par les crises, la supplémentation en vitamine B9, la transfusion sanguine, et l'administration d'hydroxyurée.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between the normal red blood cells and the abnormal sickle-shaped red blood cells described in the text?', 'role': 'user'}, {'content': 'The normal red blood cells are circular and concave, while the abnormal sickle-shaped red blood cells have a shape resembling a sickle.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les facteurs qui peuvent favoriser le déclenchement des crises chez les personnes atteintes de la drépanocytose?', 'role': 'user'}, {'content': \"Les facteurs qui peuvent favoriser le déclenchement des crises chez les personnes atteintes de la drépanocytose sont une infection, une acidose, une déshydratation, une mauvaise hygiène de vie (tabac, alcool), l'anxiété et le stress, une dépressurisation ou une altitude élevée, un effort physique intense, le froid ou un temps sec, entre autres causes possibles.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont quelques-unes des manifestations chroniques de la drépanocytose?', 'role': 'user'}, {'content': 'Quelques manifestations chroniques de la drépanocytose incluent un retard de taille et de poids, des carences alimentaires, un retard pubertaire, des troubles cardiopulmonaires, une rate augmentée de volume ou atrophiée, des anomalies rétiniennes, des douleurs chroniques, et une énurésie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les organes susceptibles d'être affectés par les crises vasoocclusives chez les personnes atteintes de drépanocytose?\", 'role': 'user'}, {'content': \"Les organes susceptibles d'être affectés par les crises vasoocclusives chez les personnes atteintes de drépanocytose sont les os, l'abdomen, les reins, le cerveau, la rétine, etc.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment sont traitées les crises douloureuses causées par les globules rouges en forme de faucille?', 'role': 'user'}, {'content': \"Les crises douloureuses sont traitées par hydratation, à l'aide d'antalgiques, voire de transfusions sanguines.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the five manifestations that characterize an acute chest syndrome?', 'role': 'user'}, {'content': 'The five manifestations that characterize an acute chest syndrome are chest pain, fever, lung infiltrate, respiratory involvement, and hypoxemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi la rate est-elle fréquemment lésée lors d'une crise drépanocytaire?\", 'role': 'user'}, {'content': \"La rate est fréquemment lésée lors d'une crise drépanocytaire en raison de son rôle dans l'élimination des globules rouges défectueux.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce que la séquestration splénique et quelles en sont les conséquences en cas d'absence de traitement?\", 'role': 'user'}, {'content': \"La séquestration splénique consiste en une augmentation brutale de la taille de la rate accompagnée d'une chute rapide du taux d'hémoglobine dans le sang. En l'absence de traitement, les patients décèdent en une heure ou deux des suites d'un choc hypovolémique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the role of the parvovirus B19 in exacerbating anemia in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'The parvovirus B19 affects the production of red blood cells by destroying reticulocytes, the immediate precursors of red blood cells, which can lead to a severe drop in red blood cell count and worsen anemia in individuals with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Qu'est-ce qu'une crise hémolytique et quels sont les patients chez qui elle est particulièrement fréquente?\", 'role': 'user'}, {'content': \"Une crise hémolytique est une chute brutale de la quantité d'hémoglobine dans le sang due à la lyse accélérée des globules rouges. Elle est particulièrement fréquente chez les patients atteints de favisme ou de déficit en G6PD.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'une des manifestations cliniques les plus précoces de la maladie mentionnée dans le texte?\", 'role': 'user'}, {'content': \"La dactylite, pouvant apparaître chez le nouveau-né âgé d'à peine 6 mois\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the complications associated with sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Some of the complications mentioned include infectious complications, complications related to worsening anemia, cerebral infarctions, pulmonary arterial hypertension, and heart failure.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le rôle de l'hémoglobine dans le sang?\", 'role': 'user'}, {'content': \"L'hémoglobine est la protéine des globules rouges assurant le transport de l'oxygène dans le sang.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main function of hemoglobin in the blood?', 'role': 'user'}, {'content': 'Hemoglobin is the protein of red blood cells that transports oxygen in the blood.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est l'hémoglobine la plus abondante des trois mentionnées dans le texte?\", 'role': 'user'}, {'content': \"L'hémoglobine A est la plus abondante des trois, constituant environ 95 % de l'hémoglobine totale d'un adulte sain.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the consequence of replacing an adenine with a thymine in the DNA strand corresponding to the glutamate codon?', 'role': 'user'}, {'content': 'The glutamate is replaced by a valine in the transcription product.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the amino acid mutation that leads to the production of sickle cell hemoglobin?', 'role': 'user'}, {'content': 'Valine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the name of the mutation that produces sickle cell hemoglobin?', 'role': 'user'}, {'content': 'The mutation that produces sickle cell hemoglobin is known as the sickle mutation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, where is the sickle cell mutation believed to have occurred independently multiple times?', 'role': 'user'}, {'content': 'In distinct geographical areas such as Central Africa, the Arabian Peninsula, and the Indian subcontinent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the inheritance pattern of sickle cell disease (drépanocytose)?', 'role': 'user'}, {'content': 'Sickle cell disease is inherited in an autosomal recessive pattern.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la probabilité de mettre au monde un enfant drépanocytaire si les deux parents sont porteurs du trait drépanocytaire?', 'role': 'user'}, {'content': 'La probabilité est de 25% si les deux parents sont porteurs du trait drépanocytaire.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the molecular impact of the substitution of glutamate by valine in the hemoglobin molecule?', 'role': 'user'}, {'content': 'The substitution of glutamate by valine in the hemoglobin molecule leads to a lower solubility of its deoxygenated form, causing it to polymerize into long fibers that deform the red blood cell.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the effect of the substitution of glutamate with valine in the protein described in the text?', 'role': 'user'}, {'content': 'The substitution creates a hydrophobic adhesion zone on the protein surface between helices E and F.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les effets de la falciformation des globules rouges dans le corps humain?', 'role': 'user'}, {'content': \"Les effets de la falciformation des globules rouges dans le corps humain incluent la séquestration prolongée, la formation de thromboses, l'hémolyse facile des globules rouges, la difficulté des drépanocytes à se frayer un passage dans les fins capillaires, la phagocytose des drépanocytes par le système phagocytaire mononucléé, et la falciformation des drépanocytes dans la rate.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the challenges faced by sickle cells (drépanocytes) in the bloodstream according to the text?', 'role': 'user'}, {'content': 'Sickle cells face challenges such as prolonged sequestration, formation of blood clots, easy hemolysis in the fine capillaries, and difficulty passing through capillaries due to their elongated shape.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont les conséquences de la déformation des globules rouges, ou drépanocytes, sur les personnes atteintes?', 'role': 'user'}, {'content': 'Les drépanocytes sont plus fragiles, ont une durée de vie plus brève, et subissent une destruction anormalement élevée, ce qui conduit à une anémie hémolytique chez les personnes atteintes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la durée de vie normale d'un globule rouge chez une personne saine?\", 'role': 'user'}, {'content': 'Trois à quatre mois', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les syndromes drépanocytaires majeurs présentés par les hétérozygotes composites SC avec l'hémoglobine C et SE avec l'hémoglobine E?\", 'role': 'user'}, {'content': \"Les hétérozygotes composites SC avec l'hémoglobine C et SE avec l'hémoglobine E présentent des syndromes drépanocytaires majeurs (SDM) semblables à ceux des homozygotes SS.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What advantage does the heterozygous form of sickle cell disease offer in relation to malaria?', 'role': 'user'}, {'content': 'The heterozygotes have a reduced susceptibility to malaria and experience milder symptoms compared to those with the homozygous form of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi l'hémoglobine S chez les hétérozygotes peut-elle protéger contre le paludisme?\", 'role': 'user'}, {'content': \"L'hémoglobine S chez les hétérozygotes peut protéger contre le paludisme en raison de l'interruption du développement du parasite à l'intérieur des globules rouges, qui se lysent prématurément et ont une durée de vie réduite, ainsi que de la difficulté du parasite à digérer l'hémoglobine S polymérisée.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi la mutation de l'allèle S du gène HBB reste-t-elle fréquente dans les zones impaludées malgré son fort désavantage pour la forme homozygote?\", 'role': 'user'}, {'content': \"La mutation de l'allèle S du gène HBB reste fréquente dans les zones impaludées en raison de l'avantage sélectif qu'elle confère contre le paludisme, même si la forme homozygote est fortement désavantagée.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What can be observed in the blood of individuals with sickle cell disease according to the text?', 'role': 'user'}, {'content': 'A concentration of hemoglobin around 6 to 8 g/dL with a high number of reticulocytes, as well as structures like codocytes and Howell-Jolly bodies on a blood smear.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Comment peut-on détecter la présence d'hémoglobine anormale selon le texte?\", 'role': 'user'}, {'content': \"La présence d'hémoglobine anormale peut être détectée par électrophorèse sur gel, un mode d'électrophorèse dans lequel les différentes hémoglobines se déplacent à des vitesses différentes qui permettent de les caractériser.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi est-il conseillé de rechercher une infection par test urinaire ou radiographie du thorax chez les personnes atteintes de drépanocytose?', 'role': 'user'}, {'content': 'Il est conseillé de rechercher une infection chez les personnes atteintes de drépanocytose car une crise drépanocytaire est souvent induite par une infection.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont certains aspects des traitements préventifs pour les patients drépanocytaires mentionnés dans le texte?', 'role': 'user'}, {'content': \"Certains aspects des traitements préventifs pour les patients drépanocytaires mentionnés dans le texte incluent l'éviction des facteurs déclenchant les crises, la supplémentation en folates, et le traitement préventif des infections à pneumocoque et méningocoque.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Pourquoi la supplémentation en acide folique est-elle débattue malgré la recommandation de l'OMS?\", 'role': 'user'}, {'content': 'Son efficacité réelle est débattue depuis la fin du siècle dernier.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle molécule a été validée par la FDA aux États-Unis en 2017 pour réduire les complications graves associées à la drépanocytose?', 'role': 'user'}, {'content': 'L-Glutamine', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'effet de la L-glutamine sur les patients atteints de drépanocytose selon l'essai clinique de phase 3 mentionné dans le texte?\", 'role': 'user'}, {'content': 'La L-glutamine a démontré son intérêt dans la réduction des crises vasoocclusives et dans la diminution de la survenue du syndrome thoracique aigu.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est l'effet du voxelotor sur le taux de l'hémoglobine et les marqueurs sanguins d'une hémolyse?\", 'role': 'user'}, {'content': \"Le voxelotor permet d'augmenter le taux de l'hémoglobine et de diminuer le taux des marqueurs sanguins d'une hémolyse.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le nom du remède proposé en 2007 au Bénin contre la drépanocytose, mais dont aucune étude sérieuse n'a jamais trouvé d'efficacité thérapeutique?\", 'role': 'user'}, {'content': 'VK500', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le nom du remède proposé en 2007 au Bénin contre la drépanocytose, mais dont aucune étude sérieuse n'a jamais trouvé d'efficacité thérapeutique?\", 'role': 'user'}, {'content': \"Le remède s'appelait 'VK500'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les principaux traitements utilisés en milieu hospitalier pour traiter les infections chez les patients drépanocytaires?', 'role': 'user'}, {'content': 'Les infections sont traitées en milieu hospitalier selon une antibiothérapie couvrant principalement les pneumocoques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels sont les objectifs du traitement de l'ostéonécrose résultant des crises drépanocytaires?\", 'role': 'user'}, {'content': 'Les objectifs du traitement sont de réduire les douleurs et de maintenir la mobilité des articulations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la principale condition pour qu'une greffe de moelle osseuse soit réussie?\", 'role': 'user'}, {'content': 'Il faut un donneur apparenté au plus près : un frère ou une sœur.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the success rate of bone marrow transplants for sickle cell disease if a compatible donor is found?', 'role': 'user'}, {'content': 'Approximately 90%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of gene was introduced into the mice to cure sickle cell disease?', 'role': 'user'}, {'content': \"A gene producing 'anti-sickle cell' hemoglobin in high quantities.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the reasons why the new gene therapy treatments for sickle cell disease may not become widely available in the near future?', 'role': 'user'}, {'content': 'The new gene therapy treatments may not become widely available in the near future due to technical difficulties, high costs, and ethical concerns.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont les conseils donnés pour prévenir la survenue des crises et de leurs complications chez les personnes drépanocytaires?', 'role': 'user'}, {'content': \"Les conseils donnés sont de boire fréquemment de l'eau, de rester à l'abri des fortes chaleurs, de ne pas s'enrhumer et d'éviter les infections respiratoires.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quels sont quelques conseils simples pour prévenir les crises et leurs complications selon le texte?', 'role': 'user'}, {'content': \"Boire fréquemment de l'eau, rester à l'abri des fortes chaleurs, ne pas s'enrhumer, éviter les infections respiratoires, porter des vêtements amples, éviter les positions contraignantes, éviter l'essoufflement, les endroits mal aérés et les altitudes élevées.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelles sont quelques recommandations pour éviter les infections respiratoires selon le texte?', 'role': 'user'}, {'content': \"ne pas s'enrhumer, porter des vêtements amples, éviter l'essoufflement et les endroits mal aérés\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is the allele S, responsible for the anomaly of sickle cell disease, most prevalent?', 'role': 'user'}, {'content': 'The allele S is most prevalent in the African continent, reaching frequencies of up to 30% in certain populations.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the genetic advantage of being a carrier of sickle cell trait (heterozygote SA) in regions where malaria is prevalent?', 'role': 'user'}, {'content': 'Carriers of sickle cell trait are relatively protected against Plasmodium falciparum, the most severe form of malaria.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When did the mutation related to sickle cell anemia occur according to Tchernia and Bartolucci?', 'role': 'user'}, {'content': 'According to Tchernia, the mutation occurred between 1,100 and 200 BC in various places in Africa and Asia. According to Bartolucci, the mutation occurred approximately 70,000 to 150,000 years ago, with five different haplotypes appearing independently.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle mutation est associée à la drépanocytose chez les cervidés comme les muntjacs?', 'role': 'user'}, {'content': \"Le remplacement de l'acide aminé glutamate par une valine.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the frequency of the sickle cell trait in West African countries like Ghana and Nigeria?', 'role': 'user'}, {'content': 'The frequency of the sickle cell trait in West African countries like Ghana and Nigeria ranges from 15 to 30%.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la fréquence du trait drépanocytaire en Ouganda chez les Ambas?', 'role': 'user'}, {'content': '45 %', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la prévalence de la drépanocytose en Arabie saoudite selon le texte?', 'role': 'user'}, {'content': 'En Arabie saoudite, environ 4,2 % de la population est porteuse du trait drépanocytaire et 0,26 % est atteint par la maladie.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la prévalence de la drépanocytose dans la province d'ash-Sharqiyah en Arabie saoudite?\", 'role': 'user'}, {'content': \"La prévalence de la drépanocytose dans la province d'ash-Sharqiyah en Arabie saoudite est de 1,2%.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la prévalence de la drépanocytose chez certains peuples d'Inde centrale selon l'étude mentionnée dans le texte?\", 'role': 'user'}, {'content': 'La prévalence de la maladie varie de 9,4 % à 22,2 % dans les régions endémiques du Rajasthan, du Madhya Pradesh et du Chhattisgarh.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is sickle cell disease endemic among the Tharus?', 'role': 'user'}, {'content': 'The Tharus in Nepal and India.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the estimated number of sickle cell disease patients in the United States in 2016?', 'role': 'user'}, {'content': 'Approximately 100,000 people', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelle est la prévalence du gène drépanocytaire chez les Afro-Américains selon l'estimation de 2016 aux États-Unis?\", 'role': 'user'}, {'content': 'Environ 7,7%, soit environ 1⁄13 des Afro-Américains.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quels pays ou régions d'Europe sont mentionnés comme ayant une forte prévalence de la drépanocytose?\", 'role': 'user'}, {'content': \"Le sud de l'Italie, la Grèce et l'Albanie\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How many cases of sickle cell disease were estimated in Germany in 2017 among the population that arrived in the country due to the European migration crisis?', 'role': 'user'}, {'content': '3,000 cases', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quelles sont les deux vagues d'immigration ayant apporté la mutation drépanocytaire au Portugal selon les études génétiques?\", 'role': 'user'}, {'content': \"Une vague entre les VIIIe siècle et XIIIe siècle venant de Méditerranée, et une autre à partir du XVe siècle venant d'Afrique.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When were the first cases of sickle cell anemia reported in France?', 'role': 'user'}, {'content': 'The first cases of sickle cell anemia were reported in France in the 1940s.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the estimated number of newborns confirmed positive for sickle cell disease in France in 2020?', 'role': 'user'}, {'content': '557', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle résolution a été adoptée par la 59ème Assemblée mondiale de la Santé en 2006 concernant la drépanocytose?', 'role': 'user'}, {'content': 'La résolution adoptée invitait les États membres concernés à mettre en œuvre des programmes nationaux de dépistage de la drépanocytose.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quand les méthodes permettant un dépistage néonatal systématique sont-elles devenues disponibles?', 'role': 'user'}, {'content': 'Les méthodes permettant un dépistage néonatal systématique sont disponibles depuis les années 1970.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la principale raison du décalage entre le test de dépistage et la politique de dépistage de la drépanocytose?', 'role': 'user'}, {'content': \"La principale raison du décalage est qu'en l'absence de traitement efficace, on pensait qu'un diagnostic précoce n'aurait aucun effet sur les taux de morbidité et de mortalité de la maladie.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle nouvelle approche de prise en charge médicale a été adoptée par le Royaume-Uni en 1992?', 'role': 'user'}, {'content': 'Le dépistage universel basé sur des raisons éthiques.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la position de la Haute Autorité de Santé (HAS) concernant le dépistage néonatal de la drépanocytose en France métropolitaine?', 'role': 'user'}, {'content': \"La HAS n'estime pas pertinent le dépistage néonatal systématique en métropole, arguant la difficulté d'en estimer l'efficacité et les bénéfices, ainsi que l'absence de 'signal clair d'inefficacité du dépistage ciblé'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Pourquoi la Haute Autorité de Santé recommande-t-elle en 2022 de généraliser le dépistage de la drépanocytose?', 'role': 'user'}, {'content': \"La Haute Autorité de Santé recommande de généraliser le dépistage de la drépanocytose en 2022 en raison de plusieurs facteurs, tels que l'augmentation de la prévalence de la maladie, l'amélioration des tests de dépistage, l'impact des pathologies associées non dépistées, les taux élevés d'échecs du dépistage ciblé, et le fait que le dépistage ciblé est devenu moins pertinent pour diverses raisons.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle maladie génétique est devenue la plus fréquente selon une tendance épidémiologique à la hausse?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la 6e maladie génétique systématiquement dépistée à la naissance à partir de janvier 2023?', 'role': 'user'}, {'content': 'La drépanocytose', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which countries have implemented national and universal screening for sickle cell disease according to the text?', 'role': 'user'}, {'content': 'Germany, Canada, Spain, Malta, Netherlands', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What method was successfully tested in Togo, Mali, and the Democratic Republic of the Congo in early 2017 for quick and cost-effective screening of a disease?', 'role': 'user'}, {'content': 'A method where blood from the patient is dropped on a filter paper, and based on the pattern formed, it can provide a result in 30 minutes for individuals aged one year or older.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What method was successfully tested in Togo, Mali, and the Democratic Republic of the Congo in early 2017?', 'role': 'user'}, {'content': \"A quick and inexpensive method that allows for obtaining results in 30 minutes by dropping the patient's blood on a filter paper.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle est la première description moderne de la drépanocytose et quand a-t-elle été publiée?', 'role': 'user'}, {'content': \"La première description moderne de la drépanocytose remonte peut-être à 1846 avec la publication aux États-Unis de l'autopsie d'un esclave fugitif dépourvu de rate.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quand les globules rouges de forme inhabituelle en faucille ont-ils été décrits pour la première fois?', 'role': 'user'}, {'content': 'Les globules rouges de forme inhabituelle en faucille ont été décrits pour la première fois en novembre 1910.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quand a été publié l'article décrivant le cas d'un patient admis à l'hôpital de l'université de Virginie avec des globules rouges falciformes?\", 'role': 'user'}, {'content': 'Le cas du patient a été publié le 15 novembre 1910.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who established the genetic properties of sickle cell disease in 1949?', 'role': 'user'}, {'content': 'James Neel', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who isolated the HBB gene of the beta chain of hemoglobin on chromosome 11 in 1978?', 'role': 'user'}, {'content': 'Tom Maniatis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who isolated the HBB gene of the beta chain of hemoglobin in 1978?', 'role': 'user'}, {'content': 'Tom Maniatis', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How is sickle cell anemia perceived in African societies?', 'role': 'user'}, {'content': 'In African societies, sickle cell anemia is perceived as a condition where the affected child is seen as a reincarnated being, either beneficial or malevolent, and is believed to be transmitted by the mother, leading to potential social consequences.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment la maladie a-t-elle été initialement qualifiée en Occident?', 'role': 'user'}, {'content': \"La maladie a été initialement qualifiée de 'maladie des Noirs' en Occident.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the significance of the presence of the sickle cell trait in certain populations?', 'role': 'user'}, {'content': 'The presence of the sickle cell trait is used as a marker of migration and a means of studying the origins of humanity.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was a significant finding regarding the presence of sickle cell anemia in different populations?', 'role': 'user'}, {'content': \"The presence of sickle cell anemia was found to be independent of skin color, challenging the notion of it being a 'disease of the Blacks'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Comment la prise en charge médico-sociale des enfants drépanocytaires était-elle gérée aux États-Unis dans les années 1960?', 'role': 'user'}, {'content': 'Elle était quasi clandestine et assurée par des sociétés de bienfaisance ou des mouvements politiques noirs, tels que les Black Muslims de Malcolm X ou le mouvement des droits civiques de Martin Luther King.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quelle loi a été signée par le président Richard Nixon en 1972 pour lutter contre la drépanocytose?', 'role': 'user'}, {'content': 'Le Sickle Cell Anemia Control Act', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Quel pays est mentionné comme ayant des difficultés à répondre au flux croissant de patients drépanocytaires en 2023?', 'role': 'user'}, {'content': 'France', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Quel est le nom du film mettant en scène une histoire d'amour entre un médecin et une patiente drépanocytaire?\", 'role': 'user'}, {'content': \"L'amour fleurit en décembre (A Warm December, 1973)\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who are some famous individuals mentioned in the text who have been diagnosed with Sickle Cell disease?', 'role': 'user'}, {'content': 'Prodigy, Jo-Wilfried Tsonga, and Bolaji Badejo', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Who played the alien in the film 'Alien' directed by Ridley Scott?\", 'role': 'user'}, {'content': 'Bolaji Badejo', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the equivalent of INSERM in France?', 'role': 'user'}, {'content': 'The equivalent of INSERM in France is referenced as ↑.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by GBD 2015 Disease and Injury Incidence and Prevalence Collaborators?', 'role': 'user'}, {'content': \"The title of the article is 'Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Recommendations for the management of sickle cell disease in South Africa', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Simon Jones et al. published in the British Journal of Haematology in November 2005?', 'role': 'user'}, {'content': \"The title of the article is 'Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Barbara P. Yawn et al. mentioned in the text?', 'role': 'user'}, {'content': 'Management of Sickle Cell Disease. Summary of the 2014 Evidence-Based Report by Expert Panel Members', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Joshua J. Field, Paul F. Austin, Ping An, Yan Yan, and Michael R. DeBaun?', 'role': 'user'}, {'content': 'Enuresis Is a Common and Persistent Problem Among Children and Young Adults with Sickle Cell Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Joshua J. Field, Paul F. Austin, Ping An, Yan Yan, and Michael R. DeBaun?', 'role': 'user'}, {'content': 'Enuresis Is a Common and Persistent Problem Among Children and Young Adults with Sickle Cell Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Scott T. Miller about treating acute chest syndrome in children with sickle cell disease?', 'role': 'user'}, {'content': \"The title of the article is 'How I treat acute chest syndrome in children with sickle cell disease'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by J. Glassberg in Emergency Medicine Practice?', 'role': 'user'}, {'content': 'Evidence-based management of sickle cell disease in the emergency department', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the research discussed in the article 'Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease'?\", 'role': 'user'}, {'content': 'The focus of the research is on pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Rabindra N. Paul, Oswaldo L. Castro, Anita Aggarwal, and Patricia A. Oneal?', 'role': 'user'}, {'content': 'Acute chest syndrome: sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Howard A. Pearson in The Journal of Infectious Diseases?', 'role': 'user'}, {'content': 'Sickle Cell Anemia and Severe Infections Due to Encapsulated Bacteria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Rana Khatib, Raja Rabah, and Sharada A. Sarnaik?', 'role': 'user'}, {'content': 'The spleen in the sickling disorders: an update', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the research discussed in the article 'Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions'?\", 'role': 'user'}, {'content': 'The focus of the research is on the impact of human parvovirus B19 on patients with sickle-cell disease and thalassemia, as well as on blood transfusions.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by B. Balkaran et al. published in The Journal of Pediatrics in March 1992?', 'role': 'user'}, {'content': \"The title of the article is 'Stroke in a cohort of patients with homozygous sickle cell disease'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Mark T. Gladwin et al. published in The New England Journal of Medicine?', 'role': 'user'}, {'content': \"The title of the article is 'Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in The New England Journal of Medicine on July 1, 2011?', 'role': 'user'}, {'content': 'A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Jon I. Scheinman related to sickle cell disease?', 'role': 'user'}, {'content': 'Sickle cell disease and the kidney', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Orah S. Platt, Donald J. Brambilla, Wendell F. Rosse, Paul F. Milner, Oswaldo Castro, Martin H. Steinberg, and Panpit P. Klug published in The New England Journal of Medicine on June 9, 1994?', 'role': 'user'}, {'content': 'Mortality In Sickle Cell Disease — Life Expectancy and Risk Factors for Early Death', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the main focus of the article 'Senegal haplotype is associated with higher HbF than benin and cameroon haplotypes in African children with sickle cell anemia'?\", 'role': 'user'}, {'content': 'The main focus of the article is the association between different haplotypes and the levels of HbF in African children with sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the main topic of the article 'Genetic control of resistance to human malaria' by Anthony C. Allison?\", 'role': 'user'}, {'content': 'The main topic of the article is genetic control of resistance to human malaria.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Dominic P. Kwiatkowski mentioned in the text?', 'role': 'user'}, {'content': 'How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the study mentioned in the article 'A trial of folate supplementation in children with homozygous sickle cell disease'?\", 'role': 'user'}, {'content': 'The focus of the study is on folate supplementation in children with homozygous sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the purpose of the trial mentioned in the British Journal of Haematology in August 1983?', 'role': 'user'}, {'content': 'The trial mentioned in the British Journal of Haematology in August 1983 was a trial of folate supplementation in children with homozygous sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Samuel Charache et al. published in The New England Journal of Medicine?', 'role': 'user'}, {'content': 'Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Who are some of the authors of the study 'Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia'?\", 'role': 'user'}, {'content': 'Some of the authors include Martin H. Steinberg, Franca Barton, Oswaldo Castro, Charles H. Pegelow, and others.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the text?', 'role': 'user'}, {'content': 'The study focuses on the effects of Hydroxyurea on fetal hemoglobin production in sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Frédéric B. Piel, Martin H. Steinberg, and David C. Rees published in The New England Journal of Medicine?', 'role': 'user'}, {'content': 'Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Henry ER, Metaferia B, Li Q et al.?', 'role': 'user'}, {'content': 'Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the article 'Treatment for avascular necrosis of bone in people with sickle cell disease'?\", 'role': 'user'}, {'content': 'The topic of the article is the treatment for avascular necrosis of bone in people with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"When was the article 'Bone Marrow Transplants for Sickle Cell Disease' on Sickle-Cell.com last accessed?\", 'role': 'user'}, {'content': 'The article was last accessed on May 4, 2024.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the subject of the article 'Correction of Sickle Cell Disease in Transgenic Mouse Models by Gene Therapy'?\", 'role': 'user'}, {'content': 'The subject of the article is the correction of Sickle Cell Disease in transgenic mouse models using gene therapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in The New England Journal of Medicine about gene therapy in a patient with sickle cell disease?', 'role': 'user'}, {'content': 'Gene Therapy in a Patient with Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the New England Journal of Medicine in 2022 regarding sickle cell disease?', 'role': 'user'}, {'content': 'LentiGlobin for sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Jean-Benoît Arlet about sickle cell disease?', 'role': 'user'}, {'content': 'Epidémiologie de la drépanocytose en France et dans le monde', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can one find information about sickle-cell anaemia on the website www.who.int?', 'role': 'user'}, {'content': 'One can find information about sickle-cell anaemia on the website www.who.int by following the link provided in the text.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the research conducted by Sheikha Salim Al Arrayed and Neva Haites?', 'role': 'user'}, {'content': 'The research focuses on the features of sickle-cell disease in Bahrain.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Sickle cell disease: Experience of a tertiary care center in a nonendemic area', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Salzano Francisco mentioned in the text?', 'role': 'user'}, {'content': 'Incidence, effects, and management of sickle cell disease in Brazil', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by R. Dickerhoff and A. von Ruecker published in Klinische Padiatrie in 1998?', 'role': 'user'}, {'content': 'Manifestations of sickle cell disease in adolescents and young adults. Clinical aspects and therapy references', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'The epidemiology of sickle cell disease in Germany following recent large-scale immigration'?\", 'role': 'user'}, {'content': 'The focus of the article is on the epidemiology of sickle cell disease in Germany following recent large-scale immigration.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the screening mentioned in the text?', 'role': 'user'}, {'content': 'The screening mentioned in the text focuses on sickle cell and thalassaemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the article 'Épidémiologie des maladies génétiques de l'hémoglobine en France métropolitaine'?\", 'role': 'user'}, {'content': 'The epidemiology of genetic diseases of hemoglobin in metropolitan France', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the article 'Drépanocytose : feu vert de la Haute Autorité de santé au dépistage généralisé'?\", 'role': 'user'}, {'content': 'The article discusses the approval by the Haute Autorité de santé for generalized screening of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Nathaniel Z. Piety et al. published in PLoS One?', 'role': 'user'}, {'content': 'Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Nathaniel Z. Piety, Xiaoxi Yang, Julie Kanter, Seth M. Vignes, Alex George, and Sergey S. Shevkoplyas?', 'role': 'user'}, {'content': 'Validation of a Low-Cost Paper-Based Screening Test for Sickle Cell Anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Samir K. Ballas, Kalpna Gupta, and Patricia Adams-Graves?', 'role': 'user'}, {'content': 'Sickle cell pain: a critical reappraisal', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who wrote the 1910 Case Report of Sickle Cell Anemia?', 'role': 'user'}, {'content': 'James B. Herrick', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Verne Rheem Mason published in JAMA on October 11, 1985?', 'role': 'user'}, {'content': 'Sickle cell anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Verne Rheem Mason published in JAMA on October 14, 1922?', 'role': 'user'}, {'content': 'Sickle cell anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Vernon M. Ingram mentioned in the text?', 'role': 'user'}, {'content': 'A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Vernon M. Ingram published in Nature in 1956?', 'role': 'user'}, {'content': 'A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the focus of the investigation conducted by F. Dreyfuss, E. W. Ikin, H. Lehmann, and A. E. Mourant in 1952?', 'role': 'user'}, {'content': 'The investigation focused on blood groups and a search for sickle-cell trait in Yemenite Jews.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the topic of the article 'Prodigy: The Truth About Sickle Cell'?\", 'role': 'user'}, {'content': 'Sickle Cell', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where can you find more information about sickle cell anemia according to the text?', 'role': 'user'}, {'content': 'You can find more information about sickle cell anemia on various websites and organizations such as Wikimedia Commons, Wikibooks, Orphanet, APIPD, CIDD, Afrik.com, RoFSED, NCBI, and the WHO report.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the organization APIPD?', 'role': 'user'}, {'content': 'The purpose of the organization APIPD is for the information and prevention of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book mentioned in the text?', 'role': 'user'}, {'content': 'La drépanocytose, regards croisés sur une maladie orpheline', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the document mentioned in the text?', 'role': 'user'}, {'content': \"The topic of the document is 'Drépanocytose' (Sickle Cell Disease).\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the signs and symptoms associated with sickle cell disease?', 'role': 'user'}, {'content': 'Some signs and symptoms associated with sickle cell disease include sickle cell crisis, vaso-occlusive crisis, splenic sequestration crisis, acute chest syndrome, aplastic crisis, haemolytic crisis, and other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some management strategies for sickle cell disease?', 'role': 'user'}, {'content': 'Some management strategies for sickle cell disease include folic acid and penicillin, malaria prevention, vaso-occlusive crisis management, stroke prevention, acute chest syndrome management, hydroxyurea treatment, blood transfusion, bone marrow transplant, psychological therapy, and gene therapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the countries mentioned in the Epidemiology section of the text?', 'role': 'user'}, {'content': 'Africa, United States, France, United Kingdom, West Asia, India and Nepal, Caribbean Islands', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What are some of the subsections listed under 'Society and culture' in the text?\", 'role': 'user'}, {'content': \"Some of the subsections listed under 'Society and culture' are United States, Uganda, Rate of sickle cell disease in Uganda, Misconceptions about sickle cell disease, and Social isolation of people with sickle cell disease.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"How many languages are listed under 'Sickle cell disease'?\", 'role': 'user'}, {'content': '62 languages', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text provided?', 'role': 'user'}, {'content': 'The topic of the text is a group of genetic blood disorders.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What causes sickle cell disease?', 'role': 'user'}, {'content': 'Genetic, Homozygous mutation in the hemoglobin S gene.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some symptoms of the medical condition described in the text?', 'role': 'user'}, {'content': 'Some symptoms include attacks of pain, anemia, swelling in the hands and feet, bacterial infections, and stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is sickle cell disease and how is it typically inherited?', 'role': 'user'}, {'content': 'Sickle cell disease is a group of hemoglobin-related blood disorders typically inherited. It is caused by a mutation in each haemoglobin gene.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some measures that may be included in the care of people with sickle cell disease?', 'role': 'user'}, {'content': 'Some measures that may be included in the care of people with sickle cell disease are infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation, pain medication, blood transfusion, medication hydroxycarbamide, new gene therapies, and bone marrow cell transplant.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is sickle cell disease more prevalent?', 'role': 'user'}, {'content': 'Sickle cell disease is more prevalent in sub-Saharan Africa, Spanish-speaking regions in the Western Hemisphere, Saudi Arabia, India, and Mediterranean countries like Turkey, Greece, and Italy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some early signs and symptoms of sickle cell disease in infants?', 'role': 'user'}, {'content': \"Some early signs and symptoms of sickle cell disease in infants include dactylitis or 'hand-foot syndrome,' pallor, jaundice, and fatigue.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most frequent initial presentation of sickle cell disease among children older than 2 years?', 'role': 'user'}, {'content': 'The most frequent initial presentation is a painful event of generalized or variable type.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some types of crises that can occur in patients with sickle cell disease?', 'role': 'user'}, {'content': 'Some types of crises that can occur in patients with sickle cell disease include vaso-occlusive crisis, aplastic crisis, splenic sequestration crisis, and haemolytic crisis.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How are painful vaso-occlusive crises typically treated?', 'role': 'user'}, {'content': 'Painful crises are treated with hydration, analgesics, and blood transfusion; pain management requires opioid drug administration at regular intervals until the crisis has settled.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is recommended to minimize the development of atelectasis in patients with vaso-occlusive crisis?', 'role': 'user'}, {'content': 'Incentive spirometry', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is the spleen frequently affected in sickle cell disease?', 'role': 'user'}, {'content': 'The spleen is frequently affected in sickle cell disease because the sickle-shaped red blood cells cause narrowing of blood vessels and reduced function in clearing the defective cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the risk associated with spleen damage in individuals with sickle cell disease?', 'role': 'user'}, {'content': 'The risk associated with spleen damage in individuals with sickle cell disease is an increased risk of infection from encapsulated organisms.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the defining signs or symptoms of acute chest syndrome?', 'role': 'user'}, {'content': 'At least two of the following: chest pain, fever, pulmonary infiltrate or focal abnormality, respiratory symptoms, or hypoxemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main trigger for an aplastic crisis in sickle cell disease patients?', 'role': 'user'}, {'content': 'The main trigger for an aplastic crisis in sickle cell disease patients is parvovirus B19.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is a haemolytic crisis and what can cause it in people with sickle cell disease?', 'role': 'user'}, {'content': 'A haemolytic crisis is an acute accelerated drop in haemoglobin level where red blood cells break down at a faster rate. In people with sickle cell disease, haemolytic crises can be caused by oxidative stress on the erythrocytes, leukocytes, and platelets.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the complications that can arise from sickle cell anaemia?', 'role': 'user'}, {'content': 'Some complications that can arise from sickle cell anaemia include dactylitis, acute chest syndrome, hematopoietic ulcers, and various other complications.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the complications that can arise from sickle cell anaemia?', 'role': 'user'}, {'content': 'Some complications of sickle cell anaemia include increased risk of severe bacterial infections and stroke.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the difference between silent stroke and symptomatic stroke?', 'role': 'user'}, {'content': 'Silent stroke causes no immediate symptoms, while symptomatic stroke is associated with noticeable symptoms.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common cause of osteomyelitis in sickle cell disease?', 'role': 'user'}, {'content': 'Salmonella', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the most common cause of osteomyelitis in sickle cell disease?', 'role': 'user'}, {'content': 'Salmonella (especially the atypical serotypes Salmonella typhimurium, Salmonella enteritidis, Salmonella choleraesuis, and Salmonella paratyphi B)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the potential complications of sickle cell disease?', 'role': 'user'}, {'content': 'Some potential complications of sickle cell disease include acute papillary necrosis in the kidneys, leg ulcers, eye problems like retinopathy and blindness, pregnancy complications like intrauterine growth restriction and pre-eclampsia, chronic pain, and pulmonary hypertension.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some typical symptoms of pulmonary hypertension?', 'role': 'user'}, {'content': 'Shortness of breath, decreased exercise tolerance, and episodes of syncope.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the dominant type of hemoglobin in humans until about 6 weeks of age?', 'role': 'user'}, {'content': 'Haemoglobin F (HbF)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the chance of a child having sickle cell disease if one parent has sickle cell anaemia and the other has sickle cell trait?', 'role': 'user'}, {'content': '50%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are the variants of the sickle cell gene mutation mentioned in the text?', 'role': 'user'}, {'content': 'The variants mentioned are Cameroon, Senegal, Benin, Bantu, and Saudi-Asian.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the result of the gene defect on the β-globin gene?', 'role': 'user'}, {'content': 'The result of the gene defect is the substitution of glutamate by valine at position 6, known as E6V substitution.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What happens to the shape of red blood cells in individuals homozygous for HbS?', 'role': 'user'}, {'content': 'The presence of long-chain polymers of HbS distort the shape of the red blood cell from a smooth, doughnut-like shape to ragged and full of spikes, making it fragile and susceptible to breaking within capillaries.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is the allele responsible for sickle cell anaemia located?', 'role': 'user'}, {'content': 'The allele responsible for sickle cell anaemia is located on the short arm of chromosome 11 at position 15.5 (11p15.5).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why do people with sickle cell traits have an adaptive advantage in malaria-stricken areas?', 'role': 'user'}, {'content': 'People with sickle cell traits have an adaptive advantage in malaria-stricken areas because the presence of the malaria parasite causes the red blood cells with defective haemoglobin to rupture prematurely, making the Plasmodium parasite unable to reproduce.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some factors that may explain the lower prevalence of sickle cell anaemia among African Americans compared to West Africans?', 'role': 'user'}, {'content': 'Genetic dilution via crossbreeding with non-African people, high health-selective pressure through slavery, and the absence of endemic malaria are some factors that may explain the lower prevalence of sickle cell anaemia among African Americans compared to West Africans.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some factors that may explain the lower prevalence of sickle cell anaemia among African Americans compared to West Africans?', 'role': 'user'}, {'content': 'Genetic dilution via crossbreeding with non-African people, high health-selective pressure through slavery, and the relative absence of polygamy are some factors that may explain the lower prevalence of sickle cell anaemia among African Americans compared to West Africans.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is central to the pathophysiology of sickle cell disease?', 'role': 'user'}, {'content': 'The loss of red blood cell elasticity', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the cause of the actual anaemia in sickle cell disease?', 'role': 'user'}, {'content': 'The actual anaemia in sickle cell disease is caused by haemolysis, the destruction of the red cells, because of their shape.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can sickling of red blood cells be induced on a blood film?', 'role': 'user'}, {'content': 'Sickling of red blood cells can be induced on a blood film by the addition of sodium metabisulfite.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can the presence of sickle haemoglobin be demonstrated?', 'role': 'user'}, {'content': \"The presence of sickle haemoglobin can be demonstrated with the 'sickle solubility test' (also called 'sickledex').\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How can abnormal haemoglobin forms be detected?', 'role': 'user'}, {'content': 'Abnormal haemoglobin forms can be detected on haemoglobin electrophoresis, a form of gel electrophoresis on which the various types of haemoglobin move at varying speeds.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of genetic counseling for people at risk of sickle cell anemia?', 'role': 'user'}, {'content': 'Genetic counseling helps families discuss genetic testing options, potential impacts of testing, and test results.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is neonatal screening also known as?', 'role': 'user'}, {'content': 'Newborn screening', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the conclusion of the American Society of Hematology regarding testing for sickle cell trait status in athletes?', 'role': 'user'}, {'content': 'The American Society of Hematology concluded that they do not support testing or disclosure of sickle cell trait status as a prerequisite for participation in athletic activities.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What measures are involved in the treatment of sickle cell disease according to the text?', 'role': 'user'}, {'content': 'The treatment of sickle cell disease involves measures such as regular exercise, avoiding dehydration, consuming a diet high in calcium, and using L-glutamine starting at the age of five.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why is penicillin recommended for children from birth to five years of age?', 'role': 'user'}, {'content': 'Penicillin is recommended for children from birth to five years of age due to their immature immune system that makes them more prone to early childhood illnesses.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the recommended treatment for vaso-occlusive crises in people with sickle cell disease?', 'role': 'user'}, {'content': 'Painful crises are treated symptomatically with pain medications; pain management requires opioid drug administration at regular intervals until the crisis has settled.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was approved in the United States in 2019 to reduce the frequency of vaso-occlusive crisis in individuals 16 years and older?', 'role': 'user'}, {'content': 'Crizanlizumab, a monoclonal antibody target towards p-selectin', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why does the National Institute of Health recommend children with sickle cell to get the Transcranial Doppler ultrasound screen annually?', 'role': 'user'}, {'content': 'The ultrasound test can detect children with sickle cell that have a high risk for stroke by measuring the rate of blood into the brain and identifying blood vessels partially obstructed by sickle cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, what is the annual stroke rate for children at risk for strokes who received blood transfusions?', 'role': 'user'}, {'content': 'Less than 1 per cent', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the recommended management for acute chest syndrome in people with sickle cell disease?', 'role': 'user'}, {'content': 'Management is similar to vaso-occlusive crisis, with the addition of antibiotics, oxygen supplementation for hypoxia, and close observation.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is indicated if the pulmonary infiltrate worsens or the oxygen requirements increase in a person with sickle cell disease?', 'role': 'user'}, {'content': 'Simple blood transfusion or exchange transfusion', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one of the potential benefits of hydroxyurea in the treatment of sickle cell anaemia?', 'role': 'user'}, {'content': 'One of the potential benefits of hydroxyurea in the treatment of sickle cell anaemia is reducing the frequency of painful episodes and the risk of life-threatening illness or death.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of using blood transfusions in the management of sickle cell disease?', 'role': 'user'}, {'content': 'Blood transfusions are used to decrease the number of red blood cells that can sickle by adding normal red blood cells.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the only known cure for Sickle Cell Disease (SCD)?', 'role': 'user'}, {'content': 'Bone marrow transplants', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What technology are researchers investigating to correct the inherited error causing sickle cell anemia?', 'role': 'user'}, {'content': 'Researchers are investigating the use of CRISPR-Cas9.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the treatment for sickle cell anemia that involves replacing dysfunctional stem cells with healthy ones from a well-matched donor?', 'role': 'user'}, {'content': 'Hematopoietic Stem Cell Transplantation (HSCT)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some current treatment options for avascular necrosis of the bone in people with sickle cell disease?', 'role': 'user'}, {'content': 'Some current treatment options include resting the joint, physical therapy, pain-relief medicine, joint-replacement surgery, or bone grafting.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of psychological therapies mentioned in the text?', 'role': 'user'}, {'content': 'Some examples of psychological therapies mentioned in the text are patient education, cognitive therapy, behavioural therapy, and psychodynamic psychotherapy.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'In which regions is the highest frequency of sickle cell disease found?', 'role': 'user'}, {'content': 'The highest frequency of sickle cell disease is found in tropical regions, particularly West Africa and Central Africa, India, and the Middle East.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the advantage of carrying a single sickle cell allele in regions where malaria is common?', 'role': 'user'}, {'content': 'Carrying a single sickle cell allele confers a heterozygote advantage; humans with one of the two alleles of sickle cell disease show less severe symptoms when infected with malaria.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the carrier frequency of the mutated gene for sickle cell anaemia in equatorial Africa?', 'role': 'user'}, {'content': 'The carrier frequency ranges between 10 and 40% across equatorial Africa.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the percentage of babies born with sickle cell disease in Uganda according to the study mentioned?', 'role': 'user'}, {'content': '0.7%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which country in the text has the highest population in 2020?', 'role': 'user'}, {'content': 'Nigeria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which country in Eastern Africa has a population of 45,741,007?', 'role': 'user'}, {'content': 'Uganda', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which country in the text has the highest population?', 'role': 'user'}, {'content': 'Ethiopia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the population of Eswatini?', 'role': 'user'}, {'content': '1,160,164', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which country in Eastern Africa has a population of 36,910,560?', 'role': 'user'}, {'content': 'Morocco', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the total population of Africa according to the text?', 'role': 'user'}, {'content': '1,338,826,604', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which country is being referred to in the text?', 'role': 'user'}, {'content': 'United States', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the life expectancy for men with sickle cell disease (SCD) in the United States?', 'role': 'user'}, {'content': 'Approximately 42 years of age', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What percentage of African Americans are carriers of sickle cell anemia?', 'role': 'user'}, {'content': 'Approximately 8% of African Americans are carriers of sickle cell anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What has become the most common genetic disease in France?', 'role': 'user'}, {'content': 'Sickle cell disease (SCD)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Which countries are included in the list of ethnic origins considered 'at-risk' for Sickle Cell Disease (SCD) in neonatal screening?\", 'role': 'user'}, {'content': 'Countries from sub-Saharan Africa, North Africa, the Mediterranean area (South Italy, Greece, and Turkey), the Arabic peninsula, the French overseas islands, and the Indian subcontinent.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why do all newborn babies in the UK receive a routine blood test?', 'role': 'user'}, {'content': 'All newborn babies in the UK receive a routine blood test to screen for the sickle cell condition, as the number of carriers is only estimated and many adults in high-risk groups may not know if they are carriers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What measures did Saudi Arabia and Bahrain take to address the prevalence of sickle cell disease?', 'role': 'user'}, {'content': 'Saudi Arabia introduced a mandatory premarital test including HB electrophoresis, while Bahrain began screening all pregnant women and passed a law requiring couples planning to marry to undergo free premarital counseling.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Where is sickle cell disease common among the Tharu people?', 'role': 'user'}, {'content': 'Sickle cell disease is common among the Tharu people of Nepal and India.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Who was the intern to Chicago cardiologist James B. Herrick and saw 'peculiar elongated and sickle-shaped' cells in the blood of a man named Walter Clement Noel?\", 'role': 'user'}, {'content': 'Ernest E. Irons', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Who first introduced the distinction between sickle cell disease and trait in 1933?', 'role': 'user'}, {'content': 'Memphis physician Lemuel Diggs', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What intervention studies were introduced in the 1970s and 1980s to combat pneumococcal infections?', 'role': 'user'}, {'content': 'Prophylaxis against pneumococcal infections', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'According to the text, which populations are mainly affected by stigmas surrounding SCD in the US?', 'role': 'user'}, {'content': 'People of African American and Latin American ancestries', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why does social stigma exist for those with sickle cell disease in Uganda?', 'role': 'user'}, {'content': 'Social stigma exists for those with sickle cell disease in Uganda due to the lack of general knowledge of the disease and culturally sanctioned secrecy about it.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How do most people learn about sickle cell disease according to the text?', 'role': 'user'}, {'content': 'Most people learn about sickle cell disease from family or friends, not from health professionals.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the trait frequency of sickle cell disease in the population of Uganda?', 'role': 'user'}, {'content': '20%', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some misconceptions about sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'Some misconceptions about sickle cell disease mentioned in the text include the belief that it is caused by environmental factors and the belief that it resulted as a punishment from God or witchcraft.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the topic of the text?', 'role': 'user'}, {'content': 'Social isolation of people with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"Why do families often hide their family members' sickle cell disease status?\", 'role': 'user'}, {'content': \"Families often hide their family members' sickle cell disease status due to the deeply rooted stigma of SCD from society, fearing being labeled, cursed, or left out of social events.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'How does the stigma and social isolation related to sickle cell disease impact school-aged children?', 'role': 'user'}, {'content': 'The stigma and social isolation related to sickle cell disease can lead to peer rejection, exclusion from social groups or gatherings, emotional distress, academic underperformance, avoidance of school, and occupational failure later in life.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why do mothers of children with sickle cell disease often receive stigma from their peers and family members?', 'role': 'user'}, {'content': \"Mothers of children with sickle cell disease often receive stigma because they are sometimes blamed for their child's diagnosis, with some people suspecting that the child's poor health may have been caused by the mother's failure to implement preventative health measures or promote a healthy environment.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why do many Ugandans place blame on the mother for sickle cell disease?', 'role': 'user'}, {'content': 'Many Ugandans place blame on the mother for sickle cell disease due to poor knowledge of how the disease is acquired, as it is determined by genetics, not environment.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What challenges do women living with sickle cell disease face when they become pregnant in Uganda?', 'role': 'user'}, {'content': 'Women living with sickle cell disease who become pregnant in Uganda often face extreme discrimination, discouragement, criticism, and judgement from their peers, healthcare professionals, and families. They may also end up being single mothers as their male partners may leave them upon learning about their SCD status.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What new treatment did the NHS initiate in 2021 for Sickle Cell?', 'role': 'user'}, {'content': 'The NHS initiated the use of Crizanlizumab, a drug given via transfusion drips, which reduces the number of visits to A&E by sufferers.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the name of the campaign launched by the NHS on World Sickle Cell Day in 2022?', 'role': 'user'}, {'content': '\"Can you tell it\\'s sickle cell?\"', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What was the name of the campaign launched by the NHS on World Sickle Cell Day?', 'role': 'user'}, {'content': '\"Can you tell it\\'s sickle cell?\"', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the risks associated with umbilical cord blood transplant?', 'role': 'user'}, {'content': 'About 7% of people die as a result of the procedure and graft versus host disease may occur.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What method did researchers use to successfully treat sickle cell disease in mice in 2001?', 'role': 'user'}, {'content': 'The researchers used a viral vector to make the mice express production of fetal haemoglobin (HbF).', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When were the Phase 1 clinical trials of gene therapy for sickle cell disease in humans started?', 'role': 'user'}, {'content': 'The Phase 1 clinical trials of gene therapy for sickle cell disease in humans were started in 2014.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What gene editing tool was approved by UK regulators in November 2023 for the treatment of sickle cell disease and transfusion-dependent beta thalassemia?', 'role': 'user'}, {'content': 'CRISPR', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What gene editing tool was approved by UK regulators in November 2023 for the treatment of sickle cell disease and transfusion-dependent beta thalassemia?', 'role': 'user'}, {'content': 'CRISPR gene editing tool', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Why was there a discrepancy in the numbering of the glutamic acid residue in the text?', 'role': 'user'}, {'content': 'The historic numbering skipped the methionine start codon, while the current nomenclature counts the methionine as the first amino acid.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"When was the information about 'What Causes Sickle Cell Disease?' last retrieved?\", 'role': 'user'}, {'content': '8 March 2016', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the document that provides information on how sickle cell disease is diagnosed?', 'role': 'user'}, {'content': 'How Is Sickle Cell Disease Diagnosed?', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the publication mentioned in the text that provides information on sickle-cell disease treatment?', 'role': 'user'}, {'content': 'How Is Sickle Cell Disease Treated?', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in Lancet by the GBD 2015 Disease and Injury Incidence and Prevalence Collaborators in October 2016?', 'role': 'user'}, {'content': \"The title of the article is 'Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the Lancet in October 2016?', 'role': 'user'}, {'content': 'Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the significance of the FDA approval mentioned in the text?', 'role': 'user'}, {'content': 'The FDA approved the first gene therapies to treat patients with Sickle Cell Disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What gene treatment was recently approved by the UK regulator for sickle cell and β thalassaemia?', 'role': 'user'}, {'content': \"The UK regulator approved a 'groundbreaking' gene treatment for sickle cell and β thalassaemia.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the title of the 1989 article by Savitt TL and Goldberg MF that discusses Herrick's 1910 case report of sickle cell anemia?\", 'role': 'user'}, {'content': 'The rest of the story', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Rees DC, Williams TN, and Gladwin MT published in December 2010?', 'role': 'user'}, {'content': \"The title of the article is 'Sickle-cell disease'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the journal Blood on July 15, 1995?', 'role': 'user'}, {'content': 'Clinical events in the first decade in a cohort of infants with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Glassberg published in August 2011?', 'role': 'user'}, {'content': 'Evidence-based management of sickle cell disease in the emergency department', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What type of therapies were discussed in the article 'Psychological therapies for sickle cell disease and pain'?\", 'role': 'user'}, {'content': 'Psychological therapies', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Sickle cell anemia and severe infections due to encapsulated bacteria'?\", 'role': 'user'}, {'content': 'The article focuses on the relationship between sickle cell anemia and severe infections caused by encapsulated bacteria.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease'?\", 'role': 'user'}, {'content': 'The article focuses on the relationship between pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Sysol JR and Machado R published in 2016?', 'role': 'user'}, {'content': 'Sickle Cell Disease and Acute Chest Syndrome: Epidemiology, Diagnosis, Management, Outcomes', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book mentioned in the text that was published on 28 May 2009?', 'role': 'user'}, {'content': 'Robbins and Cotran Pathologic Basis of Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Balgir RS published in March 2012?', 'role': 'user'}, {'content': 'Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: experience from tribal land of India', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Miller ST published in May 2011?', 'role': 'user'}, {'content': 'How I treat acute chest syndrome in children with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'How I treat acute chest syndrome in children with sickle cell disease'?\", 'role': 'user'}, {'content': 'The focus of the article is on the treatment of acute chest syndrome in children with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Adams RJ from November 2007?', 'role': 'user'}, {'content': 'Big strokes in small persons', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the study mentioned in the article 'Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism'?\", 'role': 'user'}, {'content': 'The study focuses on platelet hyperactivity in sickle-cell disease as a consequence of hyposplenism.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Sickle cell disease and the eye: old and new concepts'?\", 'role': 'user'}, {'content': 'The focus of the article is on the relationship between sickle cell disease and the eye, discussing both old and new concepts.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Smith et al. published in January 2008?', 'role': 'user'}, {'content': 'Daily assessment of pain in adults with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the British Journal of Haematology in August 2015?', 'role': 'user'}, {'content': 'Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Niss O, Fleck R, Makue F, Alsaied T, Desai P, Towbin JA, et al. published in July 2017?', 'role': 'user'}, {'content': 'Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the Annals of Internal Medicine in October 1991?', 'role': 'user'}, {'content': 'Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the Senegal haplotype associated with in African children with sickle cell anemia?', 'role': 'user'}, {'content': 'Higher HbF (fetal hemoglobin)', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the Senegal haplotype associated with in African children with sickle cell anemia?', 'role': 'user'}, {'content': 'Higher HbF levels', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Kwiatkowski DP published in August 2005?', 'role': 'user'}, {'content': 'How malaria has affected the human genome and what human genetics can teach us about malaria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Kwiatkowski published in the American Journal of Human Genetics in August 2005?', 'role': 'user'}, {'content': 'How malaria has affected the human genome and what human genetics can teach us about malaria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the journal article by Lesi FE and Bassey EE published in July 1972?', 'role': 'user'}, {'content': 'Family study in sickle cell disease in Nigeria', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book by Atkinson and Mabey mentioned in the text?', 'role': 'user'}, {'content': 'Revolutionizing Tropical Medicine: Point-of-Care Tests, New Imaging Technologies and Digital Health', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book mentioned in the text that is authored by McPherson RA and Pincus MR?', 'role': 'user'}, {'content': \"Henry's Clinical Diagnosis and Management by Laboratory Methods\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Stallings published on July 27, 2019?', 'role': 'user'}, {'content': 'Genetic Counselors Of Color Tackle Racial, Ethnic Disparities In Health Care', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the research agenda for sickle cell trait according to Goldsmith et al. (2012)?', 'role': 'user'}, {'content': 'Building on the current understanding of clinical events and their potential implications', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Sickle Cell Trait Screening of Collegiate Athletes: Ethical Reasons for Program Reform'?\", 'role': 'user'}, {'content': 'The focus of the article is on the ethical reasons for reforming the sickle cell trait screening program for collegiate athletes.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Martin C, Pialoux V, Faes C, Charrin E, Skinner S, Connes P published in February 2018?', 'role': 'user'}, {'content': \"The title of the article is 'Does physical activity increase or decrease the risk of sickle cell disease complications?'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the British Journal of Sports Medicine in February 2018?', 'role': 'user'}, {'content': 'Does physical activity increase or decrease the risk of sickle cell disease complications?', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one recommended form of treatment for sickle cell disease mentioned in the text?', 'role': 'user'}, {'content': 'twice-daily prophylactic penicillin beginning in early infancy and continuing through at least age 5', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of folate supplementation in people with sickle cell disease?', 'role': 'user'}, {'content': 'The purpose of folate supplementation in people with sickle cell disease is to help manage the condition.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Carroll CP published in January 2020?', 'role': 'user'}, {'content': 'Opioid treatment for acute and chronic pain in patients with sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of crizanlizumab-tmca in the treatment of sickle cell disease?', 'role': 'user'}, {'content': 'The purpose of crizanlizumab-tmca is to treat sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When was crizanlizumab-tmca approved by the FDA for sickle cell disease?', 'role': 'user'}, {'content': '15 November 2019', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Kolata G published on May 24, 2021?', 'role': 'user'}, {'content': 'These Sisters With Sickle Cell Had Devastating, and Preventable, Strokes', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Charache et al. published in May 1995?', 'role': 'user'}, {'content': \"The title of the article is 'Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia.'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the studies mentioned in the text?', 'role': 'user'}, {'content': 'The studies focus on the effects of hydroxyurea on sickle cell anemia, including its impact on painful crises, mortality, and morbidity.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the main focus of the study mentioned in the text?', 'role': 'user'}, {'content': 'The main focus of the study is on the treatment and management of sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the study mentioned in the article 'Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease'?\", 'role': 'user'}, {'content': 'The focus of the study is on the effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is one of the strategies mentioned in the text for directly fixing malfunctioning blood cells in individuals with genetic diseases?', 'role': 'user'}, {'content': 'CRISPR', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Dudi A published on 17 November 2023?', 'role': 'user'}, {'content': \"The title of the article is 'Unravelito the Quest: Is There a Cure for Sickle Cell Anemia? Introduction to Sickle Cell Anemia'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the study mentioned in the article 'Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers'?\", 'role': 'user'}, {'content': 'The focus of the study is to assess the potential benefits and barriers of physical therapy in pediatric and young adult patients with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the text?', 'role': 'user'}, {'content': 'The study focuses on the effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book mentioned in the first citation?', 'role': 'user'}, {'content': 'Robbins and Cotran Pathologic Basis of Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book by Costa FF and Conran N that discusses Sickle Cell Anemia?', 'role': 'user'}, {'content': 'Sickle Cell Anemia: From Basic Science to Clinical Practice', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Weatherall and Clegg published in the Bulletin of the World Health Organization?', 'role': 'user'}, {'content': 'Inherited haemoglobin disorders: an increasing global health problem', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the protective effect of the sickle cell gene mentioned in the text?', 'role': 'user'}, {'content': 'The protective effect of the sickle cell gene mentioned in the text is against malaria morbidity and mortality.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the report mentioned in the first citation?', 'role': 'user'}, {'content': 'Sickle-cell anaemia – Report by the Secretariat', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in BMC Public Health in April 2018?', 'role': 'user'}, {'content': 'Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'When is Sickle Cell Awareness Month?', 'role': 'user'}, {'content': 'September', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the significance of September in relation to sickle cell disease?', 'role': 'user'}, {'content': 'September is Sickle Cell Awareness Month.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Assessing ethnicity in preconception counseling: genetics—what nurse practitioners need to know'?\", 'role': 'user'}, {'content': 'The focus of the article is on genetics and ethnicity in preconception counseling.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the challenges faced by sickle cell patients according to the text?', 'role': 'user'}, {'content': 'Sickle cell patients endure discrimination, poor care, and shortened lives.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the study mentioned in the article 'Neonatal screening for sickle cell disease in France: evaluation of the selective process'?\", 'role': 'user'}, {'content': 'The focus of the study is on evaluating the selective process of neonatal screening for sickle cell disease in France.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the purpose of the national premarital screening and genetic counseling program for sickle cell disease and β-thalassemia in Saudi Arabia?', 'role': 'user'}, {'content': 'The purpose of the program is to screen individuals for sickle cell disease and β-thalassemia before marriage to prevent the transmission of these genetic disorders to their children.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Jastaniah W published in the Annals of Saudi Medicine in 2011?', 'role': 'user'}, {'content': \"The title of the article is 'Epidemiology of sickle cell disease in Saudi Arabia'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Awasthy et al. published in 2008?', 'role': 'user'}, {'content': \"The title of the article is 'Sickle cell disease: Experience of a tertiary care center in a nonendemic area'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the Annals of Tropical Medicine and Public Health in 2008?', 'role': 'user'}, {'content': 'Sickle cell disease: Experience of a tertiary care center in a nonendemic area', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article mentioned in the text?', 'role': 'user'}, {'content': 'Life with sickle cell – Nation – Nepali Times', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Lebby R published in 1846?', 'role': 'user'}, {'content': 'Case of absence of the spleen', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Pauling and Itano published in November 1949?', 'role': 'user'}, {'content': 'Sickle cell anemia a molecular disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Pauling and Itano published in November 1949?', 'role': 'user'}, {'content': 'Sickle cell anemia a molecular disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the study mentioned in the article by Srikanthan S?', 'role': 'user'}, {'content': \"The focus of the study mentioned in the article by Srikanthan S is 'Contested Disability: Sickle Cell Disease'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book by Harriet A. Washington that discusses the history of medical experimentation on Black Americans?', 'role': 'user'}, {'content': 'Medical apartheid : the dark history of medical experimentation on Black Americans from colonial times to the present', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Bulgin D, Tanabe P, and Jenerette C published in August 2018?', 'role': 'user'}, {'content': \"The title of the article is 'Stigma of Sickle Cell Disease: A Systematic Review'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in October 2019 by Tusuubira SK, Naggawa T, and Nakamoga V?', 'role': 'user'}, {'content': 'To Join Or Not To Join? A Case Of Sickle Cell Clubs, Stigma And Discrimination In Secondary Schools In Butambala District, Uganda', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the BMC Public Health journal in April 2018?', 'role': 'user'}, {'content': 'Knowledge, perception and practices towards sickle cell disease: a community survey among adults in Lubaga division, Kampala Uganda', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in the East African Medical Journal in September 2009?', 'role': 'user'}, {'content': \"'Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda'\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article by Sehlo MG and Kamfar HZ published in April 2015?', 'role': 'user'}, {'content': \"The title of the article is 'Depression and quality of life in children with sickle cell disease: the effect of social support'.\", 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Better protection and support for people with sickle cell disease'?\", 'role': 'user'}, {'content': 'The focus of the article is on providing improved protection and support for individuals with sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape'?\", 'role': 'user'}, {'content': 'The focus of the article is on hematopoietic stem cell transplantation for sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the research mentioned in the text?', 'role': 'user'}, {'content': 'The research focuses on gene therapy for correcting sickle cell disease in transgenic mouse models.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': \"What is the focus of the article 'Gene Therapy Corrects Sickle Cell Disease In Laboratory Study'?\", 'role': 'user'}, {'content': 'The focus of the article is on gene therapy as a potential treatment for sickle cell disease.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the article published in The New England Journal of Medicine in March 2017?', 'role': 'user'}, {'content': 'Gene Therapy in a Patient with Sickle Cell Disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the significance of the use of CRISPR tool by doctors in the U.S. mentioned in the text?', 'role': 'user'}, {'content': 'The significance is that it marks the first time doctors in the U.S. have used the CRISPR tool to treat a patient with a genetic disorder.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the focus of the gene therapy mentioned in the text?', 'role': 'user'}, {'content': 'The gene therapy aims to cure sickle-cell disease and transfusion-dependent β-thalassemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book edited by Brown RT that provides a biopsychosocial approach to childhood cancer and sickle cell disease?', 'role': 'user'}, {'content': 'Comprehensive handbook of childhood cancer and sickle cell disease', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What is the title of the book by Tapper that discusses sickle cell anemia and the politics of race?', 'role': 'user'}, {'content': 'In the blood: sickle cell anemia and the politics of race', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of hereditary enzymopathies that can affect red blood cells?', 'role': 'user'}, {'content': 'Examples of hereditary enzymopathies that can affect red blood cells include glucose-6-phosphate dehydrogenase deficiency, pyruvate kinase deficiency, triosephosphate isomerase deficiency, and hexokinase deficiency.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some examples of autoimmune hemolytic anemias mentioned in the text?', 'role': 'user'}, {'content': 'Examples of autoimmune hemolytic anemias mentioned in the text include Warm antibody autoimmune hemolytic anemia, Cold agglutinin disease, and Mixed autoimmune hemolytic anemia.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the subspecialties under the field of Surgery?', 'role': 'user'}, {'content': 'Some subspecialties under the field of Surgery include Cardiac surgery, Neurosurgery, Orthopedic surgery, and Plastic surgery.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'Which medical specialty focuses on the study and treatment of diseases of the digestive system?', 'role': 'user'}, {'content': 'Gastroenterology', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the medical specialties mentioned in the text?', 'role': 'user'}, {'content': 'Some of the medical specialties mentioned in the text include Adolescent medicine, Anesthesiology, Dermatology, Emergency medicine, Family medicine, Neurology, Pediatrics, Psychiatry, and many others.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the medical specialties mentioned in the text?', 'role': 'user'}, {'content': 'Some of the medical specialties mentioned in the text are rehabilitation, preventive medicine, prison healthcare, psychiatry, addiction psychiatry, radiation oncology, reproductive medicine, sexual medicine, venereology, sleep medicine, sports medicine, transplantation medicine, tropical medicine, travel medicine, and more.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What are some of the categories listed for the article on sickle cell disease?', 'role': 'user'}, {'content': 'Some of the categories listed for the article on sickle cell disease include Autosomal recessive disorders, Chronic pain syndromes, Disorders of globin and globulin proteins, Health in Africa, and Hereditary hemolytic anemias.', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of sources are included in the CS1 French-language sources category?', 'role': 'user'}, {'content': 'French-language sources', 'role': 'assistant'}]\n",
            "Processing conversation: [{'content': 'What type of identifiers are included in the list of articles?', 'role': 'user'}, {'content': 'Identifiers such as FAST, BNF, BNFdata, GND, J9U, LCCN, NARA are included in the list of articles.', 'role': 'assistant'}]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# Tokenize the inputs and responses\n",
        "inputs = tokenizer(user_inputs, return_tensors=\"pt\", padding=True, truncation=True)\n",
        "labels = tokenizer(assistant_responses, return_tensors=\"pt\", padding=True, truncation=True)\n",
        "\n",
        "# Create a custom dataset class\n",
        "class CustomDataset(torch.utils.data.Dataset):\n",
        "    def __init__(self, encodings, labels):\n",
        "        self.encodings = encodings\n",
        "        self.labels = labels\n",
        "\n",
        "    def __getitem__(self, idx):\n",
        "        item = {key: val[idx] for key, val in self.encodings.items()}\n",
        "        item['labels'] = self.labels['input_ids'][idx]\n",
        "        return item\n",
        "\n",
        "    def __len__(self):\n",
        "        return len(self.labels['input_ids'])\n",
        "\n",
        "# Convert the tokenized data into a custom dataset\n",
        "train_dataset = CustomDataset(inputs, labels)\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GCB01hAghjme",
        "outputId": "2f1b4f81-8c07-4229-fa07-2a3b7caf9879"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "Asking to truncate to max_length but no maximum length is provided and the model has no predefined maximum length. Default to no truncation.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "model = prepare_model_for_kbit_training(model)\n",
        "peft_config = LoraConfig(\n",
        "    lora_alpha=16,\n",
        "    lora_dropout=0.1,\n",
        "    r=64,\n",
        "    bias=\"none\",\n",
        "    task_type=\"CAUSAL_LM\",\n",
        "    target_modules=[\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\",\"gate_proj\"]\n",
        ")\n",
        "model = get_peft_model(model, peft_config)"
      ],
      "metadata": {
        "id": "Vz9WPglMiGy-"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "train_dataset[0]"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "OHrcUDxsi_ff",
        "outputId": "4334fada-be22-4f6b-c8fb-eaac705cc2d5"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "{'input_ids': tensor([    1,  2592,  1117,  8714,  1059,  4369,  8798,  1072,  1678,  2003,\n",
              "          1146,  5965,  1040, 10330,  1070, 21826,  1066,  1040,  2955, 29510,\n",
              "         29481,  1029, 20242, 29572,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2]),\n",
              " 'attention_mask': tensor([1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1,\n",
              "         1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
              "         0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0,\n",
              "         0, 0, 0, 0]),\n",
              " 'labels': tensor([    1,  1086,  1449,  1059,  4369,  8798,  1117,  1164, 23761,  5010,\n",
              "         18172, 11495,  1254, 23672,  1054, 15260,  1244, 29482,  1366,  1030,\n",
              "         29491,  1429,  1559,  1410,  1042,  1163,  1040, 10330,  1070, 21826,\n",
              "          1066,  1040,  1029, 20242,  1864,  3528,  5010,  9662,  1163,  8714,\n",
              "          1059,  4369, 15260,  1244, 29482,  1366,  1030,  1228, 17284, 29493,\n",
              "          7674, 29492, 29493,  1072,  1989,  1546,  1032,  8714,  1059,  1210,\n",
              "          1045,  1179,  2244,  6611,  1507,  1358,  7556,  1420, 21826, 29491,\n",
              "          3725,  9662,  7674,  3321, 29493,  3492,  2509,  5010, 23599, 29493,\n",
              "          1072, 28756, 29474,  1040,  7017,  1070,  8551, 29493,  4891, 21826,\n",
              "         29501,  7370,  5893,  5010, 29493, 13866,  4126, 29491,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2,     2,     2,     2,     2,     2,     2,     2,     2,\n",
              "             2,     2])}"
            ]
          },
          "metadata": {},
          "execution_count": 52
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "Da-b0BAkdUlq"
      },
      "execution_count": null,
      "outputs": []
    }
  ]
}